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  29 
Context summary 30 
 31 
Key objective: Patients that are infected with SARS-CoV-2 in the perioperative period are at high 32 
risk of pulmonary complications and death. Health systems have begun to create COVID-19 free 33 
surgical pathways in both separate elective hospitals and major acute hospitals, in which elective 34 
operating room, critical care and inpatient ward areas are not shared with COVID-19 patients. Major 35 
service redesign to provide these pathways is expensive and difficult; data are urgently needed to 36 
inform clinical practice. 37 
 38 
Knowledge generated: Our data demonstrated that postoperative pulmonary complication rates, 39 
SARS-CoV-2 infection rates, and mortality rates were consistency lower for patient within COVID-19 40 
free surgical pathways than in hospitals with no defined pathway. These findings persisted after 41 
risk-adjustment, sensitivity analyses of low risk patients and propensity score matched groups, and 42 
in patients who had a negative preoperative SARS-CoV-2 test. Differences in outcomes were 43 
observed in areas with both high and low incidence of SARS-CoV-2.  44 
 45 
Relevance: As health providers restart elective cancer surgery, they must prevent harm to cancer 46 
patients by investing in dedicated COVID-19 free surgical pathways.  47 
Summary 48 
Purpose: As cancer surgery restarts following the first COVID-19 wave, healthcare providers 49 
urgently require data to determine where elective surgery is best performed. This study aimed to 50 
determine whether COVID-19 free surgical pathways were associated with lower postoperative 51 
pulmonary complication rates than in hospitals with no defined pathway. 52 
Patients & methods: This international multicentre cohort study included patients undergoing 53 
elective surgery for 10 solid cancer types, without preoperative suspicion of SARS-CoV-2. 54 
Participating hospitals included patients from local emergence of SARS-CoV-2 until 19 April 2020. 55 
At the time of surgery, hospitals were defined as having a COVID-19 free surgical pathway 56 
(complete segregation of the operating theatre, critical care and inpatient ward areas) or no defined 57 
pathway (incomplete or no segregation, areas shared with COVID-19 patients). The primary 58 
outcome was 30-day postoperative pulmonary complications (pneumonia, ARDS, unexpected 59 
ventilation).  60 
Results: Of 9171 patients from 447 hospitals in 55 countries, 2481 were operated in COVID-19 free 61 
surgical pathways. Patients undergoing surgery within COVID-19 free surgical pathways were 62 
younger and less comorbid than those in hospitals with no defined pathway, but with similar 63 
proportions of major surgery. After adjustment, pulmonary complication rates were lower with 64 
COVID-19 free surgical pathways (2.2% versus 4.9%, adjusted odds ratio 0.62 [0.44 to 0.86]). This 65 
was consistent in sensitivity analyses for low-risk patients (ASA grade 1/2), propensity-score 66 
matched models, and patients with negative SARS-CoV-2 preoperative tests. The postoperative 67 
SARS-CoV-2 infection rate was also lower in COVID-19 free surgical pathways (2.1% versus 3.6%; 68 
adjusted odds ratio 0.53 [0.36 to 0.76]).  69 
Conclusion: Dedicated COVID-19 free surgical pathways should be established to provide safe 70 
elective cancer surgery during current and before future SARS-CoV-2 outbreaks.  71 
  72 
Introduction 73 
During the initial phases of the SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) 74 
pandemic, an estimated 2.3 million cancer operations worldwide were postponed due to the risk of 75 
in-hospital transmission [1]. Perioperative SARS-CoV-2 is associated with high risk of pulmonary 76 
complications and death [2-5]. Elective surgical activity was reduced to increase critical care 77 
capacity for COVID-19 (coronavirus disease 2019) patients, and to release surgical team members 78 
to support wider hospital responses [6-8]. However, some elective surgery for time-sensitive 79 
conditions continued, prioritising patients with resectable cancers at risk of progression and patients 80 
for whom alternative treatment modalities would be ineffective [9-11].  81 
Before the pandemic, most cancer surgery was performed in hospitals that also supported acute 82 
medical services [12-14]. Such hospitals have admitted COVID-19 patients during the pandemic, 83 
increasing the risk of cross-infection of elective surgery patients. To avoid this, some healthcare 84 
providers have established dedicated COVID-19 free surgical pathways, which deliver surgery, 85 
critical care and inpatient ward care with no shared areas with COVID-19 patients. 86 
Major reorganisation of hospital services to provide COVID-19 free surgical pathways for elective 87 
cancer surgery needs to be justified, as it will carry significant costs for providers and patients. 88 
Information is urgently required to determine whether these pathways reduce adverse postoperative 89 
outcomes. This study aimed to compare the rate of postoperative pulmonary complications after 90 
elective cancer operations in COVID-19 free surgical pathways and hospitals with no defined 91 
pathway. 92 
  93 
Methods 94 
Study design and protocol 95 
This was an international multicentre cohort study of adults undergoing elective cancer surgery. 96 
Local Principal Investigators were responsible for obtaining clinical audit, institutional review or 97 
ethical board approval in line with local and national regulations. Data were collected online and 98 
stored on a secure data server running the Research Electronic Data Capture (REDCap) web 99 
application [15].  100 
Centres and settings 101 
Hospitals performing elective cancer surgery in areas affected by the COVID-19 pandemic were 102 
eligible to participate. Enrolment of consecutive patients commenced from the date of admission of 103 
the first SARS-CoV-2 infected patient to the participating hospital or, in the case of COVID-19 free 104 
surgical pathways in hospitals where no cases had been recorded, to the nearest hospital treating 105 
COVID-19 patients.  106 
Each patient was classified as undergoing surgery within a COVID-19 free surgical pathway or with 107 
no defined pathway. In order to determine whether a COVID-19 free surgical pathway was used, an 108 
assessment was made of the operating room, critical care, and inpatient ward areas where each 109 
patient was treated. Patients were classified as being treated within a COVID-19 free pathway if 110 
there was a policy of complete segregation in all three areas away from COVID-19 patients. 111 
Patients were classified as being treated within no defined pathway if in any one of these areas was 112 
shared with COVID-19 patients. The classification was based on whether there was a policy of 113 
segregation in place rather than whether individual elective patients came in to contact with COVID-114 
19 patients, as asymptomatic SARS-CoV-2 infection is common, so contact with an infected patient 115 
was possible even if this was not known at the time. COVID-19 free surgical pathways could be 116 
provided by hospitals that only provided elective care, including specialised units set up during the 117 
pandemic. Alternatively, they could be provided by acute hospitals that designated separate 118 
COVID-19 free areas and COVID-19 treatment areas, ensuring there were no shared areas. In any 119 
particular hospital, it was possible that some patients were treated within a COVID-19 free surgical 120 
pathway whereas others had no defined pathway (e.g. where a COVID-19 free surgical pathway 121 
was introduced part way through the study inclusion period), and our patient-level classification 122 
captured this. Figure 1 displays examples of COVID-19 free surgical pathways and hospitals with no 123 
defined pathways. 124 
Surgical pathway components 125 
In order to better understand health system responses to the COVID-19 pandemic, additional data 126 
points were introduced on 2 April 2020 to capture data on individual components of the surgical 127 
pathway (operating room, critical care, inpatient ward). These were completed for consecutive 128 
patients after this date. 129 
Patients and procedures  130 
Adult patients (18 years and over) undergoing elective surgery with curative intent for a suspected 131 
cancer were included from emergence of COVID-19 up to 19 April 2020. Patients were identified 132 
preoperatively from multidisciplinary team meeting (or tumour board) lists and the subsequent 133 
operation location identified by the operating surgeon. Patients were followed up to postoperative 134 
day 30, with the day of surgery being day zero. All consecutive patients undergoing eligible surgery 135 
were included (Appendix B). Eligible cancer included colorectal, oesophagogastric, head and neck 136 
(oral, oropharyngeal, laryngeal, hypopharyngeal, salivary, thyroid, paranasal sinus, skin), thoracic 137 
(lung, pleural, mediastinal, chest wall), hepatopancreatobiliary (liver, pancreatic), urological 138 
(prostate, bladder, renal), gynaecological (uterine, ovarian, cervical, vulval, vaginal), breast, 139 
sarcoma (soft-tissue, bony), and intracranial malignancies (Appendix C). Participating centres could 140 
contribute data for either single or multiple cancers dependent on local services and capacity [16]. 141 
Patients who had clinical symptoms consistent with COVID-19 or who were confirmed to have 142 
SARS-CoV-2 infection (by quantitative Reverse Transcription Polymerase Chain Reaction [RT-PCR] 143 
and/or positive imaging by computed tomography (CT) thorax in the 72 hours before surgery) at the 144 
time of surgery were excluded. 145 
Data variables 146 
To account for different tumour grading and staging systems across solid cancers, disease status 147 
was classified as early stage (organ confined, non-nodal, non-metastatic, fully resectable) or 148 
advanced stage (growth beyond organ, nodal, metastatic operated with curative intent). Full 149 
definitions are shown in Appendix C. Grade of surgery was categorised based on the Clinical 150 
Coding & Schedule Development Group as either Minor (minor/intermediate) or Major 151 
(major/complex major) [17, 18]. Preoperative testing was defined as a swab test and/or CT thorax 152 
performed in the 72 hours before surgery in order to confirm SARS-CoV-2 status. 153 
Outcome measures 154 
The primary outcome measure was the rate of postoperative pulmonary complications within 30 155 
days after surgery. This included pneumonia, acute respiratory distress syndrome (ARDS), and/or 156 
unexpected postoperative ventilation (Appendix C). The secondary outcomes were postoperative 157 
SARS-CoV-2 infection and mortality within 30 days after surgery. Postoperative SARS-CoV-2 158 
infection was defined as a positive swab, positive CT thorax, or a clinical diagnosis of symptomatic 159 
COVID-19 in patients for whom a swab test and CT scan were unavailable. 160 
Community SARS-CoV-2 incidence 161 
The community SARS-CoV-2 incidence within each participating hospital's local community was 162 
extracted from World Health Organisation [21], European Centre for Disease Prevention and 163 
Control [22], or US Centre for Disease Control and Prevention (CDC) [23] statistics. SARS-CoV-2 164 
incidence was calculated for two-week windows in March and April 2020 based upon the number of 165 
confirmed SARS-CoV-2 cases at the smallest available administrative level (city, region, or country) 166 
[24]. Hospitals were classified as being in communities with either low (<25 cases per 100,000 167 
population) or high (≥25 cases per 100,000 population) SARS-CoV-2 incidence (Supplementary 168 
Table 1).  169 
Data integrity  170 
Previous international outcomes studies have achieved greater than 95% case ascertainment and 171 
greater than 98% data accuracy during external validation [25]. We identified low volume centres 172 
(pre-defined as ≤5 patients per participating specialty) and asked local Principal Investigators to 173 
confirm case ascertainment against MDT records. If a specialty within a hospital was found to have 174 
incomplete case ascertainment any data entered from this specialty were excluded from analysis.  175 
Statistical analysis 176 
The study was conducted according to STROBE (Strengthening the Reporting of Observational 177 
Studies in Epidemiology) [26] and reported according to SAMPL (Statistical Analyses and Methods 178 
in the Published Literature) [27]. Non-parametric data were summarised with medians and 179 
interquartile ranges and differences between groups were tested using the Mann-Whitney U test. 180 
The χ2 test was used for categorical data. Missing data were included in flowcharts and summary 181 
tables, allowing denominators to remain consistent in calculations.  182 
Bayesian univariable and multivariable mixed effects logistic regression was used to calculate odds 183 
ratios and 95% credible intervals (C.I.). Clinically plausible patient, disease, operation and location 184 
specific factors were selected a priori for inclusion in adjusted analyses, in order to identify 185 
independent predictors of postoperative pulmonary complications (primary outcome). Country was 186 
included as a random effect in both the unadjusted and adjusted models. An exploratory analysis 187 
was conducted of the association between components of the COVID-19 free surgical pathway and 188 
the primary outcome measure. Analyses were carried out using the R Foundation Statistical 189 
Program version 3.1.1 (packages: finalfit, tidyverse, BRMS) [28] (Appendix D). 190 
Sensitivity analyses 191 
We anticipated a selection bias, with lower risk patients being more likely to be treated within 192 
COVID-19 free surgical pathways. To account for this risk of bias, we: (1) explored differences in the 193 
postoperative pulmonary complications stratified by three common risk factors (age, sex, and ASA 194 
grade); (2) performed an sensitivity analysis for pulmonary complications including low risk (ASA 195 
grade 1 or 2) patients only (3) performed propensity score matching using a nearest-neighbour 196 
method including patients within COVID-19 free surgical pathways in a 1:1 ratio with those with no 197 
defined pathway (Appendix D). 198 
In order to exclude a potential confounding effect of pre-symptomatic carriage of SARS-CoV-2 in 199 
the association between hospital type and the primary outcome, we performed a further sensitivity 200 
analysis including only patients with a negative preoperative SARS-CoV-2 swab test. 201 
  202 
Results 203 
Patients and procedures 204 
At the time of this analysis (June 15, 2020), a total 9171 patients from 447 hospitals were included. 205 
These patients were from the United Kingdom (29.2%, 2679 patients), Italy (17.3%, 1583), Spain 206 
(8.3%, 764), United States (6.3%, 574), and a further 51 countries. Overall, 39.2% (3698) of 207 
patients were male, 17.9% (1644) were aged under 50 years, and 8.3% (761) were aged 80 years 208 
or over. Complete baseline patient, disease, and operative characteristics are displayed in Table 1. 209 
27.1% (2481) of patients were operated within COVID-19 free surgical pathways and 72.9% (6689) 210 
with no defined pathway. Patients in COVID-19 free surgical pathways were younger, less 211 
comorbid, and had better performance scores. Major surgery accounted for 75.6% (1866/2481) of 212 
operations in COVID-19 free surgical pathways and 77.7% (5179/6689) where there was no defined 213 
pathway; a full list of operations performed is provided in Supplementary Table 2. The missing data 214 
rates were low (Appendix E). Changes in local SARS-CoV-2 incidence over the study period are 215 
displayed in Supplementary Table 1. 216 
Preoperative testing 217 
Overall, 27.0% of patients (2473/9409) underwent preoperative SARS-CoV-2 testing; 75.9% 218 
(1878/2473) of this was performed using a swab test. The preoperative testing rate was higher in 219 
COVID-19 free surgical pathways versus patients with no defined pathway (39.1% [970] versus 220 
22.5% [1503], p<0.0001).  221 
Postoperative pulmonary complications 222 
The overall 30-day pulmonary complication rate was 4.2% (385/9171), which was lower for patients 223 
within a COVID-19 free surgical pathway than with no defined pathway (2.2% [55/2481] versus 224 
4.9% [329/6689], unadjusted odds ratio (OR) 0.49, 95% credible interval (C.I.) 0.36 to 0.66). After 225 
adjustment, surgery in a COVID-19 free surgical pathway remained associated with a lower 226 
postoperative pulmonary complication rate (adjusted odds ratio (aOR) 0.62, 95% C.I. 0.44 to 0.86). 227 
Older age, male sex, ASA grades 3 to 5, poorer performance status, higher cardiac risk, pre-existing 228 
respiratory disease, advanced disease stage, major surgery, oesophagogastric surgery, and 229 
surgery in high SARS-CoV-2 incidence areas were also associated with greater odds of pulmonary 230 
complications (Figure 2 and Supplementary Table 3). 231 
Sensitivity analyses 232 
Postoperative pulmonary complication rates stratified by age, sex, and ASA grade in hospitals with 233 
and without COVID-19 free surgical pathways are displayed in Figure 3. In a sensitivity analysis 234 
including only low risk patients (N=6489), COVID-19 free surgical pathways remained associated 235 
with reduced odds of pulmonary complications (aOR 0.58, 95% C.I. 0.36 to 0.93, Supplementary 236 
Table 4).  237 
Propensity-score matching created well balanced groups (Supplementary Table 5) with 2449 238 
patients within COVID-19 free surgical pathways matched to 2449 with no defined pathway. After 239 
adjustment, surgery within a COVID-19 free surgical pathway was associated with lower odds of 240 
pulmonary complications (aOR 0.65, 95% C.I. 0.44 to 0.96, Supplementary Table 6).  241 
In a sensitivity analysis including only patients with a negative preoperative SARS-CoV-2 test 242 
(N=2447), again a COVID-19 free surgical pathway was associated with lower pulmonary 243 
complication rates (aOR 0.52, 95% C.I. 0.29 to 0.91, Figure 4 and Supplementary Table 7). 244 
Surgical pathway components 245 
Consecutive data were available for 4505 patients. Of these, 45.6% (2053/4505) were classified as 246 
having a COVID-19 free surgical pathway. Of 2451 patients with no defined pathway, 86.5% 247 
(2120/2451) had an operating room that was shared with COVID-19 patients, 21.5% (526/2451) a 248 
shared critical care, and 59.8% (1466/2451) a shared ward area. Treatment in both a COVID-19 249 
free ward and critical care (aOR: 0.43, 95% C.I. 0.24 to 0.77), or a complete COVID-19 free surgical 250 
pathway (aOR: 0.30, 95% C.I. 0.17 to 0.54) was significantly associated with a lower odds of 251 
pulmonary complications, versus patients treated in shared operating room, critical care, and ward 252 
areas  (Figure 5). 253 
Postoperative SARS-CoV-2 infection  254 
The overall rate of postoperative SARS-CoV-2 infection was 3.2% (291/9171). A majority were 255 
confirmed with a swab test (85.6%, 249/291). The SARS-CoV-2 infection rate was lower in COVID-256 
19 free surgical pathways (2.1%, 53/2481) than with no defined pathway (3.6%, 238/6820; aOR: 257 
0.53, 95% C.I. 0.36 to 0.76). This was consistent in a sensitivity analysis with swab testing only 258 
(aOR: 0.44, 95% C.I. 0.28 to 0.68, Supplementary Table 9), and was consistent across hospitals in 259 
high (3.9% versus 8.2%) and low SARS-CoV-2 incidence areas (1.6% versus 3.1%) respectively 260 
(Table 3). SARS-CoV-2 infection was associated with increased pulmonary complication rates 261 
compared to non-infected patients (33.8% [130/385] versus 1.8% [161/8786]; OR: 29.78, 95% C.I. 262 
22.4 to 39.6).  263 
Postoperative mortality  264 
The overall postoperative mortality rate was 1.5% (134/9115). Mortality was higher in patients with 265 
pulmonary complications (OR: 25.64, 95% C.I. 17.63 to 36.67) and in patients with a SARS-CoV-2 266 
infection (OR: 29.34, 95% C.I. 20.13 to 43.04). It was lower in patients operated in COVID-19 free 267 
surgical pathways (OR: 0.45, 95% C.I. 0.25 to 0.78). Of the 30-day deaths, 49.3% (66/134) were 268 
associated with pulmonary complications and 44.0% (59/134) were associated with SARS-CoV-2 269 
infections (Figure 6). Mortality was higher following pulmonary complications in SARS-CoV-2 270 
patients (30.8%, 40/130) than in non-infected patients with pulmonary complications (10.7%, 271 
26/244).  272 
Discussion 273 
This study identified that postoperative pulmonary complication rates were lower for patients in 274 
COVID-19 free surgical pathways during the SARS-CoV-2 pandemic. Despite a tendency for lower 275 
risk cases to be performed in these pathways, effects persisted after risk adjustment, sensitivity 276 
analyses and propensity score matching. The advantage of COVID-19 free pathways was also seen 277 
in patients with a negative SARS-CoV-2 test preoperatively. Older patients, males, and patients with 278 
cardiorespiratory comorbidities were consistently at greater risk of adverse outcomes. Mortality was 279 
primarily driven by pulmonary complications, which was low in COVID-19 free surgical pathways  280 
and high with postoperative SARS-CoV-2 infection. Overall, these data support major international 281 
redesign of surgical services to provide elective cancer surgery in COVID-19 free surgical pathways. 282 
Whilst the greatest effect size was seen in areas of high SARS-CoV-2 incidence, there was also a 283 
significant difference in outcomes in low incidence areas. Setup of COVID-19 free pathways is 284 
therefore likely to be justified both during the end phases of current lockdowns in preparation for 285 
second waves. 286 
It is likely that differences in SARS-CoV-2 transmission rates are responsible for differences in 287 
pulmonary complications between COVID-19 free surgical pathways and hospitals with no defined 288 
pathway. Firstly, the rate of postoperative SARS-CoV-2 infection was consistently lower in COVID-289 
19 free surgical pathways. Secondly, SARS-CoV-2 infection was associated with a very high rate of 290 
pulmonary complications. Thirdly, the benefit of COVID-19 free pathways was greatest where in 291 
high SARS-CoV-2 incidence areas. Finally, the effect size increased in proportion with the number 292 
of COVID-19 free components of the surgical pathway. The overall preoperative testing rate was 293 
low (27.0%) and testing was not associated with lower pulmonary complication rates in the main 294 
model. Furthermore, in a sensitivity analysis for patients with a negative preoperative swab test, the 295 
benefit of COVID-19 free pathways persisted.  296 
Although we defined COVID-19 free pathways in the protocol, the exact nature varied across this 297 
pragmatic study. Comorbid and elderly patients will still need to undergo surgery in major acute 298 
hospitals due to resource availability (e.g. critical care, interventional radiology and/or multi-specialty 299 
operations), and these hospitals are likely to continue to admit COVID-19 patients. COVID-19 free 300 
pathways must be robustly quality assured within these settings. Detailed evaluations of additional 301 
in-hospital measures to reduce SARS-CoV-2 exposure, including serial preoperative testing, 302 
Personal Protective Equipment, drug prophylaxis, staff testing, and perioperative isolation are still 303 
required. 304 
The overall mortality rate with pulmonary complications (17.2%) is higher than would be expected 305 
when compared pre-pandemic rates [23–28]. Data from elective and emergency surgical patients 306 
has shown a high mortality associated with perioperative SARS-CoV-2 infection which is consistent 307 
with our series [5]. This information should be used routinely as part of informed consent for elective 308 
surgery. 309 
There were limitations to this study. Firstly, the risk of selection bias in COVID-19 free surgical 310 
pathways was accounted for this through risk adjustment and planned sensitivity analyses. Despite 311 
this, COVID-19 free pathways may have been better resourced and there may have been residual 312 
bias. However, establishing COVID-19 free areas did not appear to be determined by resource 313 
availability alone; patients were operated in these pathways in 27 of 37 countries in which five or 314 
more centres participated. Secondly, we included swab, CT, and clinical diagnoses of COVID-19 in 315 
the definition of postoperative SARS-CoV-2 infection, to reflect variable access to testing during 316 
early phases of the pandemic [31]. However, only 14.4% of infected patients had a CT or clinical 317 
diagnosis, minimising the risk of incorrect diagnosis. Thirdly, borderline operable cancers and high-318 
risk patients may not have been offered surgery during the pandemic, so the potential benefits of 319 
COVID-19 free surgical pathways may be even greater for this group [32, 33]. Fourthly, there is a 320 
possibility of incomplete case ascertainment, although we implemented a number of strategies to 321 
minimise this. 322 
COVID-19 free surgical pathways, and entirely separate elective surgery hospital, may lead to 323 
unintended consequences that include reduction in capacity for other health conditions. These 324 
consequences will need to be monitored at a whole system level.   325 
 326 
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Table 1. Patients treated within COVID-19 free surgical pathways and with no defined pathway. 
 
Factor Levels 
COVID-19 free 
surgical pathway 
N=2481 
No defined  
pathway 
N=6689 
P-value 
Age, n (%) 
<50 years 558 (22.5) 1086 (16.2) 
<0.001 
50-59 years 576 (23.2) 1404 (21.0) 
60-69 years 633 (25.5) 1911 (28.6) 
70-79 years 552 (22.2) 1689 (25.3) 
≥80 years 162 (6.5) 599 (9.0) 
Sex, n (%) 
Female 1743 (70.3) 3832 (57.3) 
<0.001 Male 737 (29.7) 2856 (42.7) 
(Missing) 1 1 
BMI, n (%) 
Normal 996 (40.1) 2542 (38.0) 
0.050 
Overweight 796 (32.1) 2091 (31.3) 
Obese 469 (18.9) 1443 (21.6) 
Underweight 53 (2.1) 164 (2.5) 
Missing 167 (6.7) 449 (6.7) 
ASA Grade, n (%) 
ASA grade 1-2 1959 (79.2) 4640 (69.7) 
<0.001 ASA grade 3-5 515 (20.8) 2016 (30.3) 
(Missing) 7 33 
RCRI, n (%) 
0 949 (38.3) 1942 (29.0) 
<0.001 
1 1181 (47.6) 3453 (51.6) 
2 306 (12.3) 1023 (15.3) 
≥3 45 (1.8) 271 (4.1) 
Respiratory comorbidity, n (%) 
No 2249 (90.6) 5929 (88.6) 
0.007 
Yes 232 (9.4) 760 (11.4) 
ECOG Performance Score, n (%) 
0 1657 (67.1) 4087 (62.2) 
<0.001 
1-2 775 (31.4) 2367 (36.0) 
3-4 36 (1.5) 115 (1.8) 
(Missing) 13 120 
Cancer type, n (%) 
Colorectal 437 (17.6) 1873 (28.0) 
<0.001 
Breast 827 (33.3) 1313 (19.6) 
Gynaecological 330 (13.3) 772 (11.5) 
Head or neck 253 (10.2) 884 (13.2) 
Hepatopancreatobilary 161 (6.5) 515 (7.7) 
Intracranial 34 (1.4) 130 (1.9) 
Thoracic 172 (6.9) 385 (5.8) 
Oesophagogastric 75 (3.0) 312 (4.7) 
Sarcoma 118 (4.8) 143 (2.1) 
Urological 74 (3.0) 362 (5.4) 
Disease stage, n (%) 
Early stage 1822 (73.5) 4707 (70.4) 
0.004 Advanced stage 657 (26.5) 1978 (29.6) 
(Missing) 2 4 
Booking type, n (%) 
Daycase 206 (8.4) 524 (7.9) 
0.493 Inpatient 2259 (91.6) 6117 (92.1) 
(Missing) 16 48 
Anaesthetic, n (%) 
Regional/local anaesthetic 99 (4.0) 388 (5.8) 
0.001 
General anaesthetic 2382 (96.0) 6301 (94.2) 
Operation grade, n (%) 
Minor 601 (24.4) 1488 (22.3) 
0.042 Major 1866 (75.6) 5179 (77.7) 
(Missing) 14 22 
Preoperative testing, n (%) 
Not screened 1511 (60.9) 5186 (77.5) 
<0.001 
Screened 970 (39.1) 1503 (22.5) 
Community SARS-Cov-2 risk, n (%) 
Low 1948 (78.5) 6079 (90.9) 
<0.001 
High 533 (21.5) 610 (9.1) 
 
COVID-19=Coronavirus disease 2019. ASA=American Society of Anaesthesiologists. RCRI=Revised Cardiac Risk Index. ECOG=Eastern 
Cooperative Oncology Group. Please see Appendix C for full definitions. Percentages calculated as a proportion of column total. P-values 
calculated using X2 test. 
Table 2. Comparison of patients with and without postoperative pulmonary complications. 
 
Factor Levels 
No pulmonary 
Complications 
N=8786 
Pulmonary 
Complications 
N=385 
P-value 
Age, n (%) 
<50 years 1624 (18.5) 20 (5.2) 
<0.001 
50-59 years 1929 (22.0) 51 (13.2) 
60-69 years 2427 (27.6) 118 (30.6) 
70-79 years 2096 (23.9) 145 (37.7) 
≥80 years 710 (8.1) 51 (13.2) 
Sex, n (%) 
Female 5455 (62.1) 121 (31.4) 
<0.001 Male 3329 (37.9) 264 (68.6) 
(Missing) 2 0  
BMI, n (%) 
Normal 3403 (38.7) 135 (35.1) 
0.100 
Overweight 2771 (31.5) 117 (30.4) 
Obese 1827 (20.8) 85 (22.1) 
Underweight 207 (2.4) 10 (2.6) 
Missing 578 (6.6) 38 (9.9) 
ASA Grade, n (%) 
ASA grade 1-2 6408 (73.3) 192 (50.1) 
<0.001 ASA grade 3-5 2340 (26.7) 191 (49.9) 
(Missing) 38  2  
Current smoker, n (%) 
No 7843 (89.3) 321 (83.4) 
<0.001 
Yes 943 (10.7) 64 (16.6) 
Pre-existing respiratory condition, n (%) 
No 7873 (89.6) 306 (79.5) 
<0.001 
Yes 913 (10.4) 79 (20.5) 
RCRI, n (%) 
0 2859 (32.5) 33 (8.6) 
<0.001 
1 4413 (50.2) 221 (57.4) 
2 1240 (14.1) 89 (23.1) 
≥3 274 (3.1) 42 (10.9) 
ECOG Performance Score, n (%) 
0 5597 (64.7) 148 (38.6) 
<0.001 
1-2 2922 (33.8) 220 (57.4) 
3-4 136 (1.6) 15 (3.9) 
(Missing) 131  2 
Cancer type, n (%) 
Colorectal 2176 (24.8) 134 (34.8) 
<0.001 
Breast 2132 (24.3) 9 (2.3) 
Gynaecological 1082 (12.3) 20 (5.2) 
Head or neck 1096 (12.5) 41 (10.6) 
Hepatopancreatobilary 626 (7.1) 50 (13.0) 
Intracranial 162 (1.8) 2 (0.5) 
Thoracic 516 (5.9) 41 (10.6) 
Oesophagogastric 322 (3.7) 65 (16.9) 
Sarcoma 253 (2.9) 8 (2.1) 
Urological 421 (4.8) 15 (3.9) 
Disease stage, n (%) 
Early stage 6308 (71.8) 222 (57.7) 
<0.001 Advanced stage 2472 (28.2) 163 (42.3) 
(Missing) 6 0  
Booking type, n (%) 
Daycase 729 (8.4) 1 (0.3) 
<0.001 Inpatient 7994 (91.6) 383 (99.7) 
(Missing) 63  1  
Anaesthetic, n (%) 
Regional/local anaesthetic 458 (5.2) 29 (7.5) 
0.061 
General anaesthetic 8328 (94.8) 356 (92.5) 
Operation grade, n (%) 
Minor 2062 (23.6) 27 (7.0) 
<0.001 Major 6689 (76.4) 356 (93.0) 
(Missing) 35 2 
Preoperative testing, n (%) 
Not tested 6412 (73.0) 286 (74.3) 
0.612 
Tested 2374 (27.0) 99 (25.7) 
Hospital type, n (%) 
COVID-19 free surgical pathway 2426 (27.6) 55 (14.3) 
<0.001 No defined pathway 6360 (72.4) 329 (85.7) 
(Missing) 0 1  
Community SARS-Cov-2 risk, n (%) 
Low 7694 (87.6) 334 (86.8) 
0.692 
High 1092 (12.4) 51 (13.2) 
 
COVID-19=Coronavirus disease 2019. ASA=American Society of Anaesthesiologists. RCRI=Revised Cardiac Risk Index. ECOG=Eastern Cooperative 
Oncology Group. Please see Appendix C for full definitions. Percentages calculated as a proportion of row total. P-values calculated using X2 test. 
Table 3. Clinical outcomes for patients undergoing surgery in a COVID-19 free surgical pathway 
versus hospitals with no defined pathway, split by low versus high community SARS-CoV-2 
incidence. 
  
 
 COVID-19 free surgical 
pathway 
N=2481 
No defined  
pathway 
N=6689 
Low community SARS-CoV-2 
incidence area 
Pulmonary 
complications 
2.2% 
(1.6% - 3.0%) 
43/1948 
4.8% 
(4.2%-5.3%) 
290/6079 
SARS-CoV-2 infection 
1.6% 
(1.1%-2.3%) 
32/1948 
3.1% 
(2.7%-3.6%) 
188/6079 
30-day mortality 
0.7% 
(0.4-1.2%) 
14/1939 
1.7% 
(1.4%-2.1%) 
103/6041 
30-day mortality and 
SARS-CoV-2 infection 
0.01% 
(0.001%-0.04%) 
2/1939 
0.7% 
(0.5%-1.0%) 
44/6041 
High community SARS-CoV-2 
incidence area 
Pulmonary 
complications 
2.3% 
(1.2-3.9%) 
12/533 
6.4% 
(4.6%-8.6%) 
39/610 
SARS-CoV-2 infection 
3.9% 
(2.5%-6.0%) 
21/533 
8.2% 
(6.1%-10.7%) 
50/610 
30-day mortality 
0.9% 
(0.3%-2.2%) 
5/527 
2.1% 
(1.1%-3.6%) 
13/608 
30-day mortality and 
SARS-CoV-2 infection 
0.8% 
(0.2%-1.9%) 
4/527 
1.4% 
(0.7%-2.8%) 
9/608 
 
Pulmonary complications were defined as pneumonia, acute respiratory distress syndrome (ARDS), and/or unexpected postoperative ventilation. 
SARS-CoV-2=Severe acute respiratory syndrome coronavirus 2. Areas defined as ‘high’ (30-day cumulative notification rate of ≥25 cases per 
100,000 population) or ‘low’ (14-day cumulative notification rate of <25 cases per 100,000 population) according to European Centre for Disease 
Control and Prevention reporting criteria during two-week periods in March and April 2020. Proportions are presented as mean averages with 95% 
confidence intervals calculated using the Pearson-Klopper exact method (package: binom.confint). 
 
  
Figure 1. Differences between hospitals with a COVID-19 free surgical pathway and hospitals with no defined pathway 
 Figure 2. Factors associated with postoperative pulmonary complications after elective cancer surgery 
 
Included data from 8971 patients with complete data. See Supplementary Table 3 for full model. COVID-19=Coronavirus disease 2019. ASA=American 
Society of Anaesthesiologists. RCRI=Revised Cardiac Risk Index. ECOG=Eastern Cooperative Oncology Group. Please see Appendix C for full 
definitions. 
 
 
 
  
Figure 3. Proportion of patient with postoperative pulmonary complications across key risk groups 
within COVID-19 free surgical pathways versus hospitals with no defined pathway. 
 
 
 
 
ASA=American Society of Anaesthesiologists. Proportions are given as percentage of total patients operated in COVID-19 free surgical 
pathways (n=2552, blue) or hospitals with no defined pathway (n=6886, red). Male gender and ASA grade 3-5 were seen consistently to 
increase the rate of pulmonary complications for patients in COVID-19 free surgical pathways and where no pathway was defined. 
 
  
Figure 4. Factors associated with postoperative pulmonary complications after elective cancer surgery in 
patients with a negative preoperative SARS-CoV-2 swab test. 
 
 
 
Included data from 2447 patients with complete data. See Supplementary Table 7 for full model. COVID-19=Coronavirus disease 2019. ASA=American 
Society of Anaesthesiologists. RCRI=Revised Cardiac Risk Index. ECOG=Eastern Cooperative Oncology Group. Please see Appendix C for full 
definitions. 
Figure 5. Association of components of a COVID-19 free surgical pathway with postoperative pulmonary complications. 
 
 
 
Included data from 4787 patients with complete data. For each patient, the operating room, critical care (where applicable) and ward areas were defined as COVID-19 free or shared with patients treated for COVID-19. 
COVID-19=Coronavirus disease 2019. ASA=American Society of Anaesthesiologists. RCRI=Revised Cardiac Risk Index. ECOG=Eastern Cooperative Oncology Group. Please see Appendix C for full definitions. 
 
Figure 6. Rates of pulmonary complications, SARS-CoV-2, and death in COVID-19 free surgical pathways versus hospitals with no defined pathway. 
 
 
 
Pulmonary complications were defined as pneumonia, acute respiratory distress syndrome (ARDS), and/or unexpected postoperative ventilation. SARS-CoV-2=Severe acute respiratory syndrome coronavirus 2. 
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Supplementary Table 1. Community risk of SARS-CoV-2 transmission in areas of participating hospitals 
 
Hospital details Patient operation location Population data Data available 
Community SARS-CoV-2 
March (Week 1-2) 
Community SARS-CoV-2 
March (Week 3-4) 
Community SARS-CoV-2 
April (Week 1-2) 
Community SARS-CoV-2 
April (Week 1-2) 
Hospital name Country City 
COVID-19 free 
surgical 
pathway 
No defined 
pathway City Region Country 
 Cases incidence Risk Cases incidence Risk Cases incidence Risk Cases incidence Risk 
 Sanatorio Allende Argentina Cordoba 4 (13.8) 25 (86.2)   3308876   Region 3 0.1 Low 93 2.8 Low 136 4.1 Low 50 1.5 Low 
 Hospital Italiano de Buenos 
Aires 
Argentina 
Buenos 
Aires 
  8 (100.0) 2891082     City 32 1.1 Low 355 12.3 Low 454 15.7 Low 724 25.0 High 
 Sanatorio 9 de julio SA Argentina Tucuman   6 (100.0)   1448188   Region 0 0.0 Low 16 1.1 Low 14 1.0 Low 8 0.6 Low 
 Nairi Medical Center Armenia Yerevan 3 (100.0)       2951745 Country 28 0.9 Low 543 18.4 Low 588 19.9 Low 989 33.5 High 
 Flinders Medical Centre Australia Adelaide 4 (17.4) 19 (82.6)   1756494   Region 17 1.0 Low 285 16.2 Low 128 7.3 Low 5 0.3 Low 
 Royal Adelaide Hospital Australia Adelaide 1 (3.2) 30 (96.8)   1756494   Region 17 1.0 Low 285 16.2 Low 128 7.3 Low 5 0.3 Low 
 Royal Brisbane and Women's 
Hospital 
Australia Brisbane 1 (1.8) 54 (98.2)   5115451   Region 53 1.0 Low 681 13.3 Low 256 5.0 Low 34 0.7 Low 
 Canberra Hospital Australia Canberra 1 (100.0)     428060   Region 1 0.2 Low 79 18.5 Low 23 5.4 Low 3 0.7 Low 
 Coffs Harbour Health Campus Australia 
Coffs 
Harbour 
NSW 
2 (50.0) 2 (50.0)   8117976   Region 128 1.6 Low 1899 23.4 Low 854 10.5 Low 130 1.6 Low 
 St Vincent's Hospital Australia 
Melbourn
e 
12 (42.9) 16 (57.1)   6629870   Region 53 0.8 Low 860 13.0 Low 382 5.8 Low 62 0.9 Low 
 Fiona Stanley Hospital Australia Perth 3 (12.5) 21 (87.5)   2630557   Region 16 0.6 Low 346 13.2 Low 168 6.4 Low 19 0.7 Low 
 Lifehouse Australia Sydney 5 (100.0)     8117976   Region 128 1.6 Low 1899 23.4 Low 854 10.5 Low 130 1.6 Low 
 Princess Alexandra Hospital Australia Brisbane   7 (100.0)   5115451   Region 53 1.0 Low 681 13.3 Low 256 5.0 Low 34 0.7 Low 
 Logan Hospital Australia Brisbane   
17 
(100.0) 
  5115451   Region 53 1.0 Low 681 13.3 Low 256 5.0 Low 34 0.7 Low 
 QEII jubilee Hospital Australia Brisbane   8 (100.0)   5115451   Region 53 1.0 Low 681 13.3 Low 256 5.0 Low 34 0.7 Low 
 Cairns Hospital Australia Cairns   1 (100.0)   5115451   Region 53 1.0 Low 681 13.3 Low 256 5.0 Low 34 0.7 Low 
 Lismore Base Hospital Australia Lismore   9 (100.0)   8117976   Region 128 1.6 Low 1899 23.4 Low 854 10.5 Low 130 1.6 Low 
 Calvary Mater Newcastle Australia 
Newcastl
e 
  
10 
(100.0) 
  8117976   Region 128 1.6 Low 1899 23.4 Low 854 10.5 Low 130 1.6 Low 
 John Hunter Hospital Australia 
Newcastl
e 
  
40 
(100.0) 
  8117976   Region 128 1.6 Low 1899 23.4 Low 854 10.5 Low 130 1.6 Low 
 Gold Coast University Hospital Australia Southport   
17 
(100.0) 
  5115451   Region 53 1.0 Low 681 13.3 Low 256 5.0 Low 34 0.7 Low 
 Concord Repatriation General 
Hospital 
Australia Sydney   5 (100.0)   8117976   Region 128 1.6 Low 1899 23.4 Low 854 10.5 Low 130 1.6 Low 
 Kardinal Schwarzenberg 
Klinikum 
Austria 
Schwarza
ch im 
Pongau 
2 (100.0)       8902600 Country 855 9.6 Low 9114 102.4 High 4347 48.8 High 1103 12.4 Low 
 Landeskrankenhaus Feldkirch Austria Feldkirch   1 (100.0)     8902600 Country 855 9.6 Low 9114 102.4 High 4347 48.8 High 1103 12.4 Low 
 Medical University of Innsbruck Austria Innsbruck   
86 
(100.0) 
    8902600 Country 855 9.6 Low 9114 102.4 High 4347 48.8 High 1103 12.4 Low 
 Paracelsus Medical University 
Salzburg 
Austria Salzburg   
10 
(100.0) 
    8902600 Country 855 9.6 Low 9114 102.4 High 4347 48.8 High 1103 12.4 Low 
 Leyla Medical Centerl Azerbaijan Baku 1 (100.0)       10027874 Country 22 0.2 Low 273 2.7 Low 955 9.5 Low 551 5.5 Low 
 Queen Elizabeth Hospital Barbados 
Bridgeto
wn 
4 (100.0)       277821 Country 0 0.0 Low 33 11.9 Low 39 14.0 Low 8 2.9 Low 
 AZ Delta Belgium Roeselare   1 (100.0)   6589069   Region 971 14.7 Low 8721 132.4 High 11889 180.4 High 6129 93.0 High 
 Hospital Geral de Pirajussara Brazil 
Taboão 
da Serra 
  3 (100.0)   41262199   Region 134 0.3 Low 2203 5.3 Low 8704 21.1 Low 
1765
5 
42.8 High 
 St. Mary's Hospital Canada Montreal 6 (100.0)     8164361   Region 35 0.4 Low 4126 50.5 High 10698 131.0 High 
1267
8 
155.3 High 
 London Health Sciences Centre 
and St Josephs Health Care 
London 
Canada London   1 (100.0)   13448494   Region 134 1.0 Low 1821 13.5 Low 6481 48.2 High 7740 57.6 High 
 Jewish General Hospital Canada Montreal   
16 
(100.0) 
  8164361   Region 35 0.4 Low 4126 50.5 High 10698 131.0 High 
1267
8 
155.3 High 
 McGill University Health Center Canada Montreal   3 (100.0)   8164361   Region 35 0.4 Low 4126 50.5 High 10698 131.0 High 
1267
8 
155.3 High 
 The Ottawa Hospital Canada Ottawa   9 (100.0)   13448494   Region 134 1.0 Low 1821 13.5 Low 6481 48.2 High 7740 57.6 High 
 Saint John Regional Hospital Canada Saint John   1 (100.0)   747101   Region 6 0.8 Low 64 8.6 Low 47 6.3 Low 1 0.1 Low 
 Clínica Universitaria de 
Concepción 
Chile 
Concepci
ón 
6 (100.0)     1557414   Region 3 0.2 Low 213 13.7 Low 326 20.9 Low 185 11.9 Low 
 Clínica san diego Colombia Bogotá 9 (100.0)       50372424 Country 45 0.1 Low 861 1.7 Low 2199 4.4 Low 3402 6.8 Low 
 Subred Sur Occidente de 
Kennedy (Hospital de Kennedy) 
Colombia Bogota   1 (100.0)     50372424 Country 45 0.1 Low 861 1.7 Low 2199 4.4 Low 3402 6.8 Low 
 University Hospital Center Croatia Rijeka   7 (100.0)     4076246 Country 42 1.0 Low 818 20.1 Low 874 21.4 Low 1209 29.7 High 
 Zadar General Hospital Croatia Zadar   4 (100.0)     4076246 Country 42 1.0 Low 818 20.1 Low 874 21.4 Low 1209 29.7 High 
 Nicosia General Hospital Cyprus Nicosia   
13 
(100.0) 
    1189265 Country 33 2.8 Low 229 19.3 Low 453 38.1 High 135 11.4 Low 
 Hospital & Oncological Centre 
Novy Jicin 
Czech 
Republic 
Novy Jicin   7 (100.0)     10649800 Country 298 2.8 Low 3010 28.3 High 2993 28.1 High 1381 13.0 Low 
 Slezská nemocnice v Opavě, p.o. 
Czech 
Republic 
Opava   1 (100.0)     10649800 Country 298 2.8 Low 3010 28.3 High 2993 28.1 High 1381 13.0 Low 
 University Hospital Ostrava 
Czech 
Republic 
Ostrava   
17 
(100.0) 
    10649800 Country 298 2.8 Low 3010 28.3 High 2993 28.1 High 1381 13.0 Low 
 Aarhus University Hospital Denmark Aarhus   3 (100.0)     5822763 Country 872 15.0 Low 2164 37.2 High 3837 65.9 High 2480 42.6 High 
 Bispebjerg Hospital Denmark 
Copenhag
en 
  
19 
(100.0) 
    5822764 Country 872 15.0 Low 2164 37.2 High 3837 65.9 High 2480 42.6 High 
 Alexandria Main University 
Hospital 
Egypt 
Alexandri
a 
18 (100.0)       
10007548
0 
Country 93 0.1 Low 616 0.6 Low 1795 1.8 Low 3032 3.0 Low 
 Alexandria Medical Research 
Institute 
Egypt 
Alexandri
a 
7 (100.0)       
10007548
0 
Country 93 0.1 Low 616 0.6 Low 1795 1.8 Low 3032 3.0 Low 
 MISR Cancer Center Egypt Al Jizah 6 (42.9) 8 (57.1)     
10007548
0 
Country 93 0.1 Low 616 0.6 Low 1795 1.8 Low 3032 3.0 Low 
 Assiut University Hospital Egypt Assiut   3 (100.0)     
10007548
0 
Country 93 0.1 Low 616 0.6 Low 1795 1.8 Low 3032 3.0 Low 
 National Cancer Institute Egypt Cairo   
24 
(100.0) 
    
10007548
0 
Country 93 0.1 Low 616 0.6 Low 1795 1.8 Low 3032 3.0 Low 
 Al Azhar University Hospitals Egypt Cairo   3 (100.0)     
10007548
0 
Country 93 0.1 Low 616 0.6 Low 1795 1.8 Low 3032 3.0 Low 
 National Liver Institute, 
Menoufia University 
Egypt 
Shibin 
Elkom 
  
12 
(100.0) 
    
10007548
0 
Country 93 0.1 Low 616 0.6 Low 1795 1.8 Low 3032 3.0 Low 
 Maddawalabu University Goba 
Referral Hospital 
Ethiopia Goba   1 (100.0)     
10922441
4 
Country 4 0.0 Low 22 0.0 Low 59 0.1 Low 46 0.0 Low 
 Oulu University Hospital FInland Oului 1 (2.6) 37 (97.4)     5526774 Country 333 6.0 Low 1344 24.3 Low 1993 36.1 High 1583 28.6 High 
 Länsi-Pohja Central Hospital Finland Kemi   
12 
(100.0) 
    5526774 Country 333 6.0 Low 1344 24.3 Low 1993 36.1 High 1583 28.6 High 
 institut mutualiste montsouris France Paris 1 (2.8) 35 (97.2)     67076000 Country 
532
3 
7.9 Low 46705 69.6 High 54078 80.6 High 
2337
5 
34.8 High 
 HUS, Pole Hépato-Digestif / 
IHU-Strasbourg 
France 
Strasbour
g 
3 (23.1) 10 (76.9)     67076000 Country 
532
3 
7.9 Low 46705 69.6 High 54078 80.6 High 
2337
5 
34.8 High 
 CHU Amiens France Amiens   
21 
(100.0) 
    67076000 Country 
532
3 
7.9 Low 46705 69.6 High 54078 80.6 High 
2337
5 
34.8 High 
 Centre Hospitalier Avignon France Avignon   7 (100.0)     67076000 Country 
532
3 
7.9 Low 46705 69.6 High 54078 80.6 High 
2337
5 
34.8 High 
 CHU Besançon France Besancon   
10 
(100.0) 
    67076000 Country 
532
3 
7.9 Low 46705 69.6 High 54078 80.6 High 
2337
5 
34.8 High 
 CHU Lille France Lille   
28 
(100.0) 
    67076000 Country 
532
3 
7.9 Low 46705 69.6 High 54078 80.6 High 
2337
5 
34.8 High 
 CHU Limoges France Limoges   
32 
(100.0) 
    67076000 Country 
532
3 
7.9 Low 46705 69.6 High 54078 80.6 High 
2337
5 
34.8 High 
 Chu de Nantes Neurochirurgie France Nantes   1 (100.0)     67076000 Country 
532
3 
7.9 Low 46705 69.6 High 54078 80.6 High 
2337
5 
34.8 High 
 Hôpital Cochin - APHP France Paris   1 (100.0)     67076000 Country 
532
3 
7.9 Low 46705 69.6 High 54078 80.6 High 
2337
5 
34.8 High 
 Hopital Lyon Sud France 
Pierre 
Bénite 
  
11 
(100.0) 
    67076000 Country 
532
3 
7.9 Low 46705 69.6 High 54078 80.6 High 
2337
5 
34.8 High 
 CHU Rennes - General Surgery France Rennes   3 (100.0)     67076000 Country 
532
3 
7.9 Low 46705 69.6 High 54078 80.6 High 
2337
5 
34.8 High 
 Hia Begin France St Mande   3 (100.0)     67076000 Country 
532
3 
7.9 Low 46705 69.6 High 54078 80.6 High 
2337
5 
34.8 High 
 CHRU NANCY France 
Vandoeuv
re-lès-
Nancy 
  1 (100.0)     67076000 Country 
532
3 
7.9 Low 46705 69.6 High 54078 80.6 High 
2337
5 
34.8 High 
 University Hospital Carl Gustav 
Carus Dresden 
Germany dresden 1 (1.5) 65 (98.5)   4077937   Region 130 3.2 Low 1752 43.0 High 1937 47.5 High 742 18.2 Low 
 Heilig Geist Hospital Germany Bensheim   5 (100.0)   6243262   Region 286 4.6 Low 2997 48.0 High 3064 49.1 High 1957 31.3 High 
 University Hospital Giessen and 
Marburg 
Germany Giessen   2 (100.0)   6243262   Region 286 4.6 Low 2997 48.0 High 3064 49.1 High 1957 31.3 High 
 University Hospital Goettingen / 
Universitätsmedizin Goettingen 
Germany 
Goettinge
n 
  
11 
(100.0) 
  7962775   Region 287 3.6 Low 3776 47.4 High 3956 49.7 High 2048 25.7 High 
 University Medical Center 
Hamburg-Eppendorf 
Germany Hamburg   
31 
(100.0) 
1822445     City 162 8.9 Low 2029 111.3 High 1678 92.1 High 693 38.0 High 
 Nordstadt Hospital Germany Hannover   6 (100.0)   7962775   Region 287 3.6 Low 3776 47.4 High 3956 49.7 High 2048 25.7 High 
 Universitätsmedizin der 
Johannes Gutenberg-Universität 
Germany Mainz   1 (100.0)   4084800   Region 168 4.1 Low 2558 62.6 High 2278 55.8 High 1025 25.1 High 
 Klinikum Rechts der Isar TUM 
School of Medicine 
Germany Munich   
10 
(100.0) 
  13076721   Region 871 6.7 Low 13924 106.5 High 19484 149.0 High 7786 59.5 High 
 LMU Klinikum Germany Munich   
31 
(100.0) 
  13076721   Region 871 6.7 Low 13924 106.5 High 19484 149.0 High 7786 59.5 High 
 Ludwig Maximilian University of 
Munich 
Germany Munich   8 (100.0)   13076721   Region 871 6.7 Low 13924 106.5 High 19484 149.0 High 7786 59.5 High 
 RoMed Klinikum Rosenheim Germany 
Rosenhei
m 
  
27 
(100.0) 
  13076721   Region 871 6.7 Low 13924 106.5 High 19484 149.0 High 7786 59.5 High 
 University Hospital Halle (Saale) Germany Saale   
25 
(100.0) 
  2208321   Region 47 2.1 Low 633 28.7 High 543 24.6 Low 326 14.8 Low 
 University Hospital Tuebingen Germany 
Tuebinge
n 
  
31 
(100.0) 
  11023424   Region 813 7.4 Low 11507 104.4 High 12706 115.3 High 6569 59.6 High 
 Alexandra General Hospital Greece Athens 10 (100.0)       10724599 Country 324 3.0 Low 983 9.2 Low 878 8.2 Low 399 3.7 Low 
 Henry Dunant Hospital Center Greece Athens 5 (100.0)       10724599 Country 324 3.0 Low 983 9.2 Low 878 8.2 Low 399 3.7 Low 
 Naval And Veterans Hospital Greece Athens 1 (100.0)       10724599 Country 324 3.0 Low 983 9.2 Low 878 8.2 Low 399 3.7 Low 
 University Hospital of Heraklion 
Crete and Interclinic Hospital of 
Crete 
Greece 
Heraklion 
Crete 
13 (92.9) 1 (7.1)     10724599 Country 324 3.0 Low 983 9.2 Low 878 8.2 Low 399 3.7 Low 
 Papageorgiou General Hospital Greece 
Thessalon
iki 
6 (100.0)       10724599 Country 324 3.0 Low 983 9.2 Low 878 8.2 Low 399 3.7 Low 
 Aretaieion Hospital Greece Athens   
26 
(100.0) 
    10724599 Country 324 3.0 Low 983 9.2 Low 878 8.2 Low 399 3.7 Low 
 Attikon University General 
Hospital 
Greece Athens   
19 
(100.0) 
    10724599 Country 324 3.0 Low 983 9.2 Low 878 8.2 Low 399 3.7 Low 
 Evaggelismos General Hospital Greece Athens   3 (100.0)     10724599 Country 324 3.0 Low 983 9.2 Low 878 8.2 Low 399 3.7 Low 
 Laiko University Hospital Greece Athens   
15 
(100.0) 
    10724599 Country 324 3.0 Low 983 9.2 Low 878 8.2 Low 399 3.7 Low 
 General University Hospital of 
Larissa 
Greece Larrisa   8 (100.0)     10724599 Country 324 3.0 Low 983 9.2 Low 878 8.2 Low 399 3.7 Low 
 George Papanikolaou General 
Hospital of Thessaloniki 
Greece 
Thessalon
iki 
  
20 
(100.0) 
    10724599 Country 324 3.0 Low 983 9.2 Low 878 8.2 Low 399 3.7 Low 
 Queen Mary Hospital 
Hong 
Kong SAR, 
China 
Pok Fu 
Lam 
  
12 
(100.0) 
    7482500 Country 50 0.7 Low 566 7.6 Low 303 4.0 Low 21 0.3 Low 
 Prince of Wales Hospital 
Hong 
Kong SAR, 
China 
Sha Tin   
69 
(100.0) 
    7482500 Country 50 0.7 Low 566 7.6 Low 303 4.0 Low 21 0.3 Low 
 National Institute of Oncology Hungary Budapest 1 (100.0)   1752286     City 
107.
5 
6.1 Low 107.5 6.1 Low 555 31.7 High 598 34.1 High 
 Szent Borbála Kórház Hungary 
Tatabány
a 
13 (44.8) 16 (55.2)   299110   Region 6 2.0 Low 6 2.0 Low 8 2.7 Low 81 27.1 High 
 Sher-i-Kashmir Institute of 
Medical Sciences 
India Srinagar   1 (100.0)   12258433   Region 2 0.0 Low 52 0.4 Low 224 1.8 Low 303 2.5 Low 
 SMHS HOSPITAL, Government 
Medical College 
India Srinagar   1 (100.0)   12258433   Region 2 0.0 Low 52 0.4 Low 224 1.8 Low 303 2.5 Low 
 South Infirmary Victoria 
University Hospital 
Ireland Cork 8 (100.0)     542868   Region 48 8.8 Low 224 41.3 High 673 124.0 High 211 38.9 High 
 Connolly Hospital 
Blanchardstown 
Ireland Dublin 1 (33.3) 2 (66.7)   1345402   Region 129 9.6 Low 1709 127.0 High 4729 351.5 High 3750 278.7 High 
 St. James's Hospital Ireland Dublin 38 (66.7) 19 (33.3)   1345402   Region 129 9.6 Low 1709 127.0 High 4729 351.5 High 3750 278.7 High 
 St Vincent's University Hospital Ireland Dublin 3 (100.0)     1345402   Region 129 9.6 Low 1709 127.0 High 4729 351.5 High 3750 278.7 High 
 Cork University Hospital Ireland Cork   
16 
(100.0) 
  542868   Region 48 8.8 Low 224 41.3 High 673 124.0 High 211 38.9 High 
 Beaumont Hospital Ireland Dublin   1 (100.0)   1345402   Region 129 9.6 Low 1709 127.0 High 4729 351.5 High 3750 278.7 High 
 University Hospital Galway Ireland Galway   
11 
(100.0) 
  258058   Region 12 4.7 Low 79 30.6 High 175 67.8 High 94 36.4 High 
 University Hospital Limerick Ireland Limerick   5 (100.0)   194899   Region 14 7.2 Low 80 41.0 High 249 127.8 High 221 113.4 High 
 University Hospital Waterford Ireland 
Waterfor
d 
  5 (100.0)   116176   Region 7 6.0 Low 32 27.5 High 64 55.1 High 37 31.8 High 
 Santa Maria degli Angeli Italy Adria 10 (100.0)   244062     City 27 11.1 Low 109 44.7 High 155 63.5 High 136 55.7 High 
 University Hospital Umberto Italy Ancona 5 (26.3) 14 (73.7) 482886     City 267 55.3 High 849 175.8 High 531 110.0 High 163 33.8 High 
 Centro di Riferimento 
Oncologico di Aviano (CRO) 
IRCCS 
Italy Aviano 6 (100.0)   312794     City 42 13.4 Low 363 116.1 High 152 48.6 High 77 24.6 Low 
 Maggiore Hospital Italy Bologna 17 (65.4) 9 (34.6) 1017196     City 228 22.4 Low 1710 168.1 High 1440 141.6 High 1036 101.8 High 
 S.Orsola-Malpighi Hospital Italy Bologna 57 (32.2) 
120 
(67.8) 
1017196     City 228 22.4 Low 1710 168.1 High 1440 141.6 High 1036 101.8 High 
 IRCCS Istituto Ortopedico Rizzoli Italy Bologna 21 (100.0)   1017196     City 228 22.4 Low 1710 168.1 High 1440 141.6 High 1036 101.8 High 
 Azienda Ospedaliera 
Universitaria Careggi 
Italy Firenze 24 (39.3) 37 (60.7) 1012388     City 157 15.5 Low 925 91.4 High 1285 126.9 High 748 73.9 High 
 IRCCS Ospedale Policlinico San 
Martino 
Italy Genoa 2 (2.1) 94 (97.9) 862175     City 274 31.8 High 821 95.2 High 2392 277.4 High 1129 130.9 High 
 P.O."Vito Fazzi" Italy Lecce 2 (4.4) 43 (95.6) 802807     City 38 4.7 Low 265 33.0 High 123 15.3 Low 61 7.6 Low 
 Fondazione IRCCS Istituto 
Nazionale dei Tumori 
Italy Milano 441 (99.8) 1 (0.2) 3259835     City 
172
0 
52.8 High 7161 219.7 High 5764 176.8 High 4662 143.0 High 
 Istituto Europeo Oncologico Italy Milan 3 (100.0)   3259835     City 
172
0 
52.8 High 7161 219.7 High 5764 176.8 High 4662 143.0 High 
 Colorectal Surgical Oncology 
Unit - Istituto Nazionale Tumori 
Fondazione, Pascale-I.R.C.C.S. 
Italy naples 1 (100.0)   3128700     City 175 5.6 Low 865 27.6 High 973 31.1 High 397 12.7 Low 
 HPB Surgical Oncology Unit - 
Istituto Nazionale Tumori 
Fondazione, Pascale-I.R.C.C.S. 
Italy naples 10 (100.0)   3128700     City 175 5.6 Low 865 27.6 High 973 31.1 High 397 12.7 Low 
 Ospedale S. Leonardo - ASL 
Napoli 3 sud, Castellammare di 
Stabia 
Italy Naples 1 (33.3) 2 (66.7) 3128700     City 175 5.6 Low 865 27.6 High 973 31.1 High 397 12.7 Low 
 Arcispedale Santa Maria Nuova Italy 
Reggio 
Emilia 
3 (60.0) 2 (40.0) 531942     City 181 34.0 High 2122 398.9 High 1675 314.9 High 678 127.5 High 
 Ospedale Di Rho - ASST 
Rhodense 
Italy Rho 2 (100.0)   3259836     City 
172
0 
52.8 High 7161 219.7 High 5764 176.8 High 4662 143.0 High 
 Fondazione Policlinico 
Universitario Agostino Gemelli 
Italy Rome 1 (1.0) 96 (99.0) 4336251     City 348 8.0 Low 1832 42.2 High 1479 34.1 High 1091 25.2 High 
 policlinico universitario campus 
bio medico of rome 
Italy rome 1 (5.9) 16 (94.1) 4336251     City 348 8.0 Low 1832 42.2 High 1479 34.1 High 1091 25.2 High 
 Valtiberina Italy 
Sansepolc
ro 
1 (100.0)   343676     City 41 11.9 Low 291 84.7 High 190 55.3 High 102 29.7 High 
 Azienda Ospedaliera 
Universitaria Integrata di Verona 
Italy Verona 23 (85.2) 4 (14.8) 923664     City 335 36.3 High 1777 192.4 High 1537 166.4 High 1017 110.1 High 
 Ospedale di Circolo, University 
of Insubria, University Hospital 
of Varese, ASST Sette Laghi, 
Regione Lombardia 
Italy 
Varese 
Lombardy 
23 (88.5) 3 (11.5) 889410     City 180 20.2 Low 709 79.7 High 991 111.4 High 783 88.0 High 
 Ospedali Riuniti di Ancona Italy Ancona   1 (100.0) 482886     City 267 55.3 High 849 175.8 High 531 110.0 High 163 33.8 High 
 Ospedale Regionale Umberto 
Parini 
Italy Aosta   3 (100.0) 34800     City 57 163.8 High 571 1640.8 High 330 948.3 High 170 488.5 High 
 Papa Giovanni XXIII Hospital Italy Bergamo   9 (100.0) 1112187     City 
330
6 
297.3 High 5387 484.4 High 1669 150.1 High 841 75.6 High 
 S.Orsola-Malpighi Hospital Italy Bologna   6 (100.0) 1017197     City 228 22.4 Low 1710 168.1 High 1440 141.6 High 1036 101.8 High 
 St. Moritz Hospital Italy Bolzano   5 (100.0) 530009     City 203 38.3 High 1167 220.2 High 853 160.9 High 294 55.5 High 
 ASST Spedali Civili, Ospedale di 
Brescia 
Italy Brescia   
10 
(100.0) 
1265964     City 
245
9 
194.2 High 5894 465.6 High 2820 222.8 High 1674 132.2 High 
 Ospedale Vittorio Emanuele III Italy 
Carate 
Brianza 
(MB) 
  1 (100.0) 871735     City 321 36.8 High 2135 244.9 High 1416 162.4 High 826 94.8 High 
 Santa Croce Hospital Italy Cuneo   
23 
(100.0) 
590309     City 61 10.3 Low 670 113.5 High 1060 179.6 High 695 117.7 High 
 Azienda Ospedaliero 
Universitaria San'Anna 
Italy Ferrara   
44 
(100.0) 
350238     City 34 9.7 Low 286 81.7 High 329 93.9 High 272 77.7 High 
 Ospedale San Giovanni di Dio Italy Firenze   
20 
(100.0) 
1012388     City 157 15.5 Low 925 91.4 High 1285 126.9 High 748 73.9 High 
 Ospedali Riuniti Azienda 
Ospedaliera Universitaria 
Italy Foggia   
15 
(100.0) 
627102     City 62 9.9 Low 395 63.0 High 299 47.7 High 288 45.9 High 
 Ospedale Maggiore di Lodi Italy Lodi   1 (100.0) 229741     City 
108
3 
471.4 High 796 346.5 High 471 205.0 High 379 165.0 High 
 ASST Mantua Italy Mantova   9 (100.0) 413663     City 338 81.7 High 1349 326.1 High 967 233.8 High 520 125.7 High 
 Fondazione IRCCS Ca' Granda - 
ospedale Maggiore Policlinico 
Italy Milan   
19 
(100.0) 
3259835     City 
172
0 
52.8 High 7161 219.7 High 5764 176.8 High 4662 143.0 High 
 ASST Santi Paolo e Carlo Italy Milan   1 (100.0) 3259835     City 
172
0 
52.8 High 7161 219.7 High 5764 176.8 High 4662 143.0 High 
 Ospedale Fatebenefratelli e 
Oftalmico 
Italy Milan   1 (100.0) 3259835     City 
172
0 
52.8 High 7161 219.7 High 5764 176.8 High 4662 143.0 High 
 Ospedale Luigi Sacco Milano Italy Milan   
17 
(100.0) 
3259835     City 
172
0 
52.8 High 7161 219.7 High 5764 176.8 High 4662 143.0 High 
 San Raffaele Scientific Institute, 
Milan 
Italy Milan   4 (100.0) 3259835     City 
172
0 
52.8 High 7161 219.7 High 5764 176.8 High 4662 143.0 High 
 Humanitas Research Hospital Italy Milan   
55 
(100.0) 
3259835     City 
172
0 
52.8 High 7161 219.7 High 5764 176.8 High 4662 143.0 High 
 Regina Montis Regalis Hospital Italy Mondovì   4 (100.0) 590309     City 61 10.3 Low 670 113.5 High 1060 179.6 High 695 117.7 High 
 Ospedale San Gerardo Italy Monza   
47 
(100.0) 
871735     City 321 36.8 High 2135 244.9 High 1416 162.4 High 826 94.8 High 
 Federico II University of Naples Italy Naples   3 (100.0) 3128702     City 175 5.6 Low 865 27.6 High 973 31.1 High 397 12.7 Low 
 ospedale del mare Italy Naples   
19 
(100.0) 
3128702     City 175 5.6 Low 865 27.6 High 973 31.1 High 397 12.7 Low 
 Azienda Ospedaliero 
Universitaria Maggiore della 
Carità 
Italy Novara   3 (100.0) 373081     City 71 19.0 Low 726 194.6 High 911 244.2 High 583 156.3 High 
 Azienda Ospedaliera di Padova Italy Padova   2 (100.0) 938957     City 577 61.5 High 1606 171.0 High 1186 126.3 High 401 42.7 High 
 Azienda Ospedaliera, Ospedali 
Riuniti Villa Sofia, Cervello 
Italy Palermo   5 (100.0) 1249533     City 30 2.4 Low 229 18.3 Low 131 10.5 Low 100 8.0 Low 
 Policlinico Paolo Giaccone di 
Palermo 
Italy Palermo   5 (100.0) 1249533     City 30 2.4 Low 229 18.3 Low 131 10.5 Low 100 8.0 Low 
 Azienda Ospedaliero-
Universitaria di Parma 
Italy Parma   
37 
(100.0) 
449191     City 627 139.6 High 1271 283.0 High 683 152.1 High 541 120.4 High 
 G. Da Saliceto Italy Piacenza   6 (100.0) 286997     City 874 304.5 High 1623 565.5 High 588 204.9 High 839 292.3 High 
 Edoardo Agnelli Italy Pinerolo   2 (100.0) 2308409     City 348 15.1 Low 4096 177.4 High 4201 182.0 High 4442 192.4 High 
 Azienda Ospedaliero 
Universitaria Pisana 
Italy Pisa   
11 
(100.0) 
421642     City 71 16.8 Low 400 94.9 High 262 62.1 High 114 27.0 High 
 Policlinico Umberto I Italy Rome   
10 
(100.0) 
4336251     City 348 8.0 Low 1832 42.2 High 1479 34.1 High 1091 25.2 High 
 Ospedale San Filippo Neri Italy Rome   7 (100.0) 4336251     City 348 8.0 Low 1832 42.2 High 1479 34.1 High 1091 25.2 High 
 Cliniche San Pietro, A.O.U. 
Sassari 
Italy Sassari   
40 
(100.0) 
493357     City 35 7.1 Low 451 91.4 High 277 56.1 High 73 14.8 Low 
 Mauriziano Hospital Italy Torino   1 (100.0) 2308409     City 348 15.1 Low 4096 177.4 High 4201 182.0 High 4442 192.4 High 
 Ca' Foncello Italy Treviso   2 (100.0) 884353     City 378 42.7 High 1109 125.4 High 511 57.8 High 478 54.1 High 
 ASST Vimercate Italy 
Vimercat
e 
  1 (100.0) 871735     City 321 36.8 High 2135 244.9 High 1416 162.4 High 826 94.8 High 
 National Cancer Center Hospital Japan Tokyo   
14 
(100.0) 
    
12615000
0 
Country 575 0.5 Low 1364 1.1 Low 6404 5.1 Low 5699 4.5 Low 
 King Hussein Cancer Center Jordan Amman 
141 
(100.0) 
      10655387 Country 12 0.1 Low 262 2.5 Low 127 1.2 Low 52 0.5 Low 
 Al-Basheer Hospital Jordan Amman   
14 
(100.0) 
    10655387 Country 12 0.1 Low 262 2.5 Low 127 1.2 Low 52 0.5 Low 
 King Abdullah University 
Hospital 
Jordan 
Ar 
Ramtha 
  4 (100.0)     10655387 Country 12 0.1 Low 262 2.5 Low 127 1.2 Low 52 0.5 Low 
 National cancer institute Libya Sabratha 8 (100.0)       6871287 Country 4 0.1 Low 4 0.1 Low 27 0.4 Low 26 0.4 Low 
 Alkhadra Hospital Libya Tripoli 2 (100.0)       6871287 Country 4 0.1 Low 4 0.1 Low 27 0.4 Low 26 0.4 Low 
 Al-jalaa hospital Libya Benghazi   1 (100.0)     6871287 Country 4 0.1 Low 4 0.1 Low 27 0.4 Low 26 0.4 Low 
 Joseph Ravoahangy 
Andrianavalona Hospital 
Madagasc
ar 
Antanana
rivo 
  2 (100.0)     26262313 Country 23 0.1 Low 23 0.1 Low 64 0.2 Low 18 0.1 Low 
 Hospital Universiti Sains 
Malaysia 
Malaysia 
Kota 
Bharu 
7 (100.0)     2001000   Region 18 0.9 Low 113 5.6 Low 23 1.1 Low 1 0.0 Low 
 Queen Elizabeth Hospital Malaysia 
Kota 
Kinabalu 
2 (100.0)     3900000   Region 57 1.5 Low 149 3.8 Low 79 2.0 Low 30 0.8 Low 
 University Malaya Medical 
Centre 
Malaysia 
Kuala 
Lumpur 
3 (8.1) 34 (91.9) 1790000     City 100 5.6 Low 324 18.1 Low 496 27.7 High 306 17.1 Low 
 Hospital Kuala Lumpur Malaysia 
Kuala 
Lumpur 
4 (28.6) 10 (71.4) 1790000     City 100 5.6 Low 324 18.1 Low 496 27.7 High 306 17.1 Low 
 Bintulu Malaysia Bintulu   1 (100.0)   2810000   Region 21 0.7 Low 135 4.8 Low 215 7.7 Low 136 4.8 Low 
 Hospital San Ángel Inn 
Chapultepec 
Mexico 
Mexico 
City 
1 (100.0)       
12864956
5 
Country 49 0.0 Low 1162 0.9 Low 4632 3.6 Low 
1337
7 
10.4 Low 
 Instituto Nacional de Ciencias 
Médicas y Nutrición "Salvador 
Zubirán" 
Mexico 
Mexico 
City 
16 (84.2) 3 (15.8)     
12864956
5 
Country 49 0.0 Low 1162 0.9 Low 4632 3.6 Low 
1337
7 
10.4 Low 
 ABC Medical Center Mexico 
Mexico 
City 
  7 (100.0)     
12864956
5 
Country 49 0.0 Low 1162 0.9 Low 4632 3.6 Low 
1337
7 
10.4 Low 
 Institut National d'Oncologie Morocco Rabat 
116 
(100.0) 
      36472000 Country 28 0.1 Low 589 1.6 Low 1407 3.9 Low 2399 6.6 Low 
 Antoni van Leeuwenhoek 
ziekenhuis 
Netherlan
ds 
Amsterda
m 
42 (100.0)       17424978 Country 
112
9 
6.5 Low 11460 65.8 High 15558 89.3 High 
1116
3 
64.1 High 
 Spaarne Gasthuis 
Netherlan
ds 
Haarlem 88 (98.9) 1 (1.1)     17424978 Country 
112
9 
6.5 Low 11460 65.8 High 15558 89.3 High 
1116
3 
64.1 High 
 Amsterdam UMC, University of 
Amsterdam 
Netherlan
ds 
Amsterda
m 
  1 (100.0)     17424978 Country 
112
9 
6.5 Low 11460 65.8 High 15558 89.3 High 
1116
3 
64.1 High 
 Gelre ziekenhuis 
Netherlan
ds 
Apeldoor
n 
  
22 
(100.0) 
    17424978 Country 
112
9 
6.5 Low 11460 65.8 High 15558 89.3 High 
1116
3 
64.1 High 
 Slingeland Ziekenhuis 
Netherlan
ds 
Doetinch
em 
  
12 
(100.0) 
    17424978 Country 
112
9 
6.5 Low 11460 65.8 High 15558 89.3 High 
1116
3 
64.1 High 
 VieCuri Medisch Centrum 
Netherlan
ds 
Venlo   9 (100.0)     17424978 Country 
112
9 
6.5 Low 11460 65.8 High 15558 89.3 High 
1116
3 
64.1 High 
 Ekiti State University Teaching 
Hospital 
Nigeria Ado-Ekiti   1 (100.0)     
20463026
9 
Country 1 0.0 Low 109 0.1 Low 232 0.1 Low 1189 0.6 Low 
 University of Ilorin Teaching 
Hospital 
Nigeria Ilorin   2 (100.0)     
20463026
9 
Country 1 0.0 Low 109 0.1 Low 232 0.1 Low 1189 0.6 Low 
 Ahmadu Bello University 
Teaching Hospital 
Nigeria Zaria   3 (100.0)     
20463026
9 
Country 1 0.0 Low 109 0.1 Low 232 0.1 Low 1189 0.6 Low 
 Khoula Hospital Oman Muscat   1 (100.0)     4829473 Country 16 0.3 Low 170 3.5 Low 718 14.9 Low 1364 28.2 High 
 Cancer Foundation Hospital Pakistan Karachi 7 (100.0)     47886051   Region 30 0.1 Low 642 1.3 Low 992 2.1 Low 4385 9.2 Low 
 The Pakistan Institute of 
Medical Sciences 
Pakistan 
Islamaba
d 
  1 (100.0)   2006572   Region 4 0.2 Low 50 2.5 Low 86 4.3 Low 203 10.1 Low 
 Dr Ruth K.M. Pfau Civil Hospital Pakistan Karachi   5 (100.0)   47886051   Region 30 0.1 Low 642 1.3 Low 992 2.1 Low 4385 9.2 Low 
 Patel Hospital Pakistan Karachi   1 (100.0)   47886051   Region 30 0.1 Low 642 1.3 Low 992 2.1 Low 4385 9.2 Low 
 Services Hospital Lahore Pakistan Lahore   6 (100.0)   
11001244
2 
  Region 1 0.0 Low 707 0.6 Low 2435 2.2 Low 3197 2.9 Low 
 Instituto Regional de 
Enfermedades Neoplásicas del 
Sur 
Peru Arequipa 3 (100.0)       32824358 Country 71 0.2 Low 994 3.0 Low 10410 31.7 High 
2550
1 
77.7 High 
 Independent Public Teaching 
Hospital No 1 in Lublin 
Poland Lublin   
19 
(100.0) 
  2147746   Region 17 0.8 Low 115 5.4 Low 138 6.4 Low 90 4.2 Low 
 IPO Coimbra Portugal Coimbra 21 (100.0)     2327026   Region 11 0.5 Low 911 39.1 High 1716 73.7 High 760 32.7 High 
 Centro Hospitalar Cova da Beira Portugal Covilha 3 (100.0)     2327026   Region 11 0.5 Low 911 39.1 High 1716 73.7 High 760 32.7 High 
 Centro Hospitalar Universitário 
Lisboa Central 
Portugal Lisbon 5 (12.2) 36 (87.8)   2815853   Region 116 4.1 Low 1683 59.8 High 2303 81.8 High 1713 60.8 High 
 Instituto Português de 
Oncologia de Lisboa Francisco 
Gentil 
Portugal Lisboa 56 (100.0)     2815853   Region 116 4.1 Low 1683 59.8 High 2303 81.8 High 1713 60.8 High 
 IPO Lisboa Portugal Lisboa 35 (100.0)     2815853   Region 116 4.1 Low 1683 59.8 High 2303 81.8 High 1713 60.8 High 
 Centro Hospitalar Lisboa Norte Portugal Lisbon 2 (100.0)     2815853   Region 116 4.1 Low 1683 59.8 High 2303 81.8 High 1713 60.8 High 
 Hospital Beatriz Angelo Portugal Loures 1 (3.1) 31 (96.9)   2815853   Region 116 4.1 Low 1683 59.8 High 2303 81.8 High 1713 60.8 High 
 IPO Porto Portugal Porto 45 (97.8) 1 (2.2)   3689173   Region 103 2.8 Low 4344 117.7 High 6299 170.7 High 4339 117.6 High 
 Hospital de Torres Vedras - 
Centro Hospitalar do Oeste 
Portugal 
Torres 
Vedras 
1 (100.0)     2327026   Region 11 0.5 Low 911 39.1 High 1716 73.7 High 760 32.7 High 
 Hospital Garcia de Orta Portugal Almada   2 (100.0)   2815853   Region 116 4.1 Low 1683 59.8 High 2303 81.8 High 1713 60.8 High 
 Hospital de Santo Espirito da 
ilha Terceira 
Portugal 
Angra do 
Heroismo 
  8 (100.0)   246772   Region 1 0.4 Low 48 19.5 Low 51 20.7 Low 27 10.9 Low 
 Centro Hospitalar e 
Universitário de Coimbra 
Portugal Coimbra   
38 
(100.0) 
  2327026   Region 11 0.5 Low 911 39.1 High 1716 73.7 High 760 32.7 High 
 Hospital Faro, Centro Hospitalar 
Universitario do Algarve 
Portugal Faro   
20 
(100.0) 
  451006   Region 10 2.2 Low 127 28.2 High 162 35.9 High 36 8.0 Low 
 Hospital da Horta, E.P.E. Portugal Horta   9 (100.0)   246772   Region 1 0.4 Low 48 19.5 Low 51 20.7 Low 27 10.9 Low 
 Hospital do Divino Espírito 
Santo 
Portugal 
Ponta 
Delgada 
  5 (100.0)   246772   Region 1 0.4 Low 48 19.5 Low 51 20.7 Low 27 10.9 Low 
 Centro Hospitalar do Tamega e 
Sousa 
Portugal Penafiel   
13 
(100.0) 
  3689173   Region 103 2.8 Low 4344 117.7 High 6299 170.7 High 4339 117.6 High 
 Centro Hospitalar Universitario 
do Algarve 
Portugal Portimao   
21 
(100.0) 
  451006   Region 10 2.2 Low 127 28.2 High 162 35.9 High 36 8.0 Low 
 Centro Hospital Universitário 
São João 
Portugal Porto   
27 
(100.0) 
  3689173   Region 103 2.8 Low 4344 117.7 High 6299 170.7 High 4339 117.6 High 
 Hospital do Litoral Alentejano Portugal 
Santiago 
do Cacém 
  6 (100.0)   758739   Region 0 0.0 Low 50 6.6 Low 105 13.8 Low 59 7.8 Low 
 Centro Hospitalar de Setúbal Portugal Setúbal   1 (100.0)   2815853   Region 116 4.1 Low 1683 59.8 High 2303 81.8 High 1713 60.8 High 
 Centro Hospitalar Tondela-Viseu Portugal Viseu   4 (100.0)   2327026   Region 11 0.5 Low 911 39.1 High 1716 73.7 High 760 32.7 High 
 Centro Hospitalar de Trás-os-
Montes e Alto Douro, E.P.E. 
Portugal Vila Real   
21 
(100.0) 
  3689173   Region 103 2.8 Low 4344 117.7 High 6299 170.7 High 4339 117.6 High 
 Instituto Gineco Oncologico 
Puerto 
Rico 
San Juan   
26 
(100.0) 
    3193694 Country 5 0.2 Low 234 7.3 Low 735 23.0 Low 565 17.7 Low 
 CHU Reunion Reunion 
Saint 
Denis 
  1 (100.0)     859959 Country 9 1.0 Low 238 27.7 High 144 16.7 Low 29 3.4 Low 
 Coltea Clinical Hospital Romania Bucharest 1 (100.0)   1883425     City 38 2.0 Low 53 2.8 Low 319 16.9 Low 451 23.9 Low 
Prof. Dr. Ion Chiricuta Institute 
of Oncology 
Romania 
Cluj-
Napoca 
11 (100.0)     691106   Region 2 0.3 Low 3 0.4 Low 109 15.8 Low 148 21.4 Low 
 Saint John Emergency Hospital Romania Bucharest   1 (100.0) 1883425     City 38 2.0 Low 53 2.8 Low 319 16.9 Low 451 23.9 Low 
 Emergency Clinical City Hospital Romania Timisoara   4 (100.0)   683540   Region 14 2.0 Low 2 0.3 Low 224 32.8 High 133 19.5 Low 
 Immanuel Kant Baltic Federal 
University, Regional Clinical 
Hospital 
Russian 
Federatio
n 
Kaliningra
d 
1 (100.0)       
14674509
8 
Country 61 0.0 Low 2274 1.5 Low 22153 15.1 Low 
8200
8 
55.9 High 
 Moscow Research and 
Educational Center, Lomonosov 
Moscow State University 
Russian 
Federatio
n 
Moscow 4 (100.0)       
14674509
8 
Country 61 0.0 Low 2274 1.5 Low 22153 15.1 Low 
8200
8 
55.9 High 
 Clinic of Coloproctology and 
Minimally Invasive Surgery, 
Sechenov Medical State 
University 
Russian 
Federatio
n 
Moscow 2 (100.0)       
14674509
8 
Country 61 0.0 Low 2274 1.5 Low 22153 15.1 Low 
8200
8 
55.9 High 
 King faisal medical complex 
Saudi 
Arabia 
Taif 1 (100.0)       34218169 Country 118 0.3 Low 1445 4.2 Low 4299 12.6 Low 176 0.5 Low 
 aseer central hospital 
Saudi 
Arabia 
abha   7 (100.0)     34218169 Country 118 0.3 Low 1445 4.2 Low 4299 12.6 Low 
1689
1 
49.4 High 
 East Jeddah general hospital 
Saudi 
Arabia 
Jeddah   1 (100.0)     34218169 Country 118 0.3 Low 1445 4.2 Low 4299 12.6 Low 
1689
1 
49.4 High 
 King Abdulaziz University 
Hospital 
Saudi 
Arabia 
Jeddah   
24 
(100.0) 
    34218169 Country 118 0.3 Low 1445 4.2 Low 4299 12.6 Low 
1689
1 
49.4 High 
 King Fahad General Hospital 
Saudi 
Arabia 
Jeddah   2 (100.0)     34218169 Country 118 0.3 Low 1445 4.2 Low 4299 12.6 Low 
1689
1 
49.4 High 
 King Khalid Hospital 
Saudi 
Arabia 
Najran   
10 
(100.0) 
    34218169 Country 118 0.3 Low 1445 4.2 Low 4299 12.6 Low 
1689
1 
49.4 High 
 King Abdulaziz Medical City 
Saudi 
Arabia 
Riyadh   
47 
(100.0) 
    34218169 Country 118 0.3 Low 1445 4.2 Low 4299 12.6 Low 
1689
1 
49.4 High 
 King Khalid University Hospital 
Saudi 
Arabia 
Riyadh   
19 
(100.0) 
    34218169 Country 118 0.3 Low 1445 4.2 Low 4299 12.6 Low 
1689
1 
49.4 High 
 King Faisal Specialist Hospital 
Saudi 
Arabia 
Riyadh   
16 
(100.0) 
    34218169 Country 118 0.3 Low 1445 4.2 Low 4299 12.6 Low 
1689
1 
49.4 High 
 Clinic for Maxillofacial Surgery, 
School of Dental Medicine, 
University of Belgrade 
Serbia Belgrade 1 (100.0)       6963764 Country 48 0.7 Low 852 12.2 Low 3973 57.1 High 4136 59.4 High 
 Clinic for Gynecology and 
Obstetrics Narodni Front 
Serbia Belgrade 1 (50.0) 1 (50.0)     6963764 Country 48 0.7 Low 852 12.2 Low 3973 57.1 High 4136 59.4 High 
 Clinic for Gynecology and 
Obstetrics, Clinical Center of 
Serbia 
Serbia Belgrade 17 (100.0)       6963764 Country 48 0.7 Low 852 12.2 Low 3973 57.1 High 4136 59.4 High 
 Clinic for Digestive Surgery, 
Clinical Centre of Serbia 
Serbia Belgrade 61 (96.8) 2 (3.2)     6963764 Country 48 0.7 Low 852 12.2 Low 3973 57.1 High 4136 59.4 High 
 Centre for endocrine surgery, 
Clinical Centre of Serbia 
Serbia Belgrade 11 (100.0)       6963764 Country 48 0.7 Low 852 12.2 Low 3973 57.1 High 4136 59.4 High 
 Clinic for emergency surgery, 
Emergency centre, Clinical 
centre of Serbia 
Serbia Belgrade 6 (100.0)       6963764 Country 48 0.7 Low 852 12.2 Low 3973 57.1 High 4136 59.4 High 
 Clinic for Otorhinolaryngology 
and Maxillofacial Surgery, 
Clinical Center of Serbia 
Serbia Belgrade 16 (100.0)       6963764 Country 48 0.7 Low 852 12.2 Low 3973 57.1 High 4136 59.4 High 
 Institute for Oncology and 
Radiology of Serbia 
Serbia Belgrade 131 (99.2) 1 (0.8)     6963764 Country 48 0.7 Low 852 12.2 Low 3973 57.1 High 4136 59.4 High 
 National University Hospital Singapore Singapore 1 (0.7) 
146 
(99.3) 
    5703600 Country 124 2.2 Low 700 12.3 Low 2773 48.6 High 
1247
0 
218.6 High 
 University Hospital Bratislava 
Slovak 
Republic 
Bratislava   3 (100.0)     5450421 Country 61 1.1 Low 339 6.2 Low 577 10.6 Low 426 7.8 Low 
 Groote Schuur Hospital 
South 
Africa 
Cape 
Town 
  
22 
(100.0) 
  5822734   Region 14 0.2 Low 311 5.3 Low 332 5.7 Low 1685 28.9 High 
 Hospital Clinic Barcelona Spain Barcelona 1 (2.4) 40 (97.6)   7522596   Region 700 9.3 Low 19088 253.7 High 17363 230.8 High 
1195
3 
158.9 High 
 Vall d'Hebron University 
Hospital 
Spain Barcelona 1 (9.1) 10 (90.9)   7522596   Region 700 9.3 Low 19088 253.7 High 17363 230.8 High 
1195
3 
158.9 High 
 Hospital del Mar Spain Barcelona 3 (17.6) 14 (82.4)   7522596   Region 700 9.3 Low 19088 253.7 High 17363 230.8 High 
1195
3 
158.9 High 
 Hospital Urduliz Spain Bizkaia 1 (50.0) 1 (50.0)   2189534   Region 621 28.4 High 6208 283.5 High 4952 226.2 High 2681 122.4 High 
 Getafe University Hospital Spain Getafe 13 (41.9) 18 (58.1)   6661949   Region 
351
5 
52.8 High 25675 385.4 High 20854 313.0 High 
1392
2 
209.0 High 
 12 de Octubre University 
Hospital 
Spain Madrid 1 (12.5) 7 (87.5)   6661949   Region 
351
5 
52.8 High 25675 385.4 High 20854 313.0 High 
1392
2 
209.0 High 
 Hospital Universitario de la 
Princesa 
Spain Madrid 1 (10.0) 9 (90.0)   6661949   Region 
351
5 
52.8 High 25675 385.4 High 20854 313.0 High 
1392
2 
209.0 High 
 Hospital Universitario de 
Torrejón de Ardoz 
Spain Madrid 7 (38.9) 11 (61.1)   6661949   Region 
351
5 
52.8 High 25675 385.4 High 20854 313.0 High 
1392
2 
209.0 High 
 Hospital Universitario Principe 
de Asturias 
Spain Madrid 1 (8.3) 11 (91.7)   6661949   Region 
351
5 
52.8 High 25675 385.4 High 20854 313.0 High 
1392
2 
209.0 High 
 Hospital del Henares Spain Madrid 5 (100.0)     6661949   Region 
351
5 
52.8 High 25675 385.4 High 20854 313.0 High 
1392
2 
209.0 High 
 Hospital Universitario la Paz Spain Madrid 2 (6.7) 28 (93.3)   6661949   Region 
351
5 
52.8 High 25675 385.4 High 20854 313.0 High 
1392
2 
209.0 High 
 Infanta Sofía University Hospital Spain 
San 
Sebastian 
de Los 
Reyes 
1 (7.7) 12 (92.3)   6661949   Region 
351
5 
52.8 High 25675 385.4 High 20854 313.0 High 
1392
2 
209.0 High 
 Hospital Universitario Donostia Spain 
San 
Sebastian 
1 (11.1) 8 (88.9)   6661949   Region 
351
5 
52.8 High 25675 385.4 High 20854 313.0 High 
1392
2 
209.0 High 
 Hospital Universitario Río 
Hortega 
Spain Valladolid 6 (100.0)     2447519   Region 289 11.8 Low 6513 266.1 High 7533 307.8 High 4505 184.1 High 
 Hospital Universitario y 
Politécnico La Fe 
Spain Valencia 2 (5.4) 35 (94.6)   5003769   Region 394 7.9 Low 5514 110.2 High 3693 73.8 High 1705 34.1 High 
 Álvaro Cunqueiro Hospital Spain Vigo 22 (64.7) 12 (35.3)   2701743   Region 195 7.2 Low 4187 155.0 High 3441 127.4 High 1766 65.4 High 
 Cruces Hospital Spain Barakaldo   
48 
(100.0) 
  2189534   Region 621 28.4 High 6208 283.5 High 4952 226.2 High 2681 122.4 High 
 Consorci Sanitari de Terrassa Spain Barcelona   6 (100.0)   7522597   Region 700 9.3 Low 19088 253.7 High 17363 230.8 High 
1195
3 
158.9 High 
 Comarcal Alt Penedés Spain Barcelona   1 (100.0)   7522597   Region 700 9.3 Low 19088 253.7 High 17363 230.8 High 
1195
3 
158.9 High 
 Hospital General Universitario 
de Ciudad Real 
Spain 
Ciudad 
Real 
  
10 
(100.0) 
  2041631   Region 398 19.5 Low 6480 317.4 High 8104 396.9 High 3188 156.1 High 
 Hospital Don Benito-Villanueva Spain 
Don 
Benito 
(Badajoz) 
  9 (100.0)   1087778   Region 89 8.2 Low 1568 144.1 High 1202 110.5 High 475 43.7 High 
 Hospital Universitario de 
Galdakao 
Spain 
Galdakao-
Usansolo 
  1 (100.0)   2189534   Region 621 28.4 High 6208 283.5 High 4952 226.2 High 2681 122.4 High 
 Hospital de Cabueñes Spain Gijón   
23 
(100.0) 
  1018706   Region 204 20.0 Low 1145 112.4 High 848 83.2 High 352 34.6 High 
 Bellvitge University Hospital Spain 
L'Hospital
et de 
Llobregat 
  1 (100.0)   7522596   Region 700 9.3 Low 19088 253.7 High 17363 230.8 High 
1195
3 
158.9 High 
 Severo Ochoa University 
Hospital 
Spain Leganés   
19 
(100.0) 
  6661949   Region 
351
5 
52.8 High 25675 385.4 High 20854 313.0 High 
1392
2 
209.0 High 
 Fundación Jimenez Diaz 
University Hospital 
Spain Madrid   4 (100.0)   6661949   Region 
351
5 
52.8 High 25675 385.4 High 20854 313.0 High 
1392
2 
209.0 High 
 Hospital General Universitario 
Gregorio Marañón 
Spain Madrid   
32 
(100.0) 
  6661949   Region 
351
5 
52.8 High 25675 385.4 High 20854 313.0 High 
1392
2 
209.0 High 
 Hospital Clínico de Madrid Spain Madrid   
26 
(100.0) 
  6661949   Region 
351
5 
52.8 High 25675 385.4 High 20854 313.0 High 
1392
2 
209.0 High 
 Hospital Universitario del 
Sureste 
Spain Madrid   1 (100.0)   6661949   Region 
351
5 
52.8 High 25675 385.4 High 20854 313.0 High 
1392
2 
209.0 High 
 Hospital Mateu Orfila Spain Mahon   7 (100.0)   1107220   Region 90 8.1 Low 1058 95.6 High 506 45.7 High 311 28.1 High 
 Hospital Sant Joan de Déu 
Althaia 
Spain Manresas   
16 
(100.0) 
  7522596   Region 700 9.3 Low 19088 253.7 High 17363 230.8 High 
1195
3 
158.9 High 
 Hospital Universitario de 
Móstoles 
Spain Móstoles   3 (100.0)   6661949   Region 
351
5 
52.8 High 25675 385.4 High 20854 313.0 High 
1392
2 
209.0 High 
 Rey Juan Carlos University 
Hospital 
Spain Móstoles   1 (100.0)   6661949   Region 
351
5 
52.8 High 25675 385.4 High 20854 313.0 High 
1392
2 
209.0 High 
 Hospital General Reina Sofía Spain Murcia   
52 
(100.0) 
  1478509   Region 71 4.8 Low 964 65.2 High 557 37.7 High 151 10.2 Low 
 Hospital Universitario Virgen de 
la Arrixaca 
Spain Murcia   1 (100.0)   1478509   Region 71 4.8 Low 964 65.2 High 557 37.7 High 151 10.2 Low 
 Hospital Santa Bárbara Spain 
Puertolla
no 
  1 (100.0)   2041631   Region 398 19.5 Low 6480 317.4 High 8104 396.9 High 3188 156.1 High 
 Hospital Universitari Sant Joan Spain Reus   2 (100.0)   7522596   Region 700 9.3 Low 19088 253.7 High 17363 230.8 High 
1195
3 
158.9 High 
 Marqués de Valdecilla 
University Hospital 
Spain 
Santande
r 
  
69 
(100.0) 
  580229   Region 41 7.1 Low 1155 199.1 High 632 108.9 High 551 95.0 High 
 Hospital Universitario Virgen 
Macarena 
Spain Seville   9 (100.0)   8388107   Region 
153
8 
18.3 Low 5838 69.6 High 4415 52.6 High 1936 23.1 Low 
 Hospital Universitari de 
Tarragona Joan XXIII 
Spain Tarragona   
14 
(100.0) 
  7522596   Region 700 9.3 Low 19088 253.7 High 17363 230.8 High 
1195
3 
158.9 High 
 Hospital Clínico Universitario de 
Valencia 
Spain Valencia   
18 
(100.0) 
  5003769   Region 394 7.9 Low 5514 110.2 High 3693 73.8 High 1705 34.1 High 
 Consorcio Hospital General 
Universitario 
Spain Valencia   1 (100.0)   5003769   Region 394 7.9 Low 5514 110.2 High 3693 73.8 High 1705 34.1 High 
 Hospital Clínico Universitario de 
Valladolid 
Spain Valladolid   
13 
(100.0) 
  2447519   Region 289 11.8 Low 6513 266.1 High 7533 307.8 High 4505 184.1 High 
 Royo Villanova Spain Zaragoza   
13 
(100.0) 
  1308563   Region 163 12.5 Low 2317 177.1 High 2075 158.6 High 954 72.9 High 
 Hospital Clinico Universitario 
Zaragoza 
Spain Zaragoza   7 (100.0)   1308563   Region 163 12.5 Low 2317 177.1 High 2075 158.6 High 954 72.9 High 
 Hospital Universitario Miguel 
Servet 
Spain Zaragoza   
50 
(100.0) 
  1308563   Region 163 12.5 Low 2317 177.1 High 2075 158.6 High 954 72.9 High 
 Umea University Hospital Sweden Umea 1 (2.2) 44 (97.8)   268067   Region 13 4.8 Low 49 18.3 Low 141 52.6 High 121 45.1 High 
 Karolinska University Hospital Sweden 
Stockhol
m 
  4 (100.0)   2377081   Region 370 15.6 Low 1751 73.7 High 2976 125.2 High 3057 128.6 High 
 South General Hospital Sweden 
Stockhol
m 
  6 (100.0)   2377081   Region 370 15.6 Low 1751 73.7 High 2976 125.2 High 3057 128.6 High 
 Ente Ospedaliero Cantonale 
Switzerlan
d 
Ticino 
(Lugano, 
Bellinzon
a, 
Locarno, 
Mendrisio
) 
10 (100.0)     353343   Region 254 71.9 High 1800 509.4 High 816 230.9 High 283 80.1 High 
 University Hospital Bern, 
Inselspital 
Switzerlan
d 
BERN   5 (100.0)   1034977   Region 58 5.6 Low 778 75.2 High 540 52.2 High 268 25.9 High 
 Hopital de Pourtales 
Switzerlan
d 
Neuchatel   3 (100.0)   176850   Region 31 17.5 Low 328 185.5 High 210 118.7 High 73 41.3 High 
 Kantonsspital Winterthur 
Switzerlan
d 
Winterth
ur 
  
19 
(100.0) 
  1520968   Region 141 9.3 Low 2073 136.3 High 1168 76.8 High 359 23.6 Low 
 Baskent university Turkey Ankara 20 (100.0)       83154997 Country 18 0.0 Low 13513 16.3 Low 55861 67.2 High 
5081
2 
61.1 High 
 Koç University Medical School Turkey Istanbul 11 (39.3) 17 (60.7)     83154997 Country 18 0.0 Low 13513 16.3 Low 55861 67.2 High 
5081
2 
61.1 High 
 Istanbul universty - Cerrahpaşa 
Medical faculty 
Turkey Istanbul 8 (33.3) 16 (66.7)     83154997 Country 18 0.0 Low 13513 16.3 Low 55861 67.2 High 
5081
2 
61.1 High 
 University of Health Sciences 
Tepecik Training and Research 
Hospital 
Turkey İzmir 46 (93.9) 3 (6.1)     83154997 Country 18 0.0 Low 13513 16.3 Low 55861 67.2 High 
5081
2 
61.1 High 
 Kocaeli University Teaching 
Hospital 
Turkey Kocaeli 13 (92.9) 1 (7.1)     83154997 Country 18 0.0 Low 13513 16.3 Low 55861 67.2 High 
5081
2 
61.1 High 
 Mus State Hospital Turkey mus 1 (2.4) 41 (97.6)     83154997 Country 18 0.0 Low 13513 16.3 Low 55861 67.2 High 
5081
2 
61.1 High 
 Sakarya Faculty Of Medicine Turkey Sakarya 45 (80.4) 11 (19.6)     83154997 Country 18 0.0 Low 13513 16.3 Low 55861 67.2 High 
5081
2 
61.1 High 
 Samsun Training and Research 
Hospital 
Turkey Samsun 2 (8.7) 21 (91.3)     83154997 Country 18 0.0 Low 13513 16.3 Low 55861 67.2 High 
5081
2 
61.1 High 
 Adana Baskent University Turkey Adana   9 (100.0)     83154997 Country 18 0.0 Low 13513 16.3 Low 55861 67.2 High 
5081
2 
61.1 High 
 Ankara CITY Hospital Turkey Ankara   
27 
(100.0) 
    83154997 Country 18 0.0 Low 13513 16.3 Low 55861 67.2 High 
5081
2 
61.1 High 
 Gazi University Medical Faculty 
Hospital 
Turkey Ankara   7 (100.0)     83154997 Country 18 0.0 Low 13513 16.3 Low 55861 67.2 High 
5081
2 
61.1 High 
 Hacettepe university hospital Turkey Ankara   
23 
(100.0) 
    83154997 Country 18 0.0 Low 13513 16.3 Low 55861 67.2 High 
5081
2 
61.1 High 
 Acibadem Altunizade Hospital Turkey Istanbul   2 (100.0)     83154997 Country 18 0.0 Low 13513 16.3 Low 55861 67.2 High 
5081
2 
61.1 High 
 Acibadem Atakent Hospital Turkey Istanbul   
17 
(100.0) 
    83154997 Country 18 0.0 Low 13513 16.3 Low 55861 67.2 High 
5081
2 
61.1 High 
 Acibadem Maslak Hospital Turkey Istanbul   
14 
(100.0) 
    83154997 Country 18 0.0 Low 13513 16.3 Low 55861 67.2 High 
5081
2 
61.1 High 
 Kanuni Sultan Suleyman 
Training and Research Hospital 
Turkey Istanbul   
16 
(100.0) 
    83154997 Country 18 0.0 Low 13513 16.3 Low 55861 67.2 High 
5081
2 
61.1 High 
 Sisli Hamidiye Etfal Training and 
Research Hospital 
Turkey Istanbul   
13 
(100.0) 
    83154997 Country 18 0.0 Low 13513 16.3 Low 55861 67.2 High 
5081
2 
61.1 High 
 Sehit Prof.Dr. İlhan Varank 
Training and Research Hospital 
Turkey Istanbul   6 (100.0)     83154997 Country 18 0.0 Low 13513 16.3 Low 55861 67.2 High 
5081
2 
61.1 High 
 Van yuzuncu yil university, 
medical faculty 
Turkey Van   1 (100.0)     83154997 Country 18 0.0 Low 13513 16.3 Low 55861 67.2 High 
5081
2 
61.1 High 
 Aberdeen Royal Infirmary UK Aberdeen 5 (8.6) 53 (91.4)   585700   Region 12 2.0 Low 74 12.6 Low 271 46.3 High 477 81.4 High 
 Antrim Area Hospital- Northern 
Health and Social Care Trust 
Northen 
Ireland 
Antrim 1 (16.7) 5 (83.3)     1893667 Country 44 2.3 Low 541 28.6 High 1502 79.3 High 1448 76.5 High 
 University Hospital Ayr UK Ayr 1 (4.3) 22 (95.7)   369360   Region 6 1.6 Low 171 46.3 High 280 75.8 High 305 82.6 High 
 City Hospital, Dudley Road UK 
Birmingha
m 
7 (30.4) 16 (69.6) 1141816     City 55 4.8 Low 1009 88.4 High 1090 95.5 High 758 66.4 High 
 Heartlands Hospital UK 
Birmingha
m 
6 (28.6) 15 (71.4) 1141816     City 55 4.8 Low 1009 88.4 High 1090 95.5 High 758 66.4 High 
 Queen Elizabeth Hospital 
Birmingham 
UK 
Birmingha
m 
24 (29.6) 57 (70.4) 1141816     City 55 4.8 Low 1009 88.4 High 1090 95.5 High 758 66.4 High 
 Sandwell General Hospital UK 
Birmingha
m 
1 (12.5) 7 (87.5) 1141816     City 55 4.8 Low 1009 88.4 High 1090 95.5 High 758 66.4 High 
 Royal Orthopaedic Hospital UK 
Birmingha
m 
18 (100.0)   1141816     City 55 4.8 Low 1009 88.4 High 1090 95.5 High 758 66.4 High 
 Royal Blackburn Hospital UK Blackburn 2 (5.6) 34 (94.4) 149696     City 23 15.4 Low 23 15.4 Low 170 113.6 High 114 76.2 High 
 Addenbrooke's Hospital UK 
Cambridg
e 
2 (2.9) 67 (97.1) 124798     City 5 4.0 Low 33 26.4 High 75 60.1 High 62 49.7 High 
 Royal Papworth Hospital UK 
Cambridg
e 
54 (94.7) 3 (5.3) 124798     City 5 4.0 Low 33 26.4 High 75 60.1 High 62 49.7 High 
 University Hospital Llandough UK Cardiff 42 (100.0)     496413   Region 15 3.0 Low 525 105.8 High 1136 228.8 High 594 119.7 High 
 University Hospital of Wales UK Cardiff 2 (18.2) 9 (81.8)   496413   Region 15 3.0 Low 525 105.8 High 1136 228.8 High 594 119.7 High 
 University Hospitals Coventry 
and Warwickshire NHS trusts 
UK Coventry 4 (5.3) 71 (94.7) 371521     City 13 3.5 Low 194 52.2 High 285 76.7 High 182 49.0 High 
 Royal Derby Hospital UK Derby 3 (20.0) 12 (80.0) 248700     City 11 4.4 Low 200 80.4 High 181 72.8 High 111 44.6 High 
 Epsom & St Helier University 
Hospitals NHS Trust 
UK Epsom 7 (70.0) 3 (30.0) 79928     City 3 3.8 Low 62 77.6 High 103 128.9 High 29 36.3 High 
 Royal Devon and Exeter 
Hospital 
UK Exeter 2 (4.8) 40 (95.2) 131405     City 6 4.6 Low 26 19.8 Low 83 63.2 High 40 30.4 High 
 Queen Elizabeth Hospital UK 
Gateshea
d 
4 (23.5) 13 (76.5) 202508     City 2 1.0 Low 100 49.4 High 436 215.3 High 317 156.5 High 
 Golden Jubilee National 
Hospital 
UK Glasgow 60 (100.0)     1183120   Region 39 3.3 Low 508 42.9 High 1114 94.2 High 1098 92.8 High 
 Royal Surrey County Hospital UK Guildford 13 (12.3) 93 (87.7) 147889     City 14 9.5 Low 53 35.8 High 176 119.0 High 85 57.5 High 
 Royal Free Hospital UK 
London 
(Camden) 
6 (30.0) 14 (70.0) 270029     City 33 12.2 Low 211 78.1 High 246 91.1 High 95 35.2 High 
 Northwick Park Hospital UK 
London 
(Harrow) 
3 (42.9) 4 (57.1) 251160     City 39 15.5 Low 352 140.1 High 344 137.0 High 203 80.8 High 
 Hull University Teaching 
Hospitals NHS Trust 
UK Hull 115 (92.7) 9 (7.3) 259778     City 10.5 4.0 Low 10.5 4.0 Low 200 77.0 High 280 107.8 High 
 St James's University Hospital 
Leeds 
UK Leeds 4 (3.4) 
112 
(96.6) 
793139     City 14 1.8 Low 224 28.2 High 587 74.0 High 629 79.3 High 
 Glenfield Hospital UK Leicester 18 (100.0)   329839     City 5 1.5 Low 129 39.1 High 313 94.9 High 238 72.2 High 
 Leicester Royal Infirmary UK Leicester 7 (100.0)   329839     City 5 1.5 Low 129 39.1 High 313 94.9 High 238 72.2 High 
 Aintree University Hospital UK Liverpool 1 (2.5) 39 (97.5) 498042     City 16 3.2 Low 331 66.5 High 730 146.6 High 373 74.9 High 
 Liverpool Heart and Chest 
Hospital 
UK Liverpool 23 (100.0)   498042     City 16 3.2 Low 331 66.5 High 730 146.6 High 373 74.9 High 
 Altnagelvin Area Hospital 
Northen 
Ireland 
Londonde
rry 
7 (21.2) 26 (78.8)     1893667 Country 44 2.3 Low 541 28.6 High 1502 79.3 High 1448 76.5 High 
 Chelsea and Westminster 
Hospital 
UK 
London 
(Kensingt
on and 
Chelsea) 
2 (50.0) 2 (50.0) 156129     City 54 34.6 High 171 109.5 High 165 105.7 High 73 46.8 High 
 Guy's Hospital UK 
London 
(Southwa
rk) 
16 (88.9) 2 (11.1) 317256     City 72 22.7 Low 470 148.1 High 511 161.1 High 156 49.2 High 
 Hammersmith Hospital UK 
London 
(Hammer
smith and 
Fulham)  
23 (100.0)   185143     City 29 15.7 Low 184 99.4 High 233 125.8 High 176 95.1 High 
 Royal London Hospital UK 
London 
(Tower 
Hamlets) 
8 (66.7) 4 (33.3) 324745     City 25 7.7 Low 235 72.4 High 277 85.3 High 69 21.2 Low 
 St George's Hospital UK 
London 
(Wandsw
orth) 
5 (41.7) 7 (58.3) 329677     City 65 19.7 Low 393 119.2 High 358 108.6 High 125 37.9 High 
 St Thomas' Hospital UK 
London 
(Lambeth
) 
4 (100.0)   326034     City 67 20.6 Low 482 147.8 High 448 137.4 High 151 46.3 High 
University College London 
Hospital at Westmoreland Street 
UK 
London 
(City of 
Westmins
ter) 
3 (100.0)   261317     City 75 28.7 High 251 96.1 High 218 83.4 High 79 30.2 High 
 University College London 
Hospital 
UK 
London 
(City of 
Westmins
ter) 
22 (88.0) 3 (12.0) 261317     City 75 28.7 High 251 96.1 High 218 83.4 High 79 30.2 High 
 Royal Lancaster Infirmary UK 
Morecam
be 
1 (20.0) 4 (80.0) 146038     City 5 3.4 Low 223 152.7 High 333 228.0 High 159 108.9 High 
 Royal Victoria Infirmary UK 
Newcastl
e upon 
Tyne 
86 (100.0)   302820     City 13 4.3 Low 216 71.3 High 445 147.0 High 260 85.9 High 
 Royal Gwent Hospital UK Newport 2 (5.4) 35 (94.6)   561400   Region 59 10.5 Low 775 138.0 High 867 154.4 High 445 79.3 High 
 Northampton General Hospital UK 
Northam
pton 
1 (14.3) 6 (85.7) 224610     City 6 2.7 Low 91 40.5 High 225 100.2 High 59 26.3 High 
 Nottingham City Hospital UK 
Nottingha
m 
115 (69.7) 50 (30.3) 321500     City 17 5.3 Low 115 35.8 High 218 67.8 High 174 54.1 High 
 Queens Medical Centre UK 
Nottingha
m 
5 (20.8) 19 (79.2) 321500     City 17 5.3 Low 115 35.8 High 218 67.8 High 174 54.1 High 
 Northumbria NHS Hospital Trust UK 
North 
Shields 
1 (5.0) 19 (95.0) 207913     City 7 3.4 Low 88 42.3 High 263 126.5 High 126 60.6 High 
 Robert Jones and Agnes Hunt 
Orthopaedic Hospital 
UK Oswestry 10 (100.0)     323136   Region 26 8.0 Low 99 30.6 High 178 55.1 High 217 67.2 High 
 John Radcliffe Hospital UK Oxford 85 (77.3) 25 (22.7) 154600     City 14 9.1 Low 76 49.2 High 272 175.9 High 1236 799.5 High 
 Nuffield Orthopaedic Centre UK Oxford 11 (100.0)   154600     City 14 9.1 Low 76 49.2 High 272 175.9 High 1236 799.5 High 
 Poole Hospital UK Poole 1 (20.0) 4 (80.0)   772268   Region 8 1.0 Low 73 9.5 Low 148 19.2 Low 90 11.7 Low 
 Royal Preston Hospital UK Preston 1 (2.9) 34 (97.1) 141818     City 3 2.1 Low 56 39.5 High 160 112.8 High 126 88.8 High 
 Queen's Hospital Romford UK 
London 
(Havering
) 
2 (50.0) 2 (50.0) 259552     City 13 5.0 Low 163 62.8 High 353 136.0 High 111 42.8 High 
 Royal Hallamshire Hospital UK Sheffield 35 (92.1) 3 (7.9) 584853     City 36 6.2 Low 730 124.8 High 1551 265.2 High 631 107.9 High 
 Royal National Orthopaedic 
Hospital 
UK 
London 
(Harrow) 
10 (100.0)   251160     City 39 15.5 Low 352 140.1 High 344 137.0 High 203 80.8 High 
 Stepping Hill Hospital UK Stockport 2 (66.7) 1 (33.3) 291775     City 15 5.1 Low 145 49.7 High 437 149.8 High 280 96.0 High 
 Royal Stoke University Hospital UK 
Stoke-on-
Trent 
10 (21.7) 36 (78.3) 256375     City 3 1.2 Low 68 26.5 High 183 71.4 High 235 91.7 High 
 Good Hope Hospital UK 
Birmingha
m (Sutton 
Coldfield) 
1 (50.0) 1 (50.0) 1141820     City 55 4.8 Low 1009 88.4 High 1090 95.5 High 758 66.4 High 
 Musgrove Park Hospital UK Taunton 5 (33.3) 10 (66.7) 118979     City 10.5 8.8 Low 10.5 8.8 Low 73 61.4 High 107 89.9 High 
 South Warwickshire NHS 
Foundation Trust 
UK Warwick 3 (37.5) 5 (62.5) 138600     City 2 1.4 Low 59 42.6 High 112 80.8 High 73 52.7 High 
 Hampshire Hospitals NHS Trust UK 
Winchete
r & 
Basingsto
ke 
18 (69.2) 8 (30.8)   1376316   Region 83 6.0 Low 696 50.6 High 1214 88.2 High 850 61.8 High 
 Wirral University Teaching 
Hospital 
UK Wirral 37 (94.9) 2 (5.1) 324011     City 10 3.1 Low 129 39.8 High 595 183.6 High 293 90.4 High 
 Royal Wolverhampton NHS 
Trust 
UK 
Wolverha
mpton 
20 (55.6) 16 (44.4) 263357     City 40 15.2 Low 221 83.9 High 270 102.5 High 324 123.0 High 
 Worcestershire Royal Hospital UK 
Worceste
r 
1 (100.0)   101328     City 3 3.0 Low 35 34.5 High 90 88.8 High 66 65.1 High 
 Ysbyty Gwynedd UK 
Bangor, 
North 
Wales 
  
15 
(100.0) 
  678500   Region 6 0.9 Low 132 19.5 Low 589 86.8 High 663 97.7 High 
 Barnsley Hospital NHS 
Foundation Trust 
UK Barnsley   4 (100.0) 246866     City 7 2.8 Low 172 69.7 High 273 110.6 High 232 94.0 High 
 Furness General Hospital UK 
Barrow in 
Furness 
  6 (100.0) 67049     City 6 8.9 Low 144 214.8 High 304 453.4 High 80 119.3 High 
 Royal Victoria Hospital 
Northen 
Ireland 
Belfast   
11 
(100.0) 
    1893667 Country 44 2.3 Low 541 28.6 High 1502 79.3 High 1448 76.5 High 
 Royal Bournemouth Hospital UK 
Bournem
outh 
  
37 
(100.0) 
183491     City 10 5.4 Low 67 36.5 High 218 118.8 High 127 69.2 High 
 Bradford Royal Infirmary UK Bradford   
19 
(100.0) 
539776     City 7 1.3 Low 142 26.3 High 372 68.9 High 407 75.4 High 
 Bristol Royal Infirmary UK Bristol   
19 
(100.0) 
463400     City 11 2.4 Low 140 30.2 High 268 57.8 High 199 42.9 High 
 Southmead Hospital UK Bristol   
30 
(100.0) 
463400     City 11 2.4 Low 140 30.2 High 268 57.8 High 199 42.9 High 
 University Hospitals Bristol NHS 
Foundation Trust 
UK Bristol   
14 
(100.0) 
463400     City 11 2.4 Low 140 30.2 High 268 57.8 High 199 42.9 High 
 West Suffolk Hospital UK 
Bury St 
Edmunds 
  6 (100.0) 179045     City 2 1.1 Low 27 15.1 Low 53 29.6 High 82 45.8 High 
 Cumberland Infirmary UK Carlisle   9 (100.0) 108678     City 12 11.0 Low 83 76.4 High 176 161.9 High 129 118.7 High 
 Broomfield Hospital UK 
Chelmsfor
d 
  5 (100.0) 178388     City 14 7.8 Low 81 45.4 High 115 64.5 High 125 70.1 High 
 Cheltenham General Hospital UK 
Cheltenha
m 
  
20 
(100.0) 
116306     City 3 2.6 Low 61 52.4 High 162 139.3 High 74 63.6 High 
 Countess of Chester Hospital UK Chester   4 (100.0) 343071     City 8 2.3 Low 120 35.0 High 396 115.4 High 313 91.2 High 
 Causeway Hospital 
Northen 
Ireland 
Coleraine   
12 
(100.0) 
    1893667 Country 44 2.3 Low 541 28.6 High 1502 79.3 High 1448 76.5 High 
 Dumfries and Galloway Royal 
Infirmary 
UK Dumfries   
27 
(100.0) 
  148860   Region 46 30.9 High 46 30.9 High 115 77.3 High 39 26.2 High 
 Ninewells Hospital UK Dundee   7 (100.0)   417470   Region 15 3.6 Low 199 47.7 High 684 163.8 High 451 108.0 High 
 Royal Infirmary of Edinburgh UK 
Edinburg
h 
  
10 
(100.0) 
  907580   Region 28 3.1 Low 241 26.6 High 771 85.0 High 940 103.6 High 
 Western General Hospital UK 
Edinburg
h 
  
23 
(100.0) 
  907580   Region 28 3.1 Low 241 26.6 High 771 85.0 High 940 103.6 High 
 Royal Bolton Hospital UK 
Farnwort
h 
  
10 
(100.0) 
287550     City 9 3.1 Low 93 32.3 High 438 152.3 High 284 98.8 High 
 Medway hospital UK 
Gillingha
m 
  
22 
(100.0) 
278556     Region 13 4.7 Low 123 44.2 High 318 114.2 High 188 67.5 High 
 Queen Elizabeth University 
Hospital 
UK Glasgow   
27 
(100.0) 
  1183120   Region 39 3.3 Low 508 42.9 High 1114 94.2 High 1098 92.8 High 
 Gloucestershire Royal Hospital UK 
Glouceste
r 
  3 (100.0) 129128     City 2 1.5 Low 49 37.9 High 145 112.3 High 150 116.2 High 
 Diana Princess of Wales 
Hospital Grimsby 
UK Grimsby   
10 
(100.0) 
159563     City 15.5 9.7 Low 15.5 9.7 Low 60 37.6 High 45 28.2 High 
 James Paget Univeristy NHS 
Foundation Trust Hospital 
UK 
Great 
Yarmouth 
  6 (100.0) 99336     City 1 1.0 Low 39 39.3 High 110 110.7 High 50 50.3 High 
 Harrogate District Hospital UK Harrogate   
17 
(100.0) 
160831     City 2 1.2 Low 42 26.1 High 89 55.3 High 99 61.6 High 
 East Sussex Healthcare 
(Conquest hospital and 
Eastbourne District General 
Hospital) 
UK Hastings   
12 
(100.0) 
92855     City 1 1.1 Low 13 14.0 Low 18 19.4 Low 9 9.7 Low 
 Princess Royal Hospital UK 
Hayward'
s Heath 
  5 (100.0) 151022     City 6 4.0 Low 61 40.4 High 123 81.4 High 75 49.7 High 
 Victoria Hospital Kirkcaldy UK Kirkcaldy   9 (100.0)   373550   Region 7 1.9 Low 69 18.5 Low 348 93.2 High 313 83.8 High 
 Forth Valley Royal Hospital UK Larbert   8 (100.0)   306640   Region 10 3.3 Low 121 39.5 High 249 81.2 High 344 112.2 High 
 Lincoln County Hospital UK Lincoln   
14 
(100.0) 
97541     City 1 1.0 Low 25 25.6 High 45 46.1 High 33 33.8 High 
 Royal Liverpool University 
Hospital 
UK Liverpool   
22 
(100.0) 
498042     City 16 3.2 Low 331 66.5 High 730 146.6 High 373 74.9 High 
 Homerton University Hospital UK 
London 
(Hackney) 
  
15 
(100.0) 
281120     City 30 10.7 Low 222 79.0 High 290 103.2 High 71 25.3 High 
 The Whittington Hospital 
Northen 
Ireland 
Londonde
rry 
  8 (100.0)     1893667 Country 44 2.3 Low 541 28.6 High 1502 79.3 High 1448 76.5 High 
 Luton and Dunstable Hospital UK Luton   
12 
(100.0) 
213052     City 3 1.4 Low 148 69.5 High 315 147.9 High 175 82.1 High 
 Tunbridge Wells Hospital UK 
Maidston
e 
  1 (100.0) 171826       3 1.7 Low 57 33.2 High 145 84.4 High 142 82.6 High 
 The University Hospital of South 
Manchester 
UK 
Manchest
er 
  
10 
(100.0) 
552858     City 18 3.3 Low 210 38.0 High 654 118.3 High 311 56.3 High 
 Manchester Royal Infirmary  UK 
Manchest
er 
  
11 
(100.0) 
552858     City 18 3.3 Low 210 38.0 High 654 118.3 High 311 56.3 High 
 James Cook University Hospital UK 
Middlesbr
ough 
  
19 
(100.0) 
138400     City 1 0.7 Low 86 62.1 High 264 190.8 High 213 153.9 High 
 Milton Keynes University 
Hospital 
UK 
Milton 
Keynes 
  1 (100.0) 229941     City 5 2.2 Low 143 62.2 High 211 91.8 High 118 51.3 High 
 Norfolk and Norwich University 
Hospital 
UK Norwich   4 (100.0) 143135     City 3 2.1 Low 14 9.8 Low 74 51.7 High 77 53.8 High 
 George Eliot Hospital UK Nuneaton   3 (100.0) 129883     City 14 10.8 Low 80 61.6 High 139 107.0 High 84 64.7 High 
 Derriford Hospital UK Plymouth   
29 
(100.0) 
262100     City 6 2.3 Low 52 19.8 Low 131 50.0 High 102 38.9 High 
 Queen Alexandra Hospital UK 
Portsmou
th 
  1 (100.0) 238800     City 9 3.8 Low 76 31.8 High 132 55.3 High 69 28.9 High 
 East Surrey Hospital UK Redhill   
27 
(100.0) 
148748     City 9 6.1 Low 125 84.0 High 223 149.9 High 117 78.7 High 
 Glan Clwyd Hospital UK Rhyl   6 (100.0)   694000   Region 6 0.9 Low 132 19.0 Low 589 84.9 High 663 95.5 High 
 Northern General Hospital UK Sheffield   
37 
(100.0) 
584853     City 36 6.2 Low 730 124.8 High 821 140.4 High 631 107.9 High 
 Southampton General Hospital UK 
Southam
pton 
  7 (100.0) 269781     City 6 2.2 Low 119 44.1 High 186 68.9 High 172 63.8 High 
 Sunderland Royal Hospital UK 
Sunderlan
d 
  
18 
(100.0) 
277417     City 3 1.1 Low 161 58.0 High 657 236.8 High 367 132.3 High 
 King's Mill Hospital UK 
Sutton-In-
Ashfield 
  7 (100.0) 127918     City 6 4.7 Low 38 29.7 High 94 73.5 High 62 48.5 High 
 Morriston Hospital Swansea UK Swansea   
12 
(100.0) 
  389372   Region 29 7.4 Low 225 57.8 High 805 206.7 High 549 141.0 High 
 Torbay and South Devon NHS 
Trust 
UK Torquay   
11 
(100.0) 
130959     City 7 5.3 Low 42 32.1 High 61 46.6 High 93 71.0 High 
 Pinderfields Hospital UK wakefield   4 (100.0) 348312     City 9 2.6 Low 105 30.1 High 268 76.9 High 162 46.5 High 
 Weston General Hospital UK 
Weston-
super-
Mare 
  5 (100.0) 215052     City 16 7.4 Low 39 18.1 Low 90 41.9 High 105 48.8 High 
 York Teaching Hospitals NHS 
Trust 
UK York   6 (100.0) 210618     City 7 3.3 Low 32 15.2 Low 121 57.4 High 150 71.2 High 
 Memorial Sloan Kettering 
Cancer Center 
United 
States 
New York 74 (100.0)   8175133     City 463 5.7 Low 46976 574.6 High 75707 926.1 High 
4654
4 
569.3 High 
 Fox Chase Cancer Center 
United 
States 
Philadelp
hia 
4 (100.0)   1584064     City 8 0.5 Low 1307 82.5 High 6126 386.7 High 7027 443.6 High 
 UCSF Mission Bay 
United 
States 
San 
Francisco 
58 (73.4) 21 (26.6) 881549     City 34 3.9 Low 411 46.6 High 649 73.6 High 554 62.8 High 
 UCSF Parnassus Campus 
United 
States 
San 
Francisco 
2 (22.2) 7 (77.8) 881550     City 34 3.9 Low 411 46.6 High 649 73.6 High 554 62.8 High 
 Moffitt Cancer Center 
United 
States 
Tampa 4 (100.0)   1471968     City 6 0.4 Low 299 20.3 Low 565 38.4 High 254 17.3 Low 
 Dell Seton Medical Center 
United 
States 
Austin   
21 
(100.0) 
1273954     City 6 0.5 Low 200 15.7 Low 771 60.5 High 677 53.1 High 
 Johns Hopkins Hospital 
United 
States 
Baltimore
, MD 
  
170 
(100.0) 
827370     City 1 0.1 Low 186 22.5 Low 875 105.8 High 1014 122.6 High 
 University of Colorado 
Hospital/Memorial 
Hospital/Medical Center of the 
Rockies (all within UCHealth 
System) 
United 
States 
Denver/C
olorado 
Springs/L
oveland 
  7 (100.0)   5758736   Region 131 2.3 Low 2835 49.2 High 5314 92.3 High 7004 121.6 High 
 Henry Ford Hospital 
United 
States 
Detroit, 
Michigan 
  2 (100.0) 1749343     City 13 0.7 Low 3722 212.8 High 8809 503.6 High 4185 239.2 High 
 Duke University Medical Center 
United 
States 
Durham, 
NC ? 
  8 (100.0) 321488     City 1 0.3 Low 121 37.6 High 208 64.7 High 398 123.8 High 
 University of Texas MD 
Anderson Cancer Center 
United 
States 
Houston   
69 
(100.0) 
4713325     City 13 0.3 Low 550 11.7 Low 3534 75.0 High 2259 47.9 High 
 Dartmouth-Hitchcock Medical 
Center 
United 
States 
Lebanon, 
NH 
  4 (100.0) 89118     City 5 5.6 Low 30 33.7 High 9 10.1 Low 6 6.7 Low 
 Kaiser Permanente West Los 
Angeles 
United 
States 
Los 
Angeles 
  6 (100.0) 9818605     City 53 0.5 Low 2958 30.1 High 7485 76.2 High 
1268
6 
129.2 High 
 University of Wisconsin 
United 
States 
Madison   
24 
(100.0) 
488075     City 5 1.0 Low 189 38.7 High 157 32.2 High 77 15.8 Low 
 Vanderbilt University Medical 
Center 
United 
States 
Nashville   
15 
(100.0) 
694144     City 17 2.4 Low 524 75.5 High 951 137.0 High 1177 169.6 High 
 Kaiser Permanente Panorama 
City Medical Center 
United 
States 
Los 
Angeles 
(Panoram
a City) 
  6 (100.0) 9818605     City 53 0.5 Low 2958 30.1 High 7485 76.2 High 
1268
6 
129.2 High 
 Kaiser Permanente San Diego 
Medical Center 
United 
States 
San Diego   
20 
(100.0) 
3095313     City 39 1.3 Low 694 22.4 Low 1278 41.3 High 1615 52.2 High 
 Harborview Medical Center 
United 
States 
Seattle   1 (100.0) 1931249     City 421 21.8 Low 1911 99.0 High 2367 122.6 High 1611 83.4 High 
 UCSF Medical Center 
United 
States 
San 
Fransisco 
  
10 
(100.0) 
881550     City 34 3.9 Low 411 46.6 High 649 73.6 High 554 62.8 High 
 SUNY Upstate University 
Hospital 
United 
States 
Syracuse   6 (100.0) 467026     City 1 0.2 Low 193 41.3 High 255 54.6 High 383 82.0 High 
 Hospital Pereira Uruguay 
Montevid
eo 
  4 (100.0)     3449285 Country 8 0.2 Low 330 9.6 Low 155 4.5 Low 150 4.3 Low 
 Health Sciences Centre Canada Winnipeg   1 (100.0)   1278365   Region 7 0.5 Low 96 7.5 Low 144 11.3 Low 29 2.3 Low 
 The Walton Centre NHS 
Foundation Trust 
UK Liverpool   2 (100.0) 498042     City 16 3.2 Low 331 66.5 High 730 146.6 High 373 74.9 High 
 The National Hospital for 
Neurology and Neurosurgery 
UK London   7 (100.0) 270029     City 32 11.9 Low 211 78.1 High 246 91.1 High 95 35.2 High 
 Whipps Cross University 
Hospital 
UK London   1 (100.0) 276983     City 15 5.4 Low 277 100.0 High 328 118.4 High 105 37.9 High 
 Salford Royal Hospital UK Salford   4 (100.0) 248419     City 9 3.6 Low 182 73.3 High 334 134.5 High 270 108.7 High 
 Tripoli Central Hospital Libya Tripoli   1 (100.0)     6871288 Country 4 0.1 Low 4 0.1 Low 27 0.4 Low 26 0.4 Low 
 Cheikh Zaid International 
University Hospital 
Morocco Rabat 3 (100.0)       36472000 Country 28 0.1 Low 589 1.6 Low 1407 3.9 Low 2399 6.6 Low 
 Centre Hospitalier Universitaire 
Ibn Sina Rabat 
Morocco Rabat   5 (100.0)     36472000 Country 28 0.1 Low 589 1.6 Low 1407 3.9 Low 2399 6.6 Low 
 Clinic for Neurosurgery, Clinical 
Center of Serbia 
Serbia Belgrade 9 (100.0)       6963764 Country 48 0.7 Low 852 12.2 Low 3973 57.1 High 4136 59.4 High 
 Sahlgrenska University Hospital Sweden 
Gothenbu
rg 
1 (100.0)     1725881   Region 170 9.9 Low 250 14.5 Low 1059 61.4 High 1277 74.0 High 
 University of Texas 
Southwestern 
United 
States 
Dallas   1 (100.0) 2635516     City 14 0.5 Low 617 23.4 Low 1355 51.4 High 1545 58.6 High 
 
 
High risk was defined as a 14-day cumulative notification rate greater than 25 per 100,000 population and low risk less than 25 cases per 100,000 population according to European Centre for Disease Control and Prevention reporting criteria 
during two-week periods in March and April 2020. The participating hospital listed is that in where the initial multidisciplinary, tumour board or surgeon decision for curative surgery was made. 
 Supplementary table 2. Primary operations performed in COVID-19 free surgical pathways and hospitals 
with no defined pathway. 
 
Primary operation(s) and OPCS-4 Code  COVID-19 free surgical pathway No defined pathway 
A021 Excision Of Lesion Of Tissue Of Frontal Lobe Of Brain 23 (23.7) 74 (76.3) 
A022 Excision Of Lesion Of Tissue Of Temporal Lobe Of Brain 12 (22.6) 41 (77.4) 
A023 Excision Of Lesion Of Tissue Of Parietal Lobe Of Brain 8 (18.2) 36 (81.8) 
A024 Excision Of Lesion Of Tissue Of Occipital Lobe Of Brain 6 (40.0) 9 (60.0) 
A025 Excision Of Lesion Of Tissue Of Cerebellum 2 (11.1) 16 (88.9) 
A026 Excision Of Lesion Of Tissue Of Brain Stem 2 (33.3) 4 (66.7) 
A032 Stereotactic Ablation Of Tissue Of Thalamus  1 (100.0) 
A034 Stereotactic Ablation Of Tissue Of Brain Stem  1 (100.0) 
A041 Open Biopsy Of Lesion Of Tissue Of Frontal Lobe Of Brain  3 (100.0) 
A042 Open Biopsy Of Lesion Of Tissue Of Temporal Lobe Of Brain  1 (100.0) 
A043 Open Biopsy Of Lesion Of Tissue Of Parietal Lobe Of Brain  1 (100.0) 
A044 Open Biopsy Of Lesion Of Tissue Of Occipital Lobe Of Brain  1 (100.0) 
A045 Open Biopsy Of Lesion Of Tissue Of Cerebellum  1 (100.0) 
A081 Biopsy Of Lesion Of Tissue Of Frontal Lobe Of Brain 3 (30.0) 7 (70.0) 
A082 Biopsy Of Lesion Of Tissue Of Temporal Lobe Of Brain  1 (100.0) 
A083 Biopsy Of Lesion Of Tissue Of Parietal Lobe Of Brain  4 (100.0) 
A086 Biopsy Of Lesion Of Tissue Of Brain Stem  3 (100.0) 
A107 Stereotactic Radiosurgery On Tissue Of Brain 2 (66.7) 1 (33.3) 
A124 Creation Of Ventriculoperitoneal Shunt 1 (50.0) 1 (50.0) 
A171 Endoscopic Extirpation Of Lesion Of Ventricle Of Brain 1 (20.0) 4 (80.0) 
A295 Excision Of Lesion Of Acoustic Nerve (Viii) 1 (14.3) 6 (85.7) 
A298 Excision Of Lesion Of Specified Cranial Nerve  5 (100.0) 
A381 Extirpation Of Lesion Of Meninges Of Cortex Of Brain 2 (10.5) 17 (89.5) 
A382 Extirpation Of Lesion Of Meninges Of Sphenoidal Ridge Of Cranium 2 (20.0) 8 (80.0) 
A383 Extirpation Of Lesion Of Meninges Of Subfrontal Region Of Brain  12 (100.0) 
A384 Extirpation Of Lesion Of Meninges Of Parasagittal Region  7 (100.0) 
A386 Extirpation Of Lesion Of Tentorium Cerebelli  1 (100.0) 
A422 Biopsy Of Lesion Of Meninges Of Brain 1 (33.3) 2 (66.7) 
A481 Biopsy Of Lesion Of Spinal Cord  1 (100.0) 
A511 Extirpation Of Lesion Of Meninges Of Spinal Cord  2 (100.0) 
A604 Radiofrequency Controlled Thermal Destruction Of Peripheral  1 (100.0) 
A611 Excision Of Lesion Of Peripheral Nerve  1 (100.0) 
A764 Chemical Destruction Of Perivascular Sympathetic Nerve  1 (100.0) 
B012 Trans-Sphenoidal Hypophysectomy 1 (50.0) 1 (50.0) 
B014 Transcranial Hypophysectomy  1 (100.0) 
B041 Excision Of Lesion Of Pituitary Gland 4 (9.3) 39 (90.7) 
B042 Biopsy Of Lesion Of Pituitary Gland  1 (100.0) 
B043 Decompression Of Pituitary Gland  1 (100.0) 
B045 Operations On Pituitary Stalk 2 (66.7) 1 (33.3) 
B081 Total Thyroidectomy 82 (31.5) 178 (68.5) 
B082 Subtotal Thyroidectomy  3 (100.0) 
B083 Hemithyroidectomy 28 (48.3) 30 (51.7) 
B084 Lobectomy Of Thyroid Gland 9 (64.3) 5 (35.7) 
B085 Isthmectomy Of Thyroid Gland 4 (66.7) 2 (33.3) 
B086 Partial Thyroidectomy  1 (100.0) 
B121 Excision Of Lesion Of Thyroid Gland  1 (100.0) 
B122 Biopsy Of Lesion Of Thyroid Gland 4 (100.0)  
B142 Global Parathyroidectomy  1 (100.0) 
B162 Biopsy Of Lesion Of Parathyroid Gland  1 (100.0) 
B181 Trans-Sternal Thymectomy 3 (17.6) 14 (82.4) 
B182 Transcervical Thymectomy 1 (50.0) 1 (50.0) 
B202 Exploration Of Thymus Gland  2 (100.0) 
B221 Bilateral Salpingoophorectomy 2 (66.7) 1 (33.3) 
B222 Bilateral Adrenalectomy  1 (100.0) 
B223 Unilateral Adrenalectomy 1 (16.7) 5 (83.3) 
B224 Partial Adrenalectomy  1 (100.0) 
B271 Total Mastectomy and Excision of both Pectoral Muscles  21 (80.8) 5 (19.2) 
B272 Total Mastectomy And Excision Of Both Pectoral Muscles 3 (16.7) 15 (83.3) 
B273 Total Mastectomy And Excision Of Pectoralis Minor Muscle 49 (90.7) 5 (9.3) 
B274 Total Mastectomy 768 (42.9) 1024 (57.1) 
B275 Subcutaneous Mastectomy 77 (46.4) 89 (53.6) 
B276 Skin Sparing Mastectomy 46 (28.8) 114 (71.2) 
B282 Partial Excision of Breast 358 (34.8) 671 (65.2) 
B283 Excision of lesion of breast 378 (33.1) 763 (66.9) 
B284 Re-excision of breast margins 5 (23.8) 16 (76.2) 
B287 Wire guided excision of lesion of breast 1 (25.0) 3 (75.0) 
B289 Unspecified other excision of breast 1 (50.0) 1 (50.0) 
B292 Reconstruction Of Breast Using Local Flap Of Skin 4 (57.1) 3 (42.9) 
B294 Reconstruction Of Breast Using Distant Flap Of Skin  1 (100.0) 
B296 Reconstruction Of Breast Using Glandular Remodelling 2 (66.7) 1 (33.3) 
B297 Reconstruction Of Breast Using Dermoglandular Flap 7 (87.5) 1 (12.5) 
B301 Insertion Of Prosthesis For Breast 2 (100.0)  
B311 Reduction mammoplasty  4 (23.5) 13 (76.5) 
B312 Augmentation mammoplasty  2 (100.0)  
B314 Revision of mammoplasty 2 (12.5) 14 (87.5) 
B321 Percutaneous Biopsy Of Lesion Of Breast  1 (100.0) 
B322 Biopsy Of Lesion Of Breast 24 (75.0) 8 (25.0) 
B323 Wire Guided Biopsy Of Lesion Of Breast 31 (27.9) 80 (72.1) 
B344 Microdochotomy  1 (100.0) 
 B376 Partial Capsulectomy Of Breast 1 (100.0)  
B393 Reconstruction Of Breast Using Free Deep Inferior Epigastric Flap  1 (100.0) 
B411 Radionuclide Guided Excision Of Lesion Of Breast  56 (100.0) 
B412 Radionuclide Guided Partial Excision Of Breast 4 (16.7) 20 (83.3) 
C011 Exenteration Of Orbit 1 (16.7) 5 (83.3) 
C061 Biopsy Of Lesion Of Orbit  1 (100.0) 
C121 Excision Of Lesion Of Eyelid 5 (83.3) 1 (16.7) 
C391 Excision Of Lesion Of Conjunctiva 1 (100.0)  
D012 Partial Excision Of External Ear  3 (100.0) 
D021 Excision Of Lesion Of External Ear 8 (50.0) 8 (50.0) 
D101 Radical Mastoidectomy  5 (100.0) 
D104 Simple Mastoidectomy 1 (14.3) 6 (85.7) 
D105 Excision Of Lesion Of Mastoid 1 (50.0) 1 (50.0) 
E011 Total Excision Of Nose 4 (66.7) 2 (33.3) 
E018 Other specified excision of nose  2 (100.0) 
E101 Biopsy Of Lesion Of Nose 2 (40.0) 3 (60.0) 
E132 Excision Of Lesion Of Maxillary Antrum 5 (11.4) 39 (88.6) 
E134 Biopsy Of Lesion Of Maxillary Antrum  1 (100.0) 
E143 External ethmoidectomy  1 (100.0) 
E172 Excision of lesion of nasal sinus 1 (100.0)  
E191 Total Pharyngectomy  8 (100.0) 
E192 Partial Pharyngectomy 2 (22.2) 7 (77.8) 
E198 Other specified excision of pharynx  1 (100.0) 
E199 Unspecified excision of pharynx  1 (100.0) 
E242 Endoscopic Extirpation Of Lesion Of Pharynx  2 (100.0) 
E251 Diagnostic Endoscopic Examination Of Nasopharynx And Biopsy 1 (100.0)  
E252 Diagnostic Endoscopic Examination Of Pharynx And Biopsy Of  4 (100.0) 
E291 Total Laryngectomy 12 (21.8) 43 (78.2) 
E292 Partial Horizontal Laryngectomy 1 (50.0) 1 (50.0) 
E293 Partial Vertical Laryngectomy  1 (100.0) 
E294 Partial Laryngectomy 1 (14.3) 6 (85.7) 
E295 Laryngofissure And Cordectomy Of Vocal Cord 14 (60.9) 9 (39.1) 
E296 Laryngectomy 4 (28.6) 10 (71.4) 
E302 Excision Of Lesion Of Larynx Using Lateral Pharyngotomy  1 (100.0) 
E303 Open Destruction Of Lesion Of Larynx 1 (25.0) 3 (75.0) 
E361 Diagnostic endoscopic Examination Of Larynx And Biopsy Of Lesion 1 (5.9) 16 (94.1) 
E391 Open Excision Of Lesion Of Trachea  1 (100.0) 
E411 Open Insertion Of Tubal Prosthesis In Trachea  1 (100.0) 
E421 Permanent tracheostomy  1 (100.0) 
E424 Revision Of Tracheostomy  2 (100.0) 
E461 Sleeve Resection Of Bronchus And Anastomosis  5 (100.0) 
E463 Excision Of Lesion Of Bronchus 1 (50.0) 1 (50.0) 
E502 Endoscopic Laser Destruction Of Lesion Of Lower Respiratory  2 (100.0) 
E504 Endoscopic Aspiration Of Lower Respiratory Tract Using Rigid  1 (100.0) 
E541 Total Pneumonectomy 5 (29.4) 12 (70.6) 
E542 Bilobectomy Of Lung 155 (30.0) 399 (72.0) 
E544 Excision Of Segment Of Lung 47 (33.1) 95 (66.9) 
E545 Partial Lobectomy Of Lung 7 (10.6) 59 (89.4) 
E552 Open Excision Of Lesion Of Lung 3 (50.0) 3 (50.0) 
E554 Open Destruction Of Lesion Of Lung  1 (100.0) 
E593 Biopsy Of Lesion Of Lung 2 (33.3) 4 (66.7) 
E621 Endoscopic Extirpation Of Lesion Of Mediastinum  2 (100.0) 
E629 Unspecified therapeutic endoscopic operations on mediastinum  1 (100.0) 
E631 Diagnostic endoscopic examination of mediastinum and biopsy   1 (100.0) 
E641 Endoscopic Extirpation Of Lesion Of Nasal Cavity 1 (20.0) 4 (80.0) 
F011 Excision Of Vermilion Border Of Lip And Advancement Of Mucosa 1 (20.0) 4 (80.0) 
F021 Excision Of Lesion Of Lip 5 (16.1) 26 (83.9) 
F062 Biopsy Of Lesion Of Lip  1 (100.0) 
F221 Total Glossectomy 2 (16.7) 10 (83.3) 
F222 Partial Glossectomy 36 (24.8) 109 (75.2) 
F231 Excision Of Lesion Of Tongue 19 (15.0) 108 (85.0) 
F241 Biopsy Of Lesion Of Tongue  5 (100.0) 
F281 Excision Of Lesion Of Palate 1 (5.3) 18 (94.7) 
F324 Operations On Uvula  1 (100.0) 
F325 Uvulopalatopharyngoplasty  1 (100.0) 
F328 Other specified other operations on palate  2 (100.0) 
F341 Bilateral Dissection Tonsillectomy  10 (100.0) 
F343 Bilateral Laser Tonsillectomy  2 (100.0) 
F344 Bilateral Excision Of Tonsil 1 (50.0) 1 (50.0) 
F348 Other specified excision of tonsil  3 (100.0) 
F362 Biopsy Of Lesion Of Tonsil  2 (100.0) 
F366 Excision Of Lesion Of Tonsil 4 (17.4) 19 (82.6) 
F381 Excision of lesion of floor of mouth  13 (100.0) 
F421 Biopsy Of Lesion Of Mouth 2 (25.0) 6 (75.0) 
F423 Removal Of Excess Mucosa From Mouth  2 (100.0) 
F441 Total Excision Of Parotid Gland 8 (17.8) 37 (82.2) 
F442 Partial Excision Of Parotid Gland 7 (20.0) 28 (80.0) 
F443 Excision Of Parotid Gland 2 (25.0) 6 (75.0) 
F444 Excision Of Submandibular Gland 2 (40.0) 3 (60.0) 
F445 Excision Of Sublingual Gland  3 (100.0) 
F451 Excision Of Lesion Of Parotid Gland 1 (20.0) 4 (80.0) 
F452 Excision Of Lesion Of Submandibular Gland 2 (100.0)  
F454 Excision Of Lesion Of Salivary Gland 1 (25.0) 3 (75.0) 
G011 Oesophagogastrectomy and Anastomosis of Oesophagus to Stomach  12 (14.8) 69 (85.2) 
G012 Oesophagogastrectomy And Anastomosis Of Oesophagus To Transposed Jejunum  2 (100.0) 
G013 Oesophagogastrectomy And Anastomosis Of Oesophagus To Jejunum 2 (16.7) 10 (83.3) 
G021 Total Oesophagectomy And Anastomosis Of Pharynx To Stomach 14 (9.3) 137 (90.7) 
 G022 Total Oesophagectomy/Interposition Of Microvascularly Attached Jejunum 1 (100.0)  
G025 Total Oesophagectomy And Interposition Of Colon  1 (100.0) 
G031 Partial Oesophagectomy And End To End Anastomosis Of Oesophagus 2 (9.5) 21 (90.5) 
G033 Partial Oesophagectomy And Anastomosis Of Oesophagus To Transposed Jejunum 1 (10.0) 9 (90.0) 
G034 Partial Oesophagectomy And Anastomosis Of Oesophagus To Jejunum 1 (10.0) 9 (90.0) 
G041 Excision Of Lesion Of Oesophagus  1 (100.0) 
G052 Bypass Of Oesophagus By Anastomosis Of Oesophagus To Stomach 1 (11.1) 8 (88.9) 
G271 Total Gastrectomy And Excision Of Surrounding Tissue 4 (100.0)  
G272 Total Gastrectomy And Anastomosis Of Oesophagus To Duodenum 2 (18.2) 9 (81.8) 
G273 Total gastrectomy and interposition of jejunum  25 (20.8) 95 (79.2) 
G274 Total Gastrectomy And Anastomosis Of Oesophagus To Transposed Jejunum 3 (33.3) 6 (66.7) 
G275 Total Gastrectomy And Anastomosis Of Oesophagus To Jejunum 41 (28.3) 104 (71.7) 
G281 Partial gastrectomy and anastomosis of stomach to duodenum  45 (30.8) 101 (69.2) 
G281 Partial Gastrectomy And Anastomosis Of Stomach To Duodenum 7 (21.2) 1 (78.8) 
G282 Partial Gastrectomy And Anastomosis Of Stomach To Transposed Jejunum 9 (39.1) 14 (60.9) 
G283 Partial Gastrectomy And Anastomosis Of Stomach To Jejunum 51 (30.4) 117 (69.6) 
G285 Sleeve Gastrectomy 3 (14.3) 18 (85.7) 
G288 Other specified partial excision of stomach  4 (100.0) 
G292 Open Excision Of Lesion Of Stomach 1 (12.5) 7 (87.5) 
G321 Bypass Of Stomach By Anastomosis Of Stomach To Transposed Je  2 (100.0) 
G336 Attention To Connection Of Stomach To Jejunum 1 (100.0)  
G341 Creation Of Permanent Gastrostomy 1 (25.0) 3 (75.0) 
G342 Creation Of Temporary Gastrostomy  2 (100.0) 
G431 Fibreoptic Endoscopic Snare Resection/Lesion Of Upper Gastrointestinal Tract 1 (100.0)  
G454 Fibreoptic Endoscopic Examination Of Upper Gastrointestinal Tract And Biopsy  1 (100.0) 
G491 Gastroduodenectomy  2 (100.0) 
G493 Partial Excision Of Duodenum 1 (16.7) 5 (83.3) 
G501 Excision Of Lesion Of Duodenum  2 (100.0) 
G511 Bypass Of Duodenum By Anastomosis Of Stomach To Jejunum 1 (8.3) 11 (91.7) 
G512 Bypass Of Duodenum By Anastomosis Of Duodenum To Duodenum  1 (100.0) 
G543 Endoscopic Insertion Of Tubal Prosthesis Into Duodenum  1 (100.0) 
G582 Total Jejunectomy And Anastomosis Of Duodenum To Ileum  1 (100.0) 
G584 Partial Jejunectomy And Anastomosis Of Jejunum To Ileum 1 (16.7) 5 (83.3) 
G601 Creation Of Jejunostomy 1 (100.0)  
G612 Bypass Of Jejunum By Anastomosis Of Jejunum To Ileum 1 (100.0)  
G692 Ileectomy And Anastomosis Of Duodenum To Ileum 1 (100.0)  
G693 Ileectomy And Anastomosis Of Ileum To Ileum 1 (10.0) 9 (90.0) 
G694 Ileectomy And Anastomosis Of Ileum To Colon  1 (100.0) 
G702 Excision Of Lesion Of Ileum 4 (80.0) 1 (20.0) 
G712 Bypass Of Ileum By Anastomosis Of Ileum To Ileum 2 (100.0)  
G721 Anastomosis Of Ileum To Caecum 2 (66.7) 1 (33.3) 
G722 Anastomosis Of Ileum To Transverse Colon  1 (100.0) 
G723 Anastomosis Of Ileum To Colon 3 (60.0) 2 (40.0) 
G724 Anastomosis Of Ileum To Rectum 1 (50.0) 1 (50.0) 
G734 Resection Of Ileocolic Anastomosis 1 (25.0) 3 (75.0) 
G742 Creation Of Temporary Ileostomy 1 (10.0) 9 (90.0) 
G743 Creation Of Defunctioning Ileostomy 3 (12.0) 22 (88.0) 
G753 Closure Of Ileostomy 1 (25.0) 3 (75.0) 
H028 Other specified other excision of appendix 1 (100.0)  
H041 Panproctocolectomy And Ileostomy 3 (17.6) 14 (82.4) 
H042 Panproctocolectomy And Anastomosis Of Ileum To Anus And Creation of Pouch 1 (33.3) 2 (66.7) 
H051 Total Colectomy And Anastomosis Of Ileum To Rectum 7 (28.0) 18 (72.0) 
H052 Total Colectomy And Ileostomy And Creation Of Rectal Fistula  3 (100.0) 
H053 Total Colectomy And Ileostomy  18 (100.0) 
H061 Extended Right Hemicolectomy And End To End Anastomosis 5 (21.7) 18 (78.3) 
H062 Extended Right Hemicolectomy And Anastomosis Of Ileum To Colon 58 (22.6) 199 (77.4) 
H063 Extended Right Hemicolectomy And Anastomosis 13 (13.8) 81 (86.2) 
H064 Extended Right Hemicolectomy And Ileostomy   17 (100.0) 
H065 Extended Right Hemicolectomy And End To Side Anastomosis 6 (26.1) 17 (73.9) 
H073 Right hemicolectomy and Anastomosis 113 (15.5) 616 (84.5) 
H074 Right hemicolectomy and ileostomy 3 (6.1) 46 (93.9) 
H081 Transverse Colectomy And End To End Anastomosis 4 (33.3) 8 (66.7) 
H082 Transverse Colectomy And Anastomosis Of Ileum To Colon 1 (20.0) 4 (80.0) 
H083 Transverse Colectomy And Anastomosis 3 (37.5) 5 (62.5) 
H084 Transverse Colectomy And Ileostomy  1 (100.0) 
H085 Transverse Colectomy And Exteriorisation Of Bowel 2 (40.0) 3 (60.0) 
H086 Transverse Colectomy And End To Side Anastomosis 2 (50.0) 2 (50.0) 
H091 Left Hemicolectomy And End To End Anastomosis Of Colon To Rectum 13 (11.1) 104 (88.9) 
H092 Left Hemicolectomy And End To End Anastomosis Of Colon To Colon 24 (25.0) 72 (75.0) 
H093 Left Hemicolectomy And Anastomosis 25 (40.0) 38 (60.3) 
H094 Left Hemicolectomy And Ileostomy  12 (100.0) 
H095 Left Hemicolectomy And Exteriorisation Of Bowel 6 (14.6) 35 (85.4) 
H096 Left Hemicolectomy And End To Side Anastomosis 6 (42.9) 8 (57.1) 
H101 Sigmoid Colectomy And End To End Anastomosis Of Ileum To Rectum 4 (44.4) 5 (55.6) 
H102 Sigmoid Colectomy And Anastomosis Of Colon To Rectum 49 (21.9) 175 (78.1) 
H103 Sigmoid Colectomy And Anastomosis 4 (11.4) 31 (88.6) 
H104 Sigmoid Colectomy And Ileostomy 1 (16.7) 5 (83.3) 
H105 Sigmoid Colectomy And Exteriorisation Of Bowel 10 (18.5) 44 (81.5) 
H106 Sigmoid Colectomy And End To Side Anastomosis 1 (12.5) 7 (87.5) 
H113 Colectomy and anastomosis 1 (100.0)  
H121 Excision Of Diverticulum Of Colon  1 (100.0) 
H122 Excision Of Lesion Of Colon  2 (100.0) 
H131 Bypass Of Colon By Anastomosis Of Ileum To Colon  3 (100.0) 
H135 Bypass Of Colon By Anastomosis Of Colon To Rectum 1 (100.0)  
H151 Loop colostomy  2 (100.0) 
H152 End colostomy 1 (100.0)  
H201 Fibreoptic Endoscopic Snare Resection Of Lesion Of Colon 1 (100.0)  
 H291 Subtotal Excision Of Colon And Rectum And Creation Of Coloni  1 (100.0) 
H293 Subtotal Excision Of Colon And Creation Of Colonic Pouch   1 (100.0) 
H295 Subtotal Excision Of Colon And Anastomosis Of Colon To Ileum 5 (20.8) 19 (79.2) 
H298 Other Specified Subtotal Excision of Colon  1 (100.0) 
H321 Resiting Of Colostomy 8 (42.1) 11 (57.9) 
H331 Abdominoperineal Excision Of Rectum And End Colostomy 47 (19.3) 196 (80.7) 
H332 Proctectomy And Anastomosis Of Colon To Anus 1 (7.1) 13 (92.9) 
H333 Anterior Resection Of Rectum And Anastomosis Of Colon To Rectum 123 (19.6) 505 (80.4) 
H334 Anterior Resection Of Rectum And Anastomosis 56 (23.5) 182 (76.5) 
H335 Rectosigmoidectomy And Closure Of Rectal Stump And Exteriorisation of Bowel 7 (20.6) 27 (79.4) 
H336 Anterior Resection Of Rectum And Exteriorisation Of Bowel 34 (17.7) 158 (82.3) 
H337 Perineal Resection Of Rectum  2 (100.0) 
H341 Open Excision Of Lesion Of Rectum 1 (20.0) 4 (80.0) 
H401 Trans-Sphincteric Excision Of Mucosa Of Rectum  2 (100.0) 
H402 Trans-Sphincteric Excision Of Lesion Of Rectum  1 (100.0) 
H404 Trans-Sphincteric Anastomosis Of Colon To Anus  1 (100.0) 
H411 Rectosigmoidectomy And Peranal Anastomosis 2 (9.1) 20 (90.9) 
H412 Peranal Excision Of Lesion Of Rectum 6 (18.2) 27 (81.8) 
H413 Peranal Destruction Of Lesion Of Rectum  1 (100.0) 
H414 Peranal Mucosal Proctectomy And Endoanal Anastomosis  1 (100.0) 
H415 Peranal Resection Of Rectum Using Staples  1 (100.0) 
H561 Biopsy Of Lesion Of Anus 1 (100.0)  
J011 Orthotopic Transplantation Of Liver  1 (100.0) 
J015 Orthotopic Transplantation Of Whole Liver 4 (40.0) 6 (60.0) 
J021 Right Hemihepatectomy 10 (13.9) 62 (86.1) 
J022 Left Hemihepatectomy 23 (37.1) 39 (62.9) 
J023 Resection Of Segment Of Liver 44 (30.3) 101 (69.7) 
J024 Wedge Excision Of Liver 27 (29.7) 64 (70.3) 
J026 Extended Right Hemihepatectomy 8 (40.0) 12 (60.0) 
J027 Extended Left Hemihepatectomy 3 (16.7) 15 (83.3) 
J028 Other specified partial excision of liver  6 (100.0) 
J031 Excision Of Lesion Of Liver 7 (15.2) 39 (84.8) 
J032 Destruction Of Lesion Of Liver  1 (100.0) 
J033 Thermal Ablation Of Single Lesion Of Liver 2 (33.3) 4 (66.7) 
J035 Excision Of Multiple Lesions Of Liver 11 (28.9) 27 (71.1) 
J053 Open Wedge Biopsy Of Lesion Of Liver  6 (100.0) 
J058 Other specified incision of liver  1 (100.0) 
J083 Endoscopic Microwave Ablation Lesion Liver Using Laparoscope  2 (100.0) 
J092 Laparoscopic Ultrasound Examination Of Liver And Biopsy Of Lesion  1 (100.0) 
J181 Total Cholecystectomy And Excision Of Surrounding Tissue  2 (100.0) 
J182 Total Cholecystectomy And Exploration Of Common Bile Duct  1 (100.0) 
J183 Total Cholecystectomy 2 (33.3) 4 (66.7) 
J273 Partial Excision/Bile Duct And Anastomosis/Bile Duct To Jejunum  1 (100.0) 
J281 Excision Of Lesion Of Bile Duct  1 (100.0) 
J291 Anastomosis Of Hepatic Duct To Transposed Jejunum  5 (100.0) 
J292 Anastomosis Of Hepatic Duct To Jejunum 1 (25.0) 3 (75.0) 
J301 Anastomosis Of Common Bile Duct To Duodenum 1 (100.0)  
J302 Anastomosis Of Common Bile Duct To Transposed Jejunum  1 (100.0) 
J303 Anastomosis Of Common Bile Duct To Jejunum 1 (25.0) 3 (75.0) 
J331 Open Removal/Calculus From Bile Duct/Drainage Of Bile Duct 1 (50.0) 1 (50.0) 
J551 Total Pancreatectomy And Excision Of Surrounding Tissue 2 (7.4) 25 (92.6) 
J558 Other specified total excision of pancreas 1 (33.3) 2 (66.7) 
J561 Pancreaticoduodenectomy And Excision Of Surrounding Tissue 32 (13.5) 205 (86.5) 
J563 Pancreaticoduodenectomy 1 (16.7) 5 (83.3) 
J564 Subtotal Excision Of Head Of Pancreas With Preservation Of Duodenum   3 (100.0) 
J571 Subtotal Pancreatectomy 4 (19.0) 17 (81.0) 
J573 Left Pancreatectomy 4 (8.9) 41 (91.1) 
J575 Excision Of Tail Of Pancreas 1 (5.3) 18 (94.7) 
J582 Excision Of Lesion Of Pancreas 3 (42.9) 4 (57.1) 
J671 Diagnostic Percutaneous Aspiration Of Lesion Of Pancreas 1 (100.0)  
J692 Total Splenectomy 1 (16.7) 5 (83.3) 
K248 Other specified other operations on ventricles of heart  1 (100.0) 
L271 Endovascular insertion of stent graft for infrarenal abdominal aortic aneurysm 1 (100.0)  
L912 Insertion of central venous catheter NEC 1 (100.0)  
L973 Isolated limb perfusion 1 (100.0)  
M021 Nephrectomy And Excision Of Perirenal Tissue 11 (15.5) 60 (84.5) 
M022 Nephroureterectomy 14 (31.1) 31 (68.9) 
M023 Bilateral Nephrectomy  1 (100.0) 
M025 Nephrectomy 23 (20.7) 88 (79.3) 
M042 Open Excision Of Lesion Of Kidney  1 (100.0) 
M182 Excision Of Segment Of Ureter  2 (100.0) 
M183 Secondary Ureterectomy  1 (100.0) 
M341 Cystoprostatectomy 9 (24.3) 28 (75.7) 
M342 Cystourethrectomy 1 (33.3) 2 (66.7) 
M343 Cystectomy 6 (17.1) 29 (82.9) 
M344 Simple Cystectomy  2 (100.0) 
M421 Endoscopic Resection Of Lesion Of Bladder 18 (28.6) 45 (71.4) 
M422 Endoscopic Cauterisation Of Lesion Of Bladder  6 (100.0) 
M423 Endoscopic Destruction Of Lesion Of Bladder  2 (100.0) 
M451 Diagnostic Endoscopic Exam Of Bladder And Biopsy/Lesion Of Bladder 2 (100.0)  
M455 Diagnostic Endoscopic Examination Of Bladder Using Rigid Cystoscope 6 (75.0) 2 (25.0) 
M611 Total Excision Of Prostate And Capsule Of Prostate 2 (3.8) 50 (96.2) 
M612 Retropubic Prostatectomy 5 (5.6) 85 (94.4) 
M614 Perineal Prostatectomy 3 (23.1) 10 (76.9) 
M651 Endoscopic Resection Of Prostate Using Electrotome  1 (100.0) 
M653 Endoscopic Resection Of Prostate  4 (100.0) 
M723 Excision Of Lesion Of Urethra 1 (100.0)  
 M832 Exploration Of Retropubic Space 1 (100.0)  
N011 Excision Of Scrotum 1 (100.0)  
N071 Excision Of Lesion Of Testis  1 (100.0) 
N243 Excision Of Male Periurethral Tissue 1 (100.0)  
N261 Total Amputation Of Penis 2 (100.0)  
N271 Excision Of Lesion Of Penis 1 (100.0)  
P051 Total Excision Of Vulva 11 (44.0) 14 (56.0) 
P052 Partial Excision Of Vulva 15 (35.7) 27 (64.3) 
P054 Excision Of Lesion Of Vulva 3 (15.8) 16 (84.2) 
P056 Reduction Labia Minor  1 (100.0) 
P065 Excision Of Lesion Of Labia 1 (100.0)  
P091 Biopsy Of Lesion Of Vulva  1 (100.0) 
P201 Excision Of Lesion Of Vagina 1 (25.0) 3 (75.0) 
P317 Extirpation Of Lesion Of Pouch Of Douglas  1 (100.0) 
Q011 Amputation Of Cervix Uteri 1 (20.0) 4 (80.0) 
Q013 Excision Of Lesion Of Cervix Uteri 2 (28.6) 5 (71.4) 
Q014 Large Loop Excision Of Transformation Zone  3 (100.0) 
Q018 Other specified excision of cervix uteri 2 (50.0) 2 (50.0) 
Q023 Cauterisation Of Lesion Of Cervix Uteri 1 (100.0)  
Q031 Knife Cone Biopsy Of Cervix Uteri  2 (100.0) 
Q033 Cone Biopsy Of Cervix Uteri  7 (100.0) 
Q071 Abdominal Hysterocolpectomy And Excision Of Periuterine Tissue 16 (43.2) 21 (56.8) 
Q072 Abdominal Hysterectomy And Excision Of Periuterine Tissue 139 (31.5) 302 (68.5) 
Q073 Abdominal Hysterocolpectomy 8 (18.2) 36 (81.8) 
Q074 Total Abdominal Hysterectomy 110 (29.2) 267 (70.8) 
Q075 Subtotal Abdominal Hysterectomy 1 (33.3) 2 (66.7) 
Q081 Vaginal Hysterocolpectomy And Excision Of Periuterine Tissue  1 (100.0) 
Q082 Vaginal Hysterectomy And Excision Of Periuterine Tissue 3 (37.5) 5 (62.5) 
Q083 Vaginal Hysterocolpectomy  4 (100.0) 
Q099 Unspecified other open operations on uterus  1 (100.0) 
Q102 Curettage Of Products Of Conception From Uterus Neck  1 (100.0) 
Q176 Endoscopic Microwave Ablation Of Endometrium 2 (66.7) 1 (33.3) 
Q181 Diagnostic Endoscopic Examination Of Uterus And Biopsy Of Le 1 (100.0)  
Q221 Bilateral Salpingoophorectomy 37 (31.6) 80 (68.4) 
Q223 Bilateral Oophorectomy  3 (100.0) 
Q231 Unilateral Salpingoophorectomy 6 (30.0) 14 (70.0) 
Q232 Salpingoophorectomy Of Remaining Solitary Fallopian Tube And  2 (100.0) 
Q233 Unilateral Salpingectomy 1 (25.0) 3 (75.0) 
Q235 Unilateral Oophorectomy  3 (100.0) 
Q43. 8 Other specified partial excision of ovary 2 (66.7) 1 (33.3) 
Q432 Excision Of Lesion Of Ovary 5 (38.5) 8 (61.5) 
Q501 Diagnostic Endoscopic Examination Of Ovary And Biopsy Of Lesion 1 (50.0) 1 (50.0) 
Q552 Examination of female genital tract under anaesthetic 2 (66.7) 1 (33.3) 
S018 Other specified plastic excision of skin of head or neck 1 (50.0) 1 (50.0) 
S022 Abdominolipectomy  1 (100.0) 
S081 Curettage And Cauterisation Of Lesion Of Skin Of Head Or Neck  1 (100.0) 
S083 Curettage Of Lesion Of Skin Of Head Or Neck  1 (100.0) 
S151 Biopsy Of Lesion Of Skin Of Head Or Neck 52 (57.8) 38 (42.2) 
S152 Biopsy Of Lesion Of Skin 2 (33.3) 4 (66.7) 
T013 Excision Of Lesion Of Chest Wall 6 (50.0) 6 (50.0) 
T071 Decortication Of Pleura  5 (100.0) 
T072 Open Excision Of Lesion Of Pleura  2 (100.0) 
T102 Endoscopic Pleurodesis Using Talc 3 (100.0)  
T111 Diagnostic Endoscopic Examination Of Pleura And Biopsy Of Lesion  1 (100.0) 
T112 Diagnostic Endoscopic Excision Biopsy of Lesion Intrathoracic Organ 1 (100.0)  
T252 Primary repair of incisional hernia using insert of prosthetic material  1 (100.0) 
T301 Reopening Of Abdomen And Re-Exploration Of Intra-abdominal Operation Site 1 (50.0) 1 (50.0) 
T303 Reopening Of Abdomen 1 (50.0) 1 (50.0) 
T304 Opening Of Abdomen And Exploration Of Groin  4 (100.0) 
T309 Laparotomy (exploratory) open and close  1 (100.0) 
T319 Unspecified other operations on anterior abdominal wall 1 (100.0)  
T331 Open Excision Of Lesion Of Peritoneum 9 (50.0) 9 (50.0) 
T332 Open Destruction Of Lesion Of Peritoneum 1 (33.3) 2 (66.7) 
T361 Omentectomy 2 (40.0) 3 (60.0) 
T362 Excision Of Lesion Of Omentum 1 (10.0) 9 (90.0) 
T364 Biopsy Of Lesion Of Omentum 3 (37.5) 5 (62.5) 
T371 Excision Of Lesion Of Mesentery Of Small Intestine  1 (100.0) 
T373 Biopsy Of Lesion Of Mesentery Of Small Intestine 1 (100.0)  
T381 Excision Of Lesion Of Mesentery Of Colon 1 (50.0) 1 (50.0) 
T383 Biopsy Of Lesion Of Mesentery Of Colon 1 (50.0) 1 (50.0) 
T391 Excision Of Lesion Of Posterior Peritoneum 11 (32.4) 23 (67.6) 
T393 Biopsy Of Lesion Of Posterior Peritoneum 7 (70.0) 3 (30.0) 
T421 Endoscopic Resection Of Lesion Of Peritoneum  3 (100.0) 
T423 Endoscopic Division Of Adhesions Of Peritoneum 1 (50.0) 1 (50.0) 
T425 Endoscopic Excision Of Peritoneum  2 (100.0) 
T431 Diagnostic Endoscopic Examination and Biopsy Of Lesion Of Peritoneum 2 (25.0) 6 (75.0) 
T432 Diag.endo.exam/Peritoneum/Biopsy/Lesion Intra-Abdominal Organ 1 (25.0) 3 (75.0) 
T434 Diagnostic Endoscopic Ultrasound Examination Of Peritoneum and Biopsy  1 (100.0) 
T482 Introduction Of Cytotoxic Substance Into Peritoneal Cavity 6 (35.3) 11 (64.7) 
T512 Excision Of Fascia Of Pelvis  2 (100.0) 
T531 Excision Of Lesion Of Fascia  3 (100.0) 
T652 Excision Of Lesion Of Tendon  1 (100.0) 
T772 Wide Excision Of Muscle 13 (40.6) 19 (59.4) 
T851 Block Dissection Of Cervical Lymph Nodes 31 (25.4) 91 (74.6) 
T852 Block Dissection Of Axillary Lymph Nodes 20 (36.4) 35 (63.6) 
T853 Block Dissection Of Mediastinal Lymph Nodes 1 (33.3) 2 (66.7) 
T854 Block Dissection Of Para-Aortic Lymph Nodes 4 (23.5) 13 (76.5) 
 T855 Block Dissection Of Inguinal Lymph Nodes 3 (20.0) 12 (80.0) 
T856 Block Dissection Of Pelvic Lymph Nodes 2 (40.0) 3 (60.0) 
T861 Sampling Of Cervical Lymph Nodes  3 (100.0) 
T862 Sampling Of Axillary Lymph Nodes 8 (50.0) 8 (50.0) 
T863 Sampling of supraclavicular lymph nodes  1 (100.0) 
T866 Sampling Of Para-Aortic Lymph Nodes  3 (100.0) 
T872 Excision Or Biopsy Of Cervical Lymph Node  9 (100.0) 
T873 Excision Or Biopsy Of Axillary Lymph Node 6 (26.1) 15 (73.9) 
T874 Excision Or Biopsy Of Mediastinal Lymph Node  4 (100.0) 
T875 Excision Or Biopsy Of Para-Aortic Lymph Node  4 (100.0) 
T876 Excision Or Biopsy Of Porta Hepatis Lymph Node 1 (50.0) 1 (50.0) 
T877 Excision Or Biopsy Of Inguinal Lymph Node 1 (50.0) 1 (50.0) 
T878 Other specified excision or biopsy of lymph node 1 (100.0)  
T882 Drainage of lesion of axillary lymph node  1 (100.0) 
T911 Biopsy Of Sentinel Lymph Node 3 (10.0) 27 (90.0) 
T926 Excision Of Lymphoedematous Tissue  1 (100.0) 
T962 Excision Of Lesion Of Soft Tissue 69 (33.8) 135 (66.2) 
T966 Biopsy Of Soft Tissue  1 (100.0) 
V032 Reopening Of Cranium And Re-Exploration Of Intracranial Operation Site  4 (100.0) 
V037 Decompressive Craniectomy 1 (12.5) 7 (87.5) 
V068 Other specified excision of maxilla  7 (100.0) 
V071 Extensive Excision Of Bone Of Face  6 (100.0) 
V072 Partial Excision Of Bone Of Face 1 (20.0) 4 (80.0) 
V073 Excision Of Lesion Of Bone Of Face  6 (100.0) 
V074 Excision Of Lesion Of Infratemporal Fossa 1 (20.0) 4 (80.0) 
V128 Other specified operations on bones of skull 1 (100.0)  
V141 Hemimandibulectomy 4 (10.5) 34 (89.5) 
V142 Extensive Excision Of Mandible 1 (2.9) 34 (97.1) 
V143 Partial Excision Of Mandible 8 (22.9) 27 (77.1) 
V144 Excision Of Lesion Of Mandible 4 (10.8) 33 (89.2) 
V191 Reconstruction Of Mandible  3 (100.0) 
V194 Biopsy Of Lesion Of Mandible  3 (100.0) 
V421 Excision of rib hump  1 (100.0) 
V431 Excision Of Lesion Of Cervical Vertebra  1 (100.0) 
V432 Excision Of Lesion Of Thoracic Vertebra 1 (50.0) 1 (50.0) 
V433 Excision Of Lesion Of Lumbar Vertebra 1 (33.3) 2 (66.7) 
W062 Total Excision Of Rib 1 (50.0) 1 (50.0) 
W065 Total Excision Of Bone Of Foot  1 (100.0) 
W067 Total Excision Of Pelvic Bones  2 (100.0) 
W088 Other specified other excision of bone 6 (42.9) 8 (57.1) 
W091 Excision Of Lesion Of Bone  7 (100.0) 
W092 Curettage Of Lesion Of Bone And Graft Hfq  1 (100.0) 
W095 Curettage Of Tumour Of Bone And Graft  2 (100.0) 
W096 Curettage Of Tumour Of Bone 1 (50.0) 1 (50.0) 
W097 Excision Of Tumour Of Bone 10 (58.8) 7 (41.2) 
X071 Forequarter Amputation 1 (50.0) 1 (50.0) 
X073 Amputation Of Arm Above Elbow 1 (50.0) 1 (50.0) 
X075 Amputation Of Arm Through Forearm  1 (100.0) 
X091 Hindquarter Amputation 3 (75.0) 1 (25.0) 
X092 Disarticulation of hip  1 (100.0) 
X093 Amputation Of Leg Above Knee 1 (16.7) 5 (83.3) 
X095 Amputation Of Leg Below Knee  4 (100.0) 
X104 Amputation Through Metatarsal Bones  1 (100.0) 
X141 Total Exenteration Of Pelvis 4 (25.0) 12 (75.0) 
X142 Anterior Exenteration Of Pelvis 2 (22.2) 7 (77.8) 
X143 Posterior Exenteration Of Pelvis 5 (50.0) 5 (50.0) 
X144 Pelvic Side Wall Clearance 1 (100.0)  
X531 Excision Of Unspecified Organ 5 (62.5) 3 (37.5) 
X532 Excision Of Lesion Of Unspecified Organ 4 (13.3) 26 (86.7) 
Y052 Partial Excision Of Organ  2 (100.0) 
Y063 Enucleation Of Lesion Of Organ 1 (50.0) 1 (50.0) 
Y067 Radiofrequency Excision Of Lesion Of Organ Noc 4 (40.0) 6 (60.0) 
Y081 Laser excision of organ NOC  2 (100.0) 
Y201 Stereotactic Biopsy Of Lesion Of Organ Noc 3 (100.0)  
Y202 Stereotactic Biopsy Of Organ Noc  1 (100.0) 
Y491 Median sternotomy approach 1 (100.0)  
Y502 Laparotomy approach 2 (11.1) 16 (88.9) 
Y752 Laparoscopic approach to abdominal cavity 1 (16.7) 5 (83.3) 
 
OPCS Classification of Interventions and Procedures (OPCS-4) codes (three digit codes) used to classify included procedures according to UK industry 
standard codes. Percentages calculated as a proportion of row total. 
 
 
 
  
 Supplementary table 3. Factors associated with postoperative pulmonary complications after elective surgery. Model 
summary presented in forest plot in Figure 2. 
 
  
Factor 
  
Level 
Outcome Univariable model  
(Odds ratio, 95% credible 
interval) 
Multivariable model  
(Odds ratio, 95% credible 
interval) 
None 
(N=8592) 
Pulmonary 
Complications 
(N=379) 
Age 
<50 years 1594 (98.8) 20 (1.2) - - 
50-59 years 1868 (97.4) 50 (2.6) 2.05 (1.20 to 3.51) 1.44 (0.86 to 2.52) 
60-69 years 2379 (95.4) 115 (4.6) 3.69 (2.30 to 6.03) 1.90 (1.18 to 3.17) 
70-79 years 2054 (93.5) 143 (6.5) 5.25 (3.33 to 8.65) 2.11 (1.30 to 3.47) 
≥80 years 697 (93.2) 51 (6.8) 5.39 (3.21 to 9.19) 1.96 (1.11 to 3.52) 
Sex 
Female 5331 (97.8) 119 (2.2) - - 
Male 3261 (92.6) 260 (7.4) 3.48 (2.79 to 4.38) 1.74 (1.37 to 2.25) 
BMI 
Normal 3362 (96.2) 134 (3.8) - - 
Overweight 2735 (96.0) 115 (4.0) 1.08 (0.83 to 1.38) 1.02 (0.78 to 1.33) 
Obese 1791 (95.5) 84 (4.5) 1.20 (0.91 to 1.59) 1.06 (0.79 to 1.43) 
Underweight 201 (95.3) 10 (4.7) 1.21 (0.59 to 2.25) 1.10 (0.51 to 2.20) 
Missing 503 (93.3) 36 (6.7) 1.56 (1.02 to 2.31) 1.69 (1.10 to 2.52) 
ASA Grade 
Grade 1-2 6299 (97.1) 190 (2.9) - - 
Grade 3-5 2293 (92.4) 189 (7.6) 2.87 (2.31 to 3.56) 1.36 (1.04 to 1.77) 
Specialty 
Colorectal 2122 (94.1) 132 (5.9) - - 
Breast 2071 (99.6) 8 (0.4) 0.06 (0.03 to 0.12) 0.30 (0.12 to 0.71) 
Gynaecological 1062 (98.2) 20 (1.8) 0.29 (0.17 to 0.46) 0.61 (0.37 to 1.01) 
Head or neck 1085 (96.4) 41 (3.6) 0.64 (0.44 to 0.93) 1.35 (0.75 to 2.34) 
Hepatopancreatobilary 618 (92.5) 50 (7.5) 1.34 (0.94 to 1.90) 1.40 (0.97 to 2.00) 
Intracranial 151 (98.7) 2 (1.3) 0.19 (0.03 to 0.69) 0.33 (0.04 to 1.42) 
Thoracic 497 (92.7) 39 (7.3) 1.08 (0.73 to 1.62) 1.05 (0.70 to 1.53) 
Oesophagogastric 317 (83.2) 64 (16.8) 3.44 (2.43 to 4.80) 3.45 (2.39 to 4.91) 
Sarcoma 250 (96.9) 8 (3.1) 0.52 (0.23 to 1.07) 0.99 (0.41 to 2.07) 
Urological 419 (96.5) 15 (3.5) 0.54 (0.29 to 0.94) 0.64 (0.36 to 1.12) 
ECOG Performance  
Score 
0 5550 (97.5) 145 (2.5) - - 
1-2 2907 (93.0) 219 (7.0) 2.81 (2.27 to 3.51) 1.67 (1.28 to 2.15) 
3-4 135 (90.0) 15 (10.0) 4.07 (2.24 to 7.07) 2.17 (1.10 to 4.02) 
Current smoker 
No 7670 (96.0) 316 (4.0) - - 
Yes 922 (93.6) 63 (6.4) 1.56 (1.17 to 2.05) 1.41 (1.03 to 1.89) 
Pre-existing 
respiratory condition 
No 7698 (96.2) 303 (3.8) - - 
Yes 894 (92.2) 76 (7.8) 1.96 (1.51 to 2.51) 1.35 (1.00 to 1.80) 
RCRI 
0 2789 (98.9) 32 (1.1) - - 
1 4319 (95.2) 217 (4.8) 4.10 (2.84 to 6.06) 1.69 (0.91 to 3.02) 
2 1218 (93.2) 89 (6.8) 6.20 (4.14 to 9.53) 1.72 (0.88 to 3.30) 
≥3 266 (86.6) 41 (13.4) 12.78 (7.71 to 21.14) 2.98 (1.43 to 6.28) 
Operation grade 
Minor 2025 (98.7) 26 (1.3) - - 
Major 6567 (94.9) 353 (5.1) 4.16 (2.87 to 6.36) 2.11 (1.33 to 3.43) 
Disease stage 
Early stage 6171 (96.6) 217 (3.4) - - 
Advanced stage 2421 (93.7) 162 (6.3) 1.86 (1.52 to 2.28) 1.43 (1.14 to 1.80) 
Preoperative testing 
Not tested 6240 (95.6) 284 (4.4) - - 
Tested 2352 (96.1) 95 (3.9) 0.92 (0.69 to 1.19) 0.92 (0.70 to 1.20) 
Hospital type 
No defined pathway 6198 (95.0) 324 (5.0) - - 
COVID-19 free surgical 
pathway 2394 (97.8) 55 (2.2) 0.49 (0.36 to 0.66) 
0.62 (0.44 to 0.86) 
Community SARS-
Cov-2 risk 
Low 7511 (95.8) 328 (4.2) - - 
Moderate or high 1081 (95.5) 51 (4.5) 1.03 (0.71 to 1.50) 1.42 (0.96 to 2.15) 
 
 
Data included from 8971 patients with complete data. COVID-19=Coronavirus disease 2019. ASA=American Society of Anaesthesiologists. RCRI= Revised Cardiac Risk Index. 
ECOG=Eastern Cooperative Oncology Group. Please see Appendix C for full definitions. Percentages calculated as a proportion of row total. R statistic <1.1 for all variables in 
the model (Supplementary Table 9). Model convergence and fit shown in Supplementary Figure 1 and 2 respectively. Area under the Receiver Operating Characteristic curve 
for model: 0.82 (excellent discrimination). 
  
 Supplementary table 4. Sensitivity analysis of factors associated with postoperative pulmonary complications 
after elective surgery in low risk patient only (ASA grade 1-2). 
 
  
Factor 
  
Level 
Outcome Univariable model  
(Odds ratio, 95% credible 
interval) 
Multivariable model  
(Odds ratio, 95% credible 
interval) 
None 
(N=6299) 
Pulmonary 
Complications 
(N=190) 
Age 
<50 years 1450 (99.0) 14 (1.0) - - 
50-59 years 1560 (97.9) 34 (2.1) 2.23 (1.21 to 4.28) 1.56 (0.85 to 3.06) 
60-69 years 1744 (96.4) 66 (3.6) 3.87 (2.17 to 7.19) 2.16 (1.20 to 4.11) 
70-79 years 1226 (95.1) 63 (4.9) 5.29 (2.98 to 9.90) 2.49 (1.36 to 4.81) 
≥80 years 319 (96.1) 13 (3.9) 3.98 (1.85 to 8.72) 1.55 (0.70 to 3.55) 
Sex 
Female 4208 (98.6) 61 (1.4) - - 
Male 2091 (94.2) 129 (5.8) 4.16 (3.03 to 5.65) 2.76 (2.01 to 3.86) 
BMI 
Normal 2631 (97.4) 71 (2.6) - - 
Overweight 2022 (97.1) 61 (2.9) 1.10 (0.78 to 1.55) 0.90 (0.64 to 1.29) 
Obese 1107 (96.5) 40 (3.5) 1.30 (0.84 to 1.96) 1.08 (0.69 to 1.67) 
Underweight 138 (97.9) 3 (2.1) 0.67 (0.17 to 1.97) 0.70 (0.18 to 2.26) 
Missing 401 (96.4) 15 (3.6) 1.05 (0.58 to 1.85) 1.12 (0.58 to 2.01) 
ECOG Performance  
Score 
0 4759 (97.9) 104 (2.1) - - 
1-2 1510 (94.7) 84 (5.3) 2.53 (1.84 to 3.41) 1.77 (1.29 to 2.46) 
3-4 30 (93.8) 2 (6.2) 2.61 (0.39 to 10.70) 2.24 (0.28 to 9.95) 
Current smoker 
No 5657 (97.2) 160 (2.8) - - 
Yes 642 (95.5) 30 (4.5) 1.57 (1.05 to 2.31) 1.44 (0.91 to 2.25) 
Pre-existing 
respiratory condition 
No 5846 (97.2) 169 (2.8) - - 
Yes 453 (95.6) 21 (4.4) 1.35 (0.82 to 2.16) 1.03 (0.61 to 1.66) 
RCRI 
0 2429 (99.1) 21 (0.9) - - 
1 3273 (96.3) 126 (3.7) 4.35 (2.78 to 7.03) 2.28 (1.41 to 3.82) 
2 557 (94.4) 33 (5.6) 6.78 (3.94 to 11.93) 2.56 (1.41 to 4.79) 
≥3 40 (80.0) 10 (20.0) 26.73 (11.24 to 61.50) 9.53 (3.73 to 23.27) 
Operation grade 
Minor 1578 (98.9) 17 (1.1) - - 
Major 4721 (96.5) 173 (3.5) 3.51 (2.14 to 6.08) 1.71 (1.01 to 3.03) 
Disease stage 
Early stage 4642 (97.6) 116 (2.4) - - 
Advanced stage 1657 (95.7) 74 (4.3) 1.75 (1.29 to 2.36) 1.47 (1.08 to 1.98) 
Preoperative testing 
Not tested 4571 (97.0) 139 (3.0)   
Tested 1728 (97.1) 51 (2.9) 1.09 (0.77 to 1.53) 1.03 (0.73 to 1.47) 
Hospital type 
No defined pathway 4393 (96.5) 160 (3.5) - - 
COVID-19 free 
surgical pathway 1906 (98.5) 30 (1.5) 
0.48 (0.31 to 0.74) 0.58 (0.36 to 0.93) 
Community SARS-
Cov-2 risk 
Low 5465 (97.1) 165 (2.9) - - 
High 834 (97.1) 25 (2.9) 1.17 (0.68 to 1.99) 1.54 (0.86 to 2.66) 
 
Data included from 6489 patients with complete data. COVID-19=Coronavirus disease 2019.  ASA=American Society of Anaesthesiologists. RCRI= Revised Cardiac Risk 
Index. ECOG=Eastern Cooperative Oncology Group. Please see Appendix C for full definitions. Percentages calculated as a proportion of row total. Odds ratios are presented 
with 95 percent credible intervals. R statistic <1.1 for all variables in the model. Area under the Receiver Operating Characteristic curve for model: 0.81 (excellent 
discrimination). 
  
 Supplementary table 5. Balance of risk factors across patients in COVID-19 free surgical 
pathways and hospitals with no defined COVID-19 free pathway in propensity score matched 
data. 
 
Factor Levels 
COVID-19 free 
surgical pathway 
N=2449 
No defined 
pathway 
N=2449 
P-value 
Age, n (%) 
<50 years 550 (22.5) 569 (23.2) 
0.757 
50-59 years 560 (22.9) 582 (23.8) 
60-69 years 630 (25.7) 628 (25.6) 
70-79 years 550 (22.5) 517 (21.1) 
≥80 years 159 (6.5) 153 (6.2) 
Sex, n (%) 
Female 1716 (70.1) 1747 (71.3) 
0.346 
Male 733 (29.9) 702 (28.7) 
ASA Grade, n (%) 
ASA grade 1-2 1936 (79.1) 1938 (79.1) 
0.972 
ASA grade 3-5 513 (20.9) 511 (20.9) 
ECOG Performance Score, n (%) 
0 1642 (67.0) 1575 (64.3) 
0.128 1-2 771 (31.5) 837 (34.2) 
3-4 36 (1.5) 37 (1.5) 
Operation grade, n (%) 
Minor 593 (24.2) 587 (24.0) 
0.867 
Major 1856 (75.8) 1862 (76.0) 
Preoperative testing, n (%) 
Not tested 1481 (60.5) 1541 (62.9) 
0.083 
Tested 968 (39.5) 908 (37.1) 
Community SARS-Cov-2 risk, n (%) 
Low 1921 (78.4) 1969 (80.4) 
0.097 
Moderate or high 528 (21.6) 480 (19.6) 
     
COVID-19=Coronavirus disease 2019.  ASA=American Society of Anaesthesiologists. RCRI= Revised Cardiac Risk Index. ECOG=Eastern 
Cooperative Oncology Group. Please see Appendix C for full definitions. Percentages calculated as a proportion of column total. 
  
 Supplementary table 6. Factors associated with postoperative pulmonary complications after elective cancer 
surgery in propensity matched data. 
 
  
Factor 
  
Level 
Outcome Univariable model  
(Odds ratio, 95% credible 
interval) 
Multivariable model  
(Odds ratio, 95% credible 
interval) 
None 
(N=4745) 
Pulmonary 
Complications 
(N=153) 
Age 
<50 years 1108 (23.4) 11 (7.2)  - 
50-59 years 1119 (23.6) 23 (15.0) 2.09 (1.02 to 4.60) 1.55 (0.74 to 3.44) 
60-69 years 1209 (25.5) 49 (32.0) 4.10 (2.15 to 8.38) 2.07 (1.03 to 4.53) 
70-79 years 1015 (21.4) 52 (34.0) 5.12 (2.76 to 10.21) 2.03 (1.01 to 4.47) 
≥80 years 294 (6.2) 18 (11.8) 6.20 (2.90 to 13.73) 1.99 (0.86 to 4.87) 
Sex Female 3401 (71.7) 62 (40.5)  - Male 1344 (28.3) 91 (59.5) 3.79 (2.72 to 5.34) 1.79 (1.24 to 2.66) 
BMI 
Normal 1977 (41.7) 56 (36.6)  - 
Overweight 1515 (31.9) 46 (30.1) 1.09 (0.72 to 1.64) 1.02 (0.69 to 1.52) 
Obese 893 (18.8) 32 (20.9) 1.31 (0.83 to 2.02) 1.16 (0.72 to 1.84) 
Underweight 109 (2.3) 4 (2.6) 1.08 (0.32 to 3.00) 1.02 (0.28 to 2.90) 
Missing 251 (5.3) 15 (9.8) 1.91 (1.01 to 3.48) 2.26 (1.13 to 4.27) 
ASA Grade Grade 1-2 3787 (79.8) 87 (56.9)  - Grade 3-5 958 (20.2) 66 (43.1) 2.91 (2.06 to 4.07) 1.17 (0.76 to 1.80) 
Specialty 
Colorectal 984 (20.7) 49 (32.0)  - 
Breast 1447 (30.5) 6 (3.9) 0.08 (0.03 to 0.18) 0.31 (0.09 to 0.94) 
Gynaecological 641 (13.5) 8 (5.2) 0.23 (0.10 to 0.47) 0.46 (0.19 to 1.01) 
Head or neck 550 (11.6) 21 (13.7) 0.79 (0.46 to 1.33) 1.43 (0.61 to 3.27) 
Hepatopancreatobilary 304 (6.4) 27 (17.6) 1.78 (1.09 to 2.95) 2.01 (1.16 to 3.42) 
Intracranial 70 (1.5) 1 (0.7) 0.18 (0.01 to 1.35) 0.43 (0.02 to 3.82) 
Thoracic 270 (5.7) 15 (9.8) 0.95 (0.50 to 1.80) 1.02 (0.50 to 1.92) 
Oesophagogastric 146 (3.1) 18 (11.8) 2.67 (1.46 to 4.72) 2.57 (1.38 to 4.68) 
Sarcoma 169 (3.6) 4 (2.6) 0.43 (0.13 to 1.12) 0.71 (0.19 to 2.11) 
Urological 164 (3.5) 4 (2.6) 0.42 (0.12 to 1.11) 0.47 (0.13 to 1.31) 
ECOG Performance  
Score 
0 3159 (66.6) 58 (37.9)  - 
1-2 1518 (32.0) 90 (58.8) 3.18 (2.24 to 4.47) 1.83 (1.25 to 2.68) 
3-4 68 (1.4) 5 (3.3) 3.52 (1.25 to 8.70) 1.70 (0.57 to 4.69) 
Current smoker No 4248 (89.5) 128 (83.7)  - Yes 497 (10.5) 25 (16.3) 1.62 (1.02 to 2.49) 1.33 (0.81 to 2.14) 
Pre-existing 
respiratory condition 
No 4309 (90.8) 125 (81.7)  - 
Yes 436 (9.2) 28 (18.3) 2.09 (1.31 to 3.22) 1.44 (0.89 to 2.26) 
RCRI 
0 1793 (37.8) 19 (12.4)  - 
1 2300 (48.5) 90 (58.8) 3.53 (2.17 to 6.03) 1.65 (0.70 to 3.84) 
2 551 (11.6) 29 (19.0) 4.88 (2.72 to 9.10) 1.50 (0.57 to 3.73) 
≥3 101 (2.1) 15 (9.8) 13.16 (6.36 to 27.49) 3.10 (1.05 to 8.77) 
Operation grade Minor 1165 (24.6) 15 (9.8)  - Major 3580 (75.4) 138 (90.2) 3.03 (1.80 to 5.34) 1.54 (0.79 to 3.16) 
Disease stage Early stage 3498 (73.7) 93 (60.8)  - Advanced stage 1247 (26.3) 60 (39.2) 1.79 (1.28 to 2.51) 1.39 (0.97 to 1.96) 
Preoperative testing Not tested 2930 (61.7) 92 (60.1)  - Tested 1815 (38.3) 61 (39.9) 1.06 (0.74 to 1.51) 0.94 (0.64 to 1.37) 
Hospital type 
No defined pathway 2351 (49.5) 98 (64.1)  - 
COVID-19 free surgical 
pathway 2394 (50.5) 55 (35.9) 
0.67 (0.47 to 0.96) 0.65 (0.44 to 0.96) 
SARS-Cov-2 risk area Low 3772 (79.5) 118 (77.1)  - High 973 (20.5) 35 (22.9) 0.87 (0.52 to 1.39) 1.05 (0.63 to 1.77) 
 
Data included from 2449 patients in a COVID-19 free surgical pathway propensity score matched with 2449 patients with no defined pathway (n=4898). COVID-19=Coronavirus 
disease 2019.  ASA=American Society of Anaesthesiologists. RCRI= Revised Cardiac Risk Index. ECOG=Eastern Cooperative Oncology Group. Please see Appendix C for 
full definitions. Percentages calculated as a proportion of row total. R statistic <1.1 for all variables in the model. Area under the Receiver Operating Characteristic curve for 
model: 0.81 (excellent discrimination). 
 
  
 Supplementary table 7. Sensitivity analysis of factors associated with postoperative pulmonary complications after 
elective surgery in patients with a negative preoperative SARS-CoV-2 test only. Model summary presented in forest 
plot in Figure 4. 
 
 
Factor 
 
Level 
Outcome Univariable model 
(Odds ratio, 95% credible 
interval) 
Multivariable model 
(Odds ratio, 95% credible 
interval) 
None 
(N=2352) 
Pulmonary 
Complications 
(N=95) 
Age 
<50 years 393 (99.0) 4 (1.0) - - 
50-59 years 529 (97.8) 12 (2.2) 2.50 (0.85 to 8.67) 1.79 (0.58 to 6.27) 
60-69 years 645 (95.4) 31 (4.6) 5.43 (1.92 to 17.13) 3.26 (1.15 to 11.22) 
70-79 years 578 (94.4) 34 (5.6) 6.90 (2.52 to 22.11) 3.02 (1.00 to 10.98) 
≥80 years 207 (93.7) 14 (6.3) 8.71 (2.86 to 31.65) 3.63 (1.10 to 13.35) 
Sex 
Female 1424 (97.6) 35 (2.4) - - 
Male 928 (93.9) 60 (6.1) 2.67 (1.72 to 4.22) 1.74 (1.11 to 2.79) 
BMI 
Normal 992 (96.5) 36 (3.5) - - 
Overweight 816 (96.5) 30 (3.5) 0.95 (0.59 to 1.55) 0.79 (0.46 to 1.33) 
Obese 427 (95.1) 22 (4.9) 1.26 (0.73 to 2.16) 0.96 (0.51 to 1.75) 
Underweight 61 (95.3) 3 (4.7) 1.19 (0.28 to 3.90) 1.07 (0.22 to 3.72) 
Missing 56 (93.3) 4 (6.7) 1.34 (0.37 to 3.82) 1.12 (0.32 to 3.35) 
ASA Grade 
Grade 1-2 1728 (97.1) 51 (2.9) - - 
Grade 3-5 624 (93.4) 44 (6.6) 2.72 (1.75 to 4.29) 1.39 (0.84 to 2.29) 
ECOG Performance  
Score 
0 1458 (97.4) 39 (2.6) - - 
1-2 857 (94.0) 55 (6.0) 2.52 (1.65 to 3.80) 1.51 (0.93 to 2.47) 
3-4 37 (97.4) 1 (2.6) 0.62 (0.02 to 4.54) 0.28 (0.01 to 2.20) 
Current smoker 
No 2103 (96.2) 82 (3.8) - - 
Yes 249 (95.0) 13 (5.0) 1.31 (0.67 to 2.37) 1.19 (0.59 to 2.25) 
Pre-existing 
respiratory condition 
No 2123 (96.6) 75 (3.4) - - 
Yes 229 (92.0) 20 (8.0) 2.43 (1.40 to 4.04) 1.75 (0.95 to 3.08) 
RCRI 
0 682 (98.7) 9 (1.3) - - 
1 1268 (96.0) 53 (4.0) 3.34 (1.68 to 7.17) 2.25 (1.08 to 4.97) 
2 336 (93.3) 24 (6.7) 5.87 (2.76 to 13.53) 3.09 (1.34 to 7.51) 
≥3 66 (88.0) 9 (12.0) 11.90 (4.11 to 33.18) 4.60 (1.50 to 14.12) 
Operation grade 
Minor 511 (98.8) 6 (1.2) - - 
Major 1841 (95.4) 89 (4.6) 4.27 (1.94 to 10.85) 2.24 (0.92 to 6.33) 
Disease stage 
Early stage 1648 (96.9) 52 (3.1) - - 
Advanced stage 704 (94.2) 43 (5.8) 1.95 (1.29 to 2.91) 1.70 (1.09 to 2.65) 
Hospital type 
No defined pathway 1407 (95.1) 72 (4.9) - - 
COVID-19 free 
surgical pathway 945 (97.6) 23 (2.4) 
0.47 (0.26 to 0.79) 0.52 (0.29 to 0.91) 
Community SARS-
Cov-2 risk 
Low 1842 (95.7) 83 (4.3) - - 
High 510 (97.7) 12 (2.3) 0.61 (0.30 to 1.27) 0.98 (0.45 to 2.05) 
 
Data included from 2447 patients with complete data. COVID-19=Coronavirus disease 2019.  ASA=American Society of Anaesthesiologists. RCRI= Revised Cardiac Risk 
Index. ECOG=Eastern Cooperative Oncology Group. Please see Appendix C for full definitions. Percentages calculated as a proportion of row total. R statistic <1.1 for all 
variables in the model. Area under the Receiver Operating Characteristic curve for model: 0.80 (excellent discrimination). 
 
 
  
 Supplementary Table 8. Factors associated with SARS-CoV-2 infection after elective cancer surgery. 
 
  
Factor 
  
Level 
Outcome Univariable model  
(Odds ratio, 95% credible 
interval) 
Multivariable model  
(Odds ratio, 95% credible 
interval) 
None 
(N=8683) 
SARS CoV-2 
(N=288) 
Age 
<50 years 1584 (98.1) 30 (1.9) - - 
50-59 years 1879 (98.0) 39 (2.0) 1.07 (0.65 to 1.77) 0.80 (0.48 to 1.30) 
60-69 years 2407 (96.5) 87 (3.5) 1.96 (1.23 to 3.05) 1.18 (0.76 to 1.88) 
70-79 years 2101 (95.6) 96 (4.4) 2.44 (1.57 to 3.81) 1.30 (0.81 to 2.07) 
≥80 years 712 (95.2) 36 (4.8) 2.81 (1.67 to 4.74) 1.44 (0.82 to 2.55) 
Sex 
Female 5331 (97.8) 119 (2.2) - - 
Male 3352 (95.2) 169 (4.8) 2.52 (1.98 to 3.24) 1.50 (1.11 to 2.06) 
BMI 
Normal 3399 (97.2) 97 (2.8) - - 
Overweight 2766 (97.1) 84 (2.9) 1.07 (0.80 to 1.44) 1.00 (0.73 to 1.35) 
Obese 1819 (97.0) 56 (3.0) 1.12 (0.78 to 1.59) 0.99 (0.69 to 1.40) 
Underweight 205 (97.2) 6 (2.8) 1.09 (0.42 to 2.40) 1.16 (0.45 to 2.61) 
Missing 494 (91.7) 45 (8.3) 2.74 (1.87 to 4.01) 2.48 (1.66 to 3.61) 
ASA Grade 
Grade 1-2 6308 (97.2) 181 (2.8) - - 
Grade 3-5 2375 (95.7) 107 (4.3) 1.83 (1.41 to 2.39) 1.14 (0.83 to 1.52) 
Specialty 
Colorectal 2157 (95.7) 97 (4.3) - - 
Breast 2055 (98.8) 24 (1.2) 0.24 (0.15 to 0.38) 0.88 (0.43 to 1.79) 
Gynaecological 1057 (97.7) 25 (2.3) 0.42 (0.26 to 0.67) 0.68 (0.39 to 1.15) 
Head or neck 1097 (97.4) 29 (2.6) 0.66 (0.43 to 1.00) 1.26 (0.68 to 2.31) 
Hepatopancreatobilary 633 (94.8) 35 (5.2) 1.45 (0.97 to 2.14) 1.36 (0.87 to 2.06) 
Intracranial 147 (96.1) 6 (3.9) 0.96 (0.35 to 2.13) 1.95 (0.68 to 5.08) 
Thoracic 511 (95.3) 25 (4.7) 0.89 (0.56 to 1.38) 0.93 (0.57 to 1.49) 
Oesophagogastric 360 (94.5) 21 (5.5) 1.66 (1.00 to 2.67) 1.71 (1.01 to 2.88) 
Sarcoma 250 (96.9) 8 (3.1) 0.64 (0.27 to 1.36) 0.91 (0.37 to 1.99) 
Urological 416 (95.9) 18 (4.1) 0.91 (0.52 to 1.50) 1.00 (0.57 to 1.68) 
ECOG Performance  
Score 
0 5553 (97.5) 142 (2.5) - - 
1-2 2985 (95.5) 141 (4.5) 1.85 (1.43 to 2.39) 1.24 (0.93 to 1.63) 
3-4 145 (96.7) 5 (3.3) 0.81 (0.26 to 2.11) 0.36 (0.10 to 1.08) 
Current smoker 
No 7736 (96.9) 250 (3.1) - - 
Yes 947 (96.1) 38 (3.9) 1.19 (0.82 to 1.70) 1.17 (0.77 to 1.71) 
Pre-existing 
respiratory condition 
No 7758 (97.0) 243 (3.0) - - 
Yes 925 (95.4) 45 (4.6) 1.47 (1.05 to 2.04)  1.17 (0.80 to 1.69) 
RCRI 
0 2781 (98.6) 40 (1.4) - - 
1 4377 (96.5) 159 (3.5) 2.44 (1.72 to 3.50) 2.13 (1.19 to 3.78) 
2 1236 (94.6) 71 (5.4) 4.20 (2.80 to 6.30) 3.00 (1.56 to 5.79) 
≥3 289 (94.1) 18 (5.9) 4.40 (2.37 to 7.95) 2.60 (1.12 to 5.91) 
Operation grade 
Minor 2015 (98.2) 36 (1.8) - - 
Major 6668 (96.4) 252 (3.6) 2.12 (1.49 to 3.14) 1.32 (0.85 to 2.10) 
Disease stage 
Early stage 6207 (97.2) 181 (2.8) - - 
Advanced stage 2476 (95.9) 107 (4.1) 1.58 (1.24 to 2.02) 1.38 (1.06 to 1.79) 
Preoperative testing 
Not tested 6303 (96.6) 221 (3.4) - - 
Tested 2380 (97.3) 67 (2.7) 0.72 (0.52 to 0.97) 0.79 (0.57 to 1.08) 
Hospital type 
No defined pathway 6287 (96.4) 235 (3.6) - - 
COVID-19 free surgical 
pathway 2396 (97.8) 53 (2.2) 0.52 (0.37 to 0.73) 0.53 (0.36 to 0.76) 
Community SARS-
Cov-2 risk 
Low 7621 (97.2) 218 (2.8) - - 
High 1062 (93.8) 70 (6.2) 2.26 (1.55 to 3.32) 3.03 (2.00 to 4.62) 
 
Data included from 8971 patients with complete data. COVID-19=Coronavirus disease 2019. ASA=American Society of Anaesthesiologists. RCRI= Revised Cardiac Risk 
Index. ECOG=Eastern Cooperative Oncology Group. Please see Appendix C for full definitions. Percentages calculated as a proportion of row total. R statistic <1.1 for all 
variables in the model (Supplementary Table 9). Area under the Receiver Operating Characteristic curve for model: 0.80 (excellent discrimination). 
 
  
 Supplementary Table 9. Sensitivity analysis of factors associated with SARS-CoV-2 infection on nasopharyngeal 
swab after elective cancer surgery. 
 
 
Factor Level 
Outcome Univariable model  
(Odds ratio, 95% 
credible interval) 
Multivariable model  
(Odds ratio, 95% 
credible interval) 
None 
(N=8724) 
SARS CoV-2 
(N=247) 
Age 
<50 years 1589 (98.5) 25 (1.5) - - 
50-59 years 1884 (98.2) 34 (1.8) 1.08 (0.63 to 1.88) 0.84 (0.48 to 1.47) 
60-69 years 2422 (97.1) 72 (2.9) 1.86 (1.16 to 3.05) 1.15 (0.68 to 1.96) 
70-79 years 2112 (96.1) 85 (3.9) 2.44 (1.53 to 3.96) 1.36 (0.81 to 2.35) 
≥80 years 717 (95.9) 31 (4.1) 2.68 (1.54 to 4.68) 1.44 (0.77 to 2.73) 
Sex 
Female 5345 (98.1) 105 (1.9) - - 
Male 3379 (96.0) 142 (4.0) 2.35 (1.81 to 3.09) 1.50 (1.09 to 2.08) 
BMI 
Normal 3418 (97.8) 78 (2.2) - - 
Overweight 2777 (97.4) 73 (2.6) 1.17 (0.82 to 1.65) 1.10 (0.78 to 1.56) 
Obese 1821 (97.1) 54 (2.9) 1.38 (0.93 to 1.98) 1.23 (0.84 to 1.78) 
Underweight 206 (97.6) 5 (2.4) 1.14 (0.42 to 2.75) 1.28 (0.43 to 3.07) 
Missing 502 (93.1) 37 (6.9) 2.87 (1.87 to 4.32) 2.59 (1.68 to 3.98) 
ASA Grade 
Grade 1-2 6333 (97.6) 156 (2.4) - - 
Grade 3-5 2391 (96.3) 91 (3.7) 1.75 (1.33 to 2.32) 1.04 (0.75 to 1.44) 
Specialty 
Colorectal 2174 (96.5) 80 (3.5) - - 
Breast 2057 (98.9) 22 (1.1) 0.28 (0.16 to 0.47) 1.13 (0.50 to 2.38) 
Gynaecological 1059 (97.9) 23 (2.1) 0.49 (0.29 to 0.78) 0.78 (0.44 to 1.36) 
Head or neck 1101 (97.8) 25 (2.2) 0.69 (0.43 to 1.12) 1.42 (0.74 to 2.65) 
Hepatopancreatobilary 636 (95.2) 32 (4.8) 1.71 (1.09 to 2.60) 1.63 (1.04 to 2.58) 
Intracranial 148 (96.7) 5 (3.3) 0.92 (0.31 to 2.24) 1.84 (0.57 to 5.14) 
Thoracic 515 (96.1) 21 (3.9) 0.94 (0.57 to 1.53) 1.03 (0.59 to 1.71) 
Oesophagogastric 365 (95.8) 16 (4.2) 1.46 (0.80 to 2.53) 1.61 (0.89 to 2.82) 
Sarcoma 250 (96.9) 8 (3.1) 0.82 (0.34 to 1.72) 1.33 (0.53 to 3.02) 
Urological 419 (96.5) 15 (3.5) 0.93 (0.51 to 1.63) 1.05 (0.57 to 1.87) 
ECOG Performance  
Score 
0 5575 (97.9) 120 (2.1) - - 
1-2 3003 (96.1) 123 (3.9) 1.90 (1.46 to 2.48) 1.27 (0.94 to 1.72) 
3-4 146 (97.3) 4 (2.7) 0.70 (0.18 to 2.08) 0.33 (0.08 to 1.05) 
Current smoker 
No 7768 (97.3) 218 (2.7) - - 
Yes 956 (97.1) 29 (2.9) 1.03 (0.68 to 1.53) 1.01 (0.65 to 1.52) 
Pre-existing 
respiratory condition 
No 7792 (97.4) 209 (2.6) - - 
Yes 932 (96.1) 38 (3.9) 1.43 (1.01 to 2.06) 1.17 (0.79 to 1.71) 
RCRI 
0 2785 (98.7) 36 (1.3) - - 
1 4402 (97.0) 134 (3.0) 2.27 (1.57 to 3.33) 2.06 (1.11 to 3.84) 
2 1248 (95.5) 59 (4.5) 3.81 (2.48 to 5.93) 2.83 (1.39 to 5.55) 
≥3 289 (94.1) 18 (5.9) 4.75 (2.58 to 8.66) 3.00 (1.27 to 6.76) 
Operation grade 
Minor 2021 (98.5) 30 (1.5) - - 
Major 6703 (96.9) 217 (3.1) 2.19 (1.51 to 3.30) 1.55 (0.97 to 2.49) 
Disease stage 
Early stage 6230 (97.5) 158 (2.5) - - 
Advanced stage 2494 (96.6) 89 (3.4) 1.50 (1.15 to 1.97) 1.34 (0.99 to 1.78) 
Preoperative testing 
Not tested 6326 (97.0) 198 (3.0) - - 
Tested 2398 (98.0) 49 (2.0) 0.56 (0.39 to 0.79) 0.63 (0.43 to 0.91) 
Hospital type 
No defined pathway 6317 (96.9) 205 (3.1) - - 
COVID-19 free surgical pathway 2407 (98.3) 42 (1.7) 0.46 (0.30 to 0.69) 0.44 (0.28 to 0.68) 
Community SARS-
Cov-2 risk 
Low 7657 (97.7) 182 (2.3) - - 
Moderate or high 1067 (94.3) 65 (5.7) 2.51 (1.66 to 3.86) 3.28 (2.13 to 5.04) 
 
Data included from 8971 patients with complete data. COVID-19=Coronavirus disease 2019. ASA=American Society of Anaesthesiologists. RCRI= Revised Cardiac 
Risk Index. ECOG=Eastern Cooperative Oncology Group. Please see Appendix C for full definitions. Percentages calculated as a proportion of row total. R statistic 
<1.1 for all variables in the model. Area under the Receiver Operating Characteristic curve for model: 0.79 (good discrimination). 
 
  
 Supplementary table 10. Outcomes after elective surgery in COVID-19 free surgical pathways and 
hospitals with no defined pathway. 
 
Factor Levels 
COVID-19 free 
surgical 
pathway 
(N=2481) 
No defined 
pathway 
(N=6689) 
Univariable model  
(Odds ratio, 95% 
credible interval) 
SARS-CoV-2 infection 
No 2428 (97.9) 6451 (96.4) 
0.51 (0.36 to 0.72)  
Yes 53 (2.1) 238 (3.6) 
Pulmonary respiratory 
complications 
No 2426 (97.8) 6360 (95.1) 
 
0.48 (0.35 to 0.64) 
 
Yes 55 (2.2) 329 (4.9) 
Pneumonia 46 (1.9) 288 (4.3) 
ARDS 10 (0.4) 56 (0.8) 
Non-invasive ventilation 5 (0.2) 10 (0.1) 
Invasive ventilation 6 (0.2) 29 (0.4) 
Patient status 
Alive 2448 (99.3) 6533 (98.3) 
 
0.45 (0.25 to 0.78) 
 
Alive - remains admitted in hospital 28 (1.1) 137 (2.1) 
Alive - transferred to another hospital 26 (1.1) 29 (0.4) 
Alive - discharged to a rehabilitation centre 13 (0.5) 76 (1.1) 
Alive - discharged home 2381 (96.6) 6291 (94.6) 
Died 18 (0.7) 116 (1.7) 
Died - on-table 2 (0.1) 2 (0.0) 
Died - on days 0-7 after surgery 3 (0.1) 18 (0.3) 
Died - on days 8-30 after surgery 13 (0.5) 96 (1.4) 
(Missing) 15 40 
Critical care 
No 1925 (78.8) 5010 (76.1) 
 
0.94 (0.82 to 1.08) 
 
Yes 517 (21.2) 1570 (23.9) 
Planned from theatre 480 (19.7) 1456 (22.1) 
Unplanned from theatre 17 (0.7) 54 (0.8) 
Unplanned from ward 20 (0.8) 60 (0.9) 
(Missing) 39 109 
Length of stay Median [IQR] 4.0 [6.0] 4.0 [6.0]  
 
COVID-19=Coronavirus disease 2019. SD=standard deviation. Critical care defined as admission to a Level 2 (High Dependency Unit) or Level 3 (Intensive Care) 
bed. Percentages calculated as a proportion of column total. Estimates calculated using univariable Bayesian mixed effects logistic regression. 
 
 
 
 
 
  
 Supplementary table 11. Clinical impact of postoperative pulmonary complications after elective surgery 
during the COVID-19 pandemic. 
 
Factor Levels 
No pulmonary 
Complications 
(n=8786) 
Pulmonary 
Complication 
(N=385) 
Univariable model  
(Odds ratio, 95% 
credible interval) 
Patient status 
Alive (all) 8663 (99.2) 318 (82.8) 
25.64 (17.63 to 36.67) 
Alive - remains admitted in hospital 113 (1.3) 52 (13.5) 
Alive - transferred to another hospital 45 (0.5) 10 (2.6) 
Alive - discharged to a rehabilitation centre 67 (0.8) 22 (5.7) 
Alive - discharged home 8438 (96.6) 234 (60.9) 
Died (all) 68 (0.8) 66 (17.2) 
Died - on-table 4 (0.0) 0 (0)  
Died - on days 0-7 after surgery 12 (0.1) 9 (2.3) 
Died - on days 8-30 after surgery 52 (0.6) 57 (14.8) 
(Missing) 55 1 
SARS CoV-2 
No 8625 (98.2) 255 (66.2) 
29.78 (22.44 to 39.55) 
Yes 161 (1.8) 130 (33.8) 
Critical care 
No 6789 (78.6) 146 (38.1) 
6.48  (5.17 to 8.06) 
Yes 1850 (21.4) 237 (61.9) 
Planned from theatre 1751 (20.3) 185 (48.3) 
Unplanned from theatre 50 (0.6) 21 (5.5) 
Unplanned from ward 49 (0.6) 31 (8.1) 
(Missing) 147 2 
Length of stay Median [IQR] 4.0 [6.0] 14.0 [16.0] 
 
COVID-19=Coronavirus disease 2019. SD=standard deviation. Critical care defined as admission to a Level 2 (High Dependency Unit) or Level 3 (Intensive 
Care) bed. Percentages calculated as a proportion of column total. Estimates calculated using univariable Bayesian mixed effects logistic regression 
 
 
 
 
 
 
 
 
 
 
 
 
  
 Supplementary Figure 1. Trace plots for the fixed effects parameters in the primary model 
 
 
A common check for the Markov Chain Monte Carlo sampler convergence is the trace plot. The plots above show the behaviour of the simulations (i.e., the chains) used to approximate the posterior 
distribution, where the x-axis represents the number of iterations and the y-axis the value of the parameter. To ensure the reliability of a finite set of samples, we routinely run several chains, i.e. we start the 
procedure at different random initial starting points and check whether the different chains have converged to stable values. In the figure above, the chains appear to be indistinguishable except for random 
noise and have converged to stable values. If the chains had not converged, the trajectories of the chains would be in different directions. 
 Supplementary Figure 2. Posterior predictive checks for the primary model of factors 
associated with postoperative pulmonary complications (summarised in Figure 2, and 
Supplementary Table 3) 
 
 
 
Lines labelled ‘yrep’ refer to the posterior predictive values generated by the model, and the black solid line are the observed data. 
 Supplementary table 12. Posterior summary statistics for primary model of factors associated with postoperative pulmonary complications 
(summarised in Figure 2, and Supplementary Table 3). 
Factor Level n_eff Rhat mean mcse Quantile estimate 
 2.50% 25% 50% 75% 97.50% 
Age 50-59 years 2,185 1.001 0.4 0.006 -0.17 0.17 0.36 0.55 0.90 
Age 60-69 years 2,181 1.001 0.6 0.006 0.13 0.43 0.60 0.79 1.12 
Age 70-79 years 2,148 1.001 0.7 0.006 0.26 0.55 0.73 0.91 1.24 
Age ≥80 years 2,256 1.000 0.7 0.006 0.13 0.48 0.67 0.88 1.26 
Sex Male 3,000 1.000 0.6 0.002 0.35 0.50 0.59 0.67 0.84 
BMI Overweight 3,000 1.000 0.0 0.002 -0.25 -0.07 0.02 0.11 0.28 
BMI Obese 3,000 0.999 0.0 0.003 -0.26 -0.06 0.05 0.16 0.34 
BMI Underweight 3,000 1.000 0.1 0.007 -0.68 -0.19 0.07 0.30 0.71 
BMI Missing 3,000 0.999 0.6 0.004 0.16 0.44 0.58 0.72 0.96 
ASA Grade 3-5 3,000 1.000 0.4 0.002 0.10 0.27 0.35 0.44 0.60 
ECOG Performance Score 1-2 3,000 0.999 0.5 0.002 0.24 0.39 0.48 0.56 0.72 
ECOG Performance Score 3-4 3,000 1.000 0.7 0.006 0.03 0.50 0.73 0.94 1.33 
Current smoker Yes 3,000 1.000 0.4 0.003 0.04 0.25 0.35 0.46 0.65 
Pre-existing respiratory 
condition Yes 
3,000 1.000 0.3 0.003 0.00 0.19 0.29 0.39 0.56 
RCRI 1 1,922 1.000 0.5 0.007 -0.05 0.34 0.54 0.73 1.12 
RCRI 2 1,976 1.000 0.5 0.007 -0.09 0.32 0.53 0.74 1.14 
RCRI ≥3 2,053 1.000 1.1 0.008 0.39 0.82 1.06 1.29 1.75 
Operation grade Major 3,000 0.999 0.8 0.005 0.30 0.60 0.77 0.95 1.28 
Disease stage Advanced 3,000 1.000 0.4 0.002 0.14 0.28 0.36 0.43 0.58 
Preoperative testing Yes 3,000 1.000 -0.1 0.002 -0.36 -0.18 -0.10 -0.02 0.15 
Hospital type COVID-19 free surgical pathway 
3,000 1.000 -0.5 0.003 -0.83 -0.61 -0.49 -0.38 -0.16 
Specialty Breast 3,000 1.000 -1.2 0.008 -2.14 -1.52 -1.21 -0.92 -0.39 
Specialty Gynaecological 3,000 1.000 -0.5 0.005 -1.03 -0.66 -0.48 -0.29 0.04 
Specialty Head or neck 2,265 1.000 0.3 0.006 -0.26 0.10 0.29 0.47 0.83 
Specialty Hepatopancreatobilary 3,000 0.999 0.3 0.003 -0.03 0.20 0.33 0.45 0.69 
Specialty Intracranial 3,000 1.000 -1.2 0.016 -3.06 -1.73 -1.12 -0.59 0.26 
Specialty Thoracic 3,000 0.999 0.1 0.004 -0.28 0.00 0.14 0.26 0.51 
Specialty Oesophagogastric 3,000 1.000 1.2 0.003 0.83 1.05 1.17 1.28 1.50 
Specialty Sarcoma 3,000 1.000 -0.1 0.007 -0.94 -0.36 -0.07 0.19 0.64 
Specialty Urological 3,000 1.000 -0.2 0.005 -0.71 -0.36 -0.17 0.00 0.32 
SARS-Cov-2 risk area Moderate or high 3,000 1.000 0.4 0.004 0.01 0.24 0.38 0.52 0.76 
 
COVID-19=Coronavirus disease 2019. ASA=American Society of Anaesthesiologists. RCRI= Revised Cardiac Risk Index. ECOG=Eastern Cooperative Oncology Group. Please see Appendix C for full definitions. 
n_eff = effective sample size, Rhat = R statistic, mean = point estimate, mcse = standard error of the mean.
 Appendix A: Collaborators (PubMed-citable) 
Full list to be confirmed with final submission. 
  
 Appendix B. Processes to maximise case ascertainment and data completeness 
Participating hospitals screened patients in order to ensure that all consecutive eligible 
patients were captured. Patients were identified from multidisciplinary team/tumour board 
meetings, operating theatre lists, ward handover lists, critical care records and other 
routinely collected health records. 
Low case ascertainment might introduce bias, for example if patients who did not develop 
COVID-19 were missed. Site training, including written materials, webinars, infographics, 
specialty-specific social media training groups, and regular videoconferencing was used to 
support proactive data collection and eligible patient identification. No minimal case volume 
was imposed to include a broad sample of both high and low volume hospitals. There was 
an absolute requirement for all consecutive patients to be included.  
Patients were followed up to 30 days from the day of surgery using electronic health records, 
ward handover lists, critical care records, emergency department readmission records, and 
outpatient telephone and/or in-person clinic appointments where this was performed as part 
of routine postoperative follow-up pathways. 
Data were collected online and stored on a secure data server running the Research 
Electronic Data Capture (REDCap) web application[15]. All data were pseudonymized at 
source by each collaborating institution holding a secure, encrypted record of linked 
REDCap unique identification numbers and local medical record numbers. Site-specific data 
completeness summaries were distributed to site Principal Investigators at regular intervals 
to promote data completion and proactive identification of postoperative events. 
 Appendix C. Protocol definitions 
Suspected cancer 
Patients who were operated for suspected cancer but whose histology subsequently 
demonstrated pre-invasive lesions (e.g. high-grade dysplasia, carcinoma in situ) were 
included, but those with benign histology were excluded.  
Elective surgery 
Elective surgery was defined as an operation booked in advance of a planned admission to 
hospital. 
Disease stage 
To account for different tumour grading and staging systems across solid cancer types, 
disease status was classified as early stage (organ confined, non-nodal, non-metastatic, fully 
resectable) or advanced stage (growth beyond organ, nodal, metastatic with curative intent, 
debulking with life prolonging intent). 
American Society of Anesthesiologists physical status classification (ASA)[38]  
A validated system used to assess and communicate a patient’s pre-anaesthesia medical 
co-morbidities. The classification system alone does not predict the perioperative risks but 
can be used with other factors (grade of surgery, ECOG performance status) to stratify risks 
of postoperative complications. The following grades were defined in the study protocol: 
Grade 1: Healthy person; Grade 2: Mild systemic disease; Grade 3: Severe systemic 
disease; Grade 4: Severe systemic disease that is a constant threat to life; Grade 5: A 
moribund person who is not expected to survive without the operation. 
Revised Cardiac Risk Index (RCRI)[39, 40]  
 The RCRI represents a multifactorial approach to assessing the cardiac risk of non-cardiac 
surgery. It was calculated as a composite of procedural risk (intraperitoneal/intrathoracic 
versus other), history of ischemic heart disease, myocardial infarction, congestive heart 
failure, cerebrovascular disease, diabetes mellitus, and/or chronic kidney disease. This gave 
an attributable risk score from 0 (lowest risk) to 6 (highest risk). 
Tumour type(s) Early stage Advanced stage 
Colorectal 
Oesophagogastric 
Head and neck 
Thoracic 
Urological 
Breast  
Sarcoma 
All of the following according to TNM 
classification[34]: 
 
T1 or T2 or T3 
N0 
M0 
Any of the following according to TNM classification: 
 
T4 
N1 or N2 or N3 
M1 
Hepatopancreatobiliary 
All of the following according to National 
Comprehensive Cancer Network 
classification[35, 36]:  
 
Resectable 
Non-metastatic 
Any of the following according to National 
Comprehensive Cancer Network classification: 
 
Borderline resectable or locally advanced 
Metastatic 
Gynaecological 
Any of the following according to 
International Federation of Gynecology and 
Obstetrics (FIGO) staging system[37]: 
 
Stage 0: Carcinoma in situ  
Stage I: Confined to organ of origin  
Any of the following according to International 
Federation of Gynecology and Obstetrics (FIGO) 
staging system: 
 
Stage II: Invasion of surrounding organs/tissue  
Stage III: Spread to distant nodes  
Stage IV: Distant metastasis 
Intracranial tumours 
Histopathological classification: 
 
Low grade glioma 
Meningioma 
Vestibular schwannoma 
Pituitary adenoma 
Histopathological classification: 
 
High grade glioma 
Primary CNS lymphoma 
Cerebral metastasis 
 
Eastern Cooperative Oncology Group (ECOG) Risk Score[41]  
The ECOG Scale of Performance Status describes a patient’s level of functioning in terms of 
their ability to care for themself, daily activity, and physical ability (walking, working, etc). The 
performance status ranges from 0 (fully active without restriction) to 5 (dead), is freely 
available and widely validated. 
 GRADE ECOG PERFORMANCE STATUS 
0 Fully active, able to carry on all pre-disease performance without restriction 
1 Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light housework, office work 
2 Ambulatory and capable of all selfcare but unable to carry out any work activities; up and about more than 50% of waking hours 
3 Capable of only limited selfcare; confined to bed or chair more than 50% of waking hours 
4 Completely disabled; cannot carry on any selfcare; totally confined to bed or chair 
5 Dead 
Postoperative pulmonary complications 
The primary outcome measure was postoperative pulmonary complications defined as 
pneumonia, acute respiratory distress syndrome or unexpected ventilation within 30-days of 
surgery with the day of surgery as Day 0. This outcome was adapted from the Prevention of 
Respiratory Insufficiency after Surgical Management (PRISM) randomised controlled trial [19] 
and has previously been used to report postoperative pulmonary complications in SARS-CoV-
2 infected patients [20]. 
Postoperative pneumonia 
As recommended by international consensus on outcome measures for perioperative care, 
the US Centers for Disease Control (CDC) definition of pneumonia was used within 30 days 
after surgery, modified to accommodate limited availability of radiological facilities: 
• Fever (>38°C) with no other recognised cause 
• Leucopaenia (white cell count <4x109 L-1) or leucocytosis (white cell count >12x109 
L-1) 
• For adults >70 years old, altered mental status with no other recognised cause;  
AND at least two of the following: 
 • New onset of purulent sputum or change in character of sputum, or increased 
respiratory secretions, or increased suctioning requirements 
• New onset or worsening cough, or dyspnoea, or tachypnoea 
• Rales, crackles or bronchial breath sounds 
• Worsening gas exchange (hypoxaemia, increased oxygen requirement).  
Wherever possible, the diagnosis was confirmed with a chest radiograph. The following 
findings were considered to confirm pneumonia:  
• New or progressive and persistent infiltrates 
• Consolidation 
• Cavitation 
Unexpected post-operative ventilation 
Unexpected postoperative ventilation was defined as either an episode of non-invasive 
ventilation, invasive ventilation, or extracorporeal membrane oxygenation after initial 
extubation following surgery, or unexpected failure to extubate following surgery. 
Appendix D. Statistical analysis 
Bayesian mixed-effect models 
Models only included factors that occurred before the outcome of interest. For all models, 
non-informative priors were used with sensitivity analyses done on alternative priors and 
different chain initiation points or chain lengths. Model convergence was assessed using the 
R statistic. The ratio of between-chain variability and the within-chain variability should be 
approximately 1 when sampling from the posterior, so an R statistic of approximately 1 for 
each parameter is an indication that the model has converged. In addition, visual check of 
the trace plots for the fixed effects parameters gives an indication of the model convergence. 
Model fit was assessed by how well it matched the observed data using the posterior 
 predictive checks. If the predicted and observed data have similar distributions, it can be 
concluded that the model has a reasonable fit. For data with greater than 5% missingness, 
we pre-planned to add a separate category level for ‘missing’ data within the mixed-effects 
model to avoid loss of data. Model coefficients are presented as adjusted odds ratio (aOR) 
and 95% credible intervals (C.I).  
Propensity score matched analyses 
Propensity score matching (PSM) was used for sensitivity analysis. PSM involved building a 
binary logistic regression model to derive predictors of 30-day postoperative pulmonary 
complications by using a 3-step approach. Propensity scores were developed by including 
age, sex, ASA grade, operation grade, preoperative testing for SARS-CoV-2, ECOG 
performance score and community SARS-CoV-2 risk in a binary logistic regression model.  
This logistic regression model was then combined with the PSMATCH2 command in Stata 
(Version 16.0; Statacorp, College Station, TX) to calculate propensity scores representing 
the estimated probability of 30-day postoperative pulmonary complications on each 
participant's characteristics. Participants in COVID-19 free surgical pathways were matched 
to participants with no defined pathway with the closest propensity score on a ratio of 1:1 
using a nearest-neighbour algorithm with no replacement, and matching was restricted to 
within the common support region.  
To ensure that the matching was effective, we checked the balance of covariates between 
the patients in COVID-19 free surgical pathways and with no defined pathway after the 
matching process.  
Appendix E. Missing data summary 
The overall missing data rate was 2.6% across all key risk variables included in the mixed-
effects models, excluding Body Mass Index; this was not recorded in 6.9% (647/9409) of 
 patients, and so was entered as entered as a separate factor level in the mixed effects 
models in accordance with our statistical analysis plan. In the primary mixed effects models 
were no significant differences in the proportions of data missing from patients in COVID-19 
free surgical pathway (2.7%) and with no defined pathway (2.5%) surgical units. One patient 
only was missing their operation location and 0.6% (61/9409) were missing postoperative 
mortality outcome data. No patients were missing data on postoperative SARS-CoV-2 
status, postoperative pulmonary complications or community SARS-CoV-2 risk. 
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 Item 
No Recommendation 
Page No 
Title and abstract 1 (a) Indicate the study’s design with a commonly used term in the 
title or the abstract 
1 
(b) Provide in the abstract an informative and balanced summary 
of what was done and what was found 
5 
Introduction 
Background/rationale 2 Explain the scientific background and rationale for the 
investigation being reported 
7 
Objectives 3 State specific objectives, including any prespecified hypotheses 7 
Methods 
Study design 4 Present key elements of study design early in the paper 8 
Setting 5 Describe the setting, locations, and relevant dates, including 
periods of recruitment, exposure, follow-up, and data collection 
8-9 
Participants 6 (a) Give the eligibility criteria, and the sources and methods of 
selection of participants. Describe methods of follow-up 
8-9 
(b) For matched studies, give matching criteria and number of 
exposed and unexposed 
 
Variables 7 Clearly define all outcomes, exposures, predictors, potential 
confounders, and effect modifiers. Give diagnostic criteria, if 
applicable 
9-10 
Data sources/ 
measurement 
8*  For each variable of interest, give sources of data and details of 
methods of assessment (measurement). Describe comparability 
of assessment methods if there is more than one group 
9 
Bias 9 Describe any efforts to address potential sources of bias 11, 
Appendix 
B, 
Appendix 
C 
Study size 10 Explain how the study size was arrived at N/A 
Quantitative variables 11 Explain how quantitative variables were handled in the analyses. 
If applicable, describe which groupings were chosen and why 
11 
Statistical methods 12 (a) Describe all statistical methods, including those used to 
control for confounding 
 
(b) Describe any methods used to examine subgroups and 
interactions 
11 
(c) Explain how missing data were addressed  
(d) If applicable, explain how loss to follow-up was addressed  
(e) Describe any sensitivity analyses  
Results  
Participants 13* (a) Report numbers of individuals at each stage of study—eg 
numbers potentially eligible, examined for eligibility, confirmed 
eligible, included in the study, completing follow-up, and 
analysed 
12-14 
 (b) Give reasons for non-participation at each stage  
(c) Consider use of a flow diagram N/A 
Descriptive data 14* (a) Give characteristics of study participants (eg demographic, 
clinical, social) and information on exposures and potential 
confounders 
12 
 
(b) Indicate number of participants with missing data for each 
variable of interest 
12-14 
(c) Summarise follow-up time (eg, average and total amount) N/A 
Outcome data 15* Report numbers of outcome events or summary measures over 
time 
13-14 
 
 
*Give information separately for exposed and unexposed groups. 
 
Note: An Explanation and Elaboration article discusses each checklist item and gives 
methodological background and published examples of transparent reporting. The STROBE 
checklist is best used in conjunction with this article (freely available on the Web sites of 
PLoS Medicine at http://www.plosmedicine.org/, Annals of Internal Medicine at 
http://www.annals.org/, and Epidemiology at http://www.epidem.com/). Information on the 
STROBE Initiative is available at http://www.strobe-statement.org. 
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adjusted estimates and their precision (eg, 95% confidence 
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Tables 
1,2,3 
(c) If relevant, consider translating estimates of relative risk into 
absolute risk for a meaningful time period 
 
Other analyses 17 Report other analyses done—eg analyses of subgroups and 
interactions, and sensitivity analyses 
N/A 
Discussion 
Key results 18 Summarise key results with reference to study objectives 15 
Limitations 19 Discuss limitations of the study, taking into account sources of 
potential bias or imprecision. Discuss both direction and 
magnitude of any potential bias 
18 
Interpretation 20 Give a cautious overall interpretation of results considering 
objectives, limitations, multiplicity of analyses, results from 
similar studies, and other relevant evidence 
16-18 
Generalisability 21 Discuss the generalisability (external validity) of the study results 18 
Other information 
Funding 22 Give the source of funding and the role of the funders for the 
present study and, if applicable, for the original study on which 
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